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Abstract 
The Gram-negative, spiral, microaerophilic bacterium, Campylobacter jejuni, has established 
itself as the leading cause of food- and water-borne human gastroenteritis world-wide, and this 
gastroenteritis is sometimes followed by unprecedented complications, ranging from localized 
peritonitis, pericarditis and encephalopathy to generalised neuropathy and bacteraemia. 
Although much progress has been made in the past three decades in regards to its virulence 
determinants, our understanding of the molecular basis of C. jejuni pathogenesis still lags behind 
that of other enteric pathogens. 
Bacterial pathogenesis is often dependent on the panoply of proteinaceous virulence factors 
which are either transported to the bacterial cell surface or released into the external 
environment. Understanding the molecular basis of interactions between these proteins and host 
cells is necessary in understanding and controlling infections. 
Background: Previously identified adhesins of C. jejuni NCTC11168 have still not provided us 
with a total understanding of the pathogenesis of campylobacteriosis. It is hypothesized that as 
yet unidentified C. jejuni surface proteins interact with host proteins in a number of ways which 
contribute to colonisation and pathogenesis, through processes such as adhesion, toxigenicity, 
and iron acquisition. This study, thus, sought to screen the whole genome of C. jejuni NCTC11168 
to identify additional genes that may code for other adhesins to some key components of host 
extracellular molecules and other host-secreted proteins such as lactoferrin, using phage display 
technology and in silico sequence analysis.  
Phage display has been widely used in peptide-ligand interaction studies, including whole 
microbial genome libraries in identification of microbial adhesins that are vital for colonization. 
By searching the genome of C. jejuni for homologues of virulence factors previously described in 
other pathogens, it is possible to predict the role of such genes in C. jejuni. 
Auto-transported proteins or autotransporters have become a rapidly growing family of proteins 
among Gram-negative bacteria due to their diverse passenger domains and different functions. 
These proteins have been known to function as adhesins, proteases, mucinases, and toxins or to 
mediate serum resistance. 
Methods: A phage display library was constructed by the insertion of randomly fragmented 
chromosomal DNA of C. jejuni NCTC11168 into the phagemid vector pG8SAET. Following three 
rounds of affinity panning of the library against holo- and apo-lactoferrin, enriched clones were 
further screened with ELISA to identify affinity-binding clones. Several phage clones were 
randomly selected and their C. jejuni DNA inserts sequenced and analysed with bio-informatic 
tools. 
In order to identify novel autotransporter proteins of C. jejuni, the amino acid sequences of 
previously described adhesion-associated and other well-characterized autotransporters were 
employed in BLAST searches of the predicted coding sequences of C. jejuni NCTC11168 genome 
database. 
Results: The screening of the phage display library resulted in the identification of a unique C. 
jejuni NCTC11168 gene, Cj0609c, which encodes an uncharacterized ca. 45-kDa putative 
periplasmic protein, predicted to be a periplasmic member of the SGNH-family of hydrolases, a 
diverse family of lipases and esterases. 
Using the amino acid sequences of known autotransporters to search the genome of C. jejuni 
NCTC11168, Cj0628 was identified as coding for a ca.116-kDa protein that bears all of the typical 
characteristics of autotransporters and was designated CapA. CapA was demonstrated to be 
surface-exposed, mutants of which had a significantly lowered ability to associate with or invade 
Caco-2 cells and failed to colonize chicken guts, indicating that CapA plays a role in host 
association and colonization by Campylobacter.  
Conclusion: Cj0609c possesses signal peptide sequences and although periplasmic, may be 
involved in binding of C. jejuni to lactoferrin for iron acquisition in vivo, and/or play further role 
in adhesion, colonization and internalisation of C. jejuni into host cells. We therefore designate 
Cj0609c as lactoferrin-interacting molecule of Campylobacter jejuni (LimC).  
CapA also possesses signal peptide sequences and is surface exposed, playing a role in adhesion. 
In view of its demonstrated role, CapA is proposed to stand for Campylobacter adhesion protein 
A. Further characterization of these identified proteins, CapA and LimC, should therefore 
contribute to our understanding of the pathogenesis of C. jejuni. 
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CHAPTER ONE 
1.0 General Introduction 
1.1 Campylobacter jejuni 
Campylobacter jejuni subspecies jejuni, hereby referred to as Campylobacter 
jejuni in this thesis, is a member of the delta-epsilon group of Proteobacteria, a 
phylum which contains 1534 species or 32.3% of all known bacteria (Ludwig & 
Klenk, 2001). It is a slim (1.5-6.0 ȝP E\ -0.5 ȝP PLFURDHURSKLOLF
caprophilic (requiring 3-15% O2 and 3-5% CO2 concentrations), Gram-negative, 
spiral, moderately thermophilic bacterium (growing best at 42°C) with a polar 
flagellum at one or both ends (Bolton & Coates, 1983; Ketley, 1997; Smibert, 
1978). Despite emerging as the leading cause of acute diarrhoea in humans with 
several debilitating sequelae such as Guillain-Barré syndrome and its milder 
variant, Miller-Fisher syndrome and several other unprecedented complications, 
the pathogenesis of its diseases continues to elude the scientific community 
(Samuel et al., 2004; Young et al., 2007; Zilbauer et al., 2008). Poultry and 
livestock remain a major risk in the transmission of Campylobacter in most 
developed countries (Yamazaki et al., 2009). 
 
Figure 1. 1 | Electron micrograph of Campylobacter jejuni cells. Photograph shows the typical 
spiral morphology of healthy C. jejuni bacteria. Older cells progressively degenerate to coccoid 
(spherical) bodies via unusual curled, and even donut-shaped forms, with some becoming 
aflagellate and thus non-motile, straight and even fusiform in some cases [Courtesy: Professor D 
E Taylor, University of Alberta, Canada]. 
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1.2 The Genus Campylobacter 
The Genus Campylobacter comprises of a large group of closely related Gram-
negative, non-sporing, mostly microaerophilic bacteria that are known to 
colonize the gastrointestinal tracts of humans and a wide range of animal hosts. 
The majority of Campylobacter species may be commensals, but 
Campylobacter jejuni and Campylobacter coli are known human 
enteropathogens responsible for acute enteritis worldwide (Acke et al., 2009; 
French et al., 2009; Ketley, 1997; Young et al., 2009). 
First cultured from samples from aborting ewes as far back as 1906 by 
McFadyean in the United Kingdom (Figure 1.2), the first species of this genus 
was described in detail in 1913 and thought to belong to the genus Vibrio 
(Butzler, 2004; McFadyean & Stockman, 1913; Skirrow, 2006). It was formally 
assigned to the genus Vibrio in 1919, with the species name fetus following 
similar work by Smith and Taylor (Smith, 1919; Smith & Taylor, 1919) and 
belonged here until 1963 when the name Campylobacter was proposed due to 
fundamental differences between these and the well-known species of Vibrio, 
Vibrio cholerae, such as GC content and growth requirements (Sebald & Veron, 
1963; Veron, 1966). 
 
Figure 1. 2 | 0F)DG\HDQ¶VSKRWRJUDSKVRIWKH³Vibrio´VSHFLHV. John McFadyean and Stewart 
Stockman observed these organisms in smears of uterine exudate from an infected ewe (A), and 
a FXOWXUHRIWKH³Vibrio´VSHFLHVin agar (B), which had been inoculated and mixed while liquid 
and then solidified. The characteristic subsurface band of growth, where there is reduced oxygen 
tension, resembles that of Brucella abortus [Courtesy: Professor M B Skirrow, Microbiologist 
Public Health Laboratory, Gloucestershire Royal Hospital, Gloucester, UK]. 
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,W LV SXUSRUWHG WKDW 7KHRGRU (VFKHULFK¶V REVHUYDWLRQ RI spiral bacteria in the 
faeces of infants with diarrhoea DQGWKHFRORQVRIFKLOGUHQZKRGLHGRI³FKolera 
LQIDQWXP´ LQ  FRXOG KDYH EHHQ Campylobacter, but he regarded them as 
non-culturable and strangely did not consider them to be of great clinical 
significance (Butzler, 2004; Kist, 1985a; Siegel et al., 1990). Kist argued that 
the organisms observed by Theodor Escherich was Campylobacter because of 
the typical morphology of the organism and its association with enteritis in 
neonates, infants and kittens, the failure to grow on solid medium despite 
microscopic detection and the fact that to date no other bacteria with 
comparable morphology had been associated with human enteric infections 
(Kist, 1986)+RZHYHU(VFKHULFK¶Vdrawing of these spiral bacteria (Figure 1.3) 
leaves little doubt that they were campylobacters, just as he did not consider 
these to have any relation to the aetiology of intestinal diseases (Kist, 1985b). 
 
Figure 1. 3 | (VFKHULFK¶VGUDZLQJRI Vibrio-like organisms. Theodor Escherich observed that 
the colons of children who died of cholera infantum had Vibrio-like organisms which were 
unculturable. Strangely, he did not consider these organisms to be of great clinical significance 
[Courtesy: Professor M B Skirrow, MicrobiologistPublic Health Laboratory, Gloucestershire 
Royal Hospital, Gloucester, UK]. 
By 1973, several Gram-negative bacteria, from microaerophilic to aerophilic, 
and fermentative to oxidase-positive, had been added to the genus including the 
species originally described under the names Vibrio jejuni (Jones et al., 1931), 
V. coli (Doyle, 1944), V. fetus venerealis (Stegenga & Terpstra, 1949), V. fetus 
intestinalis (Florent, 1959), V. sputorum (Prevot, 1940; Tunnicliff, 1914), and V. 
bubulus (Florent, 1953) whilst some scientists also proposed that the genus be 
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redefined to include and exclude some bacteria (Loesche et al., 1965; Veron & 
Chatelain, 1973). The description of isolation methods by Butzler and co-
workers in 1972 and its simplification by Skirrow in 1977 sparked enormous 
interest in Campylobacter and related organisms (Dekeyser et al., 1972; 
Skirrow, 1977).  
 
Figure 1. 4 | Phylogenetic tree of Campylobacteraceae family. This is given alongside its 
closest genetic neighbours based on the percentage difference between the compared 16s RNA 
gene sequences [Courtesy: Prof. Dr. Peter A. R. Vandamme, Universiteit Gent, Belgium]. 
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The following decade saw several phylogenetic studies that sought to clarify this 
ill-defined genus, and by 1992 16S/23S rRNA sequence analyses and DNA-
DNA hybridization experiments had revealed the presence of four independent 
branches within this group of organisms (Lau et al., 1987; Paster & Dewhirst, 
1988; Schumacher et al., 1992; Vandamme et al., 1991). The name 
Campylobacter was maintained for the C. fetus lineage, whereas Helicobacter 
was proposed to accommodate C. pylori, C. mustelae, C. cinaedae, and C. 
fennelliae. Arcobacter was suggested for C. nitrofigilis, C. cryaerophilus, and 
C. butzleri whilst the fourth branch was referred to as Sulfuospirillum. 
The genus Campylobacter now contains 16 species and 6 subspecies namely; C. 
coli, C. concisus, C. curvus, C. fetus (C. fetus subsp. fetus and C. fetus subsp. 
venerealis), C. gracilis, C. helveticus, C. hyointestinalis (C. hyointestinalis 
subsp. hyointestinalis and C. hyointestinalis subsp. lawsonii), C. jejuni (C. jejuni 
subsp. jejuni and C. jejuni subsp. doylei), C. lari, C. lanienae, C. mucosalis, C. 
rectus, C. showae, C. sputorum, C. upsaliensis, and an unusual species which is 
not yet properly characterized, Candidatus C. hominis [Campynet: 
http://campynet.vetinst.dk/]. 
1.3 Genetics and Bio-Informatics of Campylobacter jejuni 
Belonging to the 16S rRNA superfamily VI of the delta-epsilon (į-İ) 
Proteobacteria, Campylobacter species are known to have small, AT-rich 
genomes of between 1.6 and 1.7 Mbp, with a  low GC content of around 30% 
(Newnham et al., 1996; Taylor et al., 1992). The genome of the Campylobacter 
jejuni type strain NCTC11168, which was the first C. jejuni strain to be 
sequenced, is a circular chromosome of 1,641,481 base pairs (bp) encoding 
1,643 proteins (previously thought to be 1,654) and is known to have 29 
homopolymeric G tracts i.e. tracts of   FRQVHFXWLYH * UHVLGXHV, in genes 
encoding products required for the biosynthesis or modification of surface 
structures such as the capsule, lipooligosaccharides (LOS) and flagellum, or in 
closely linked genes of unknown function (Gundogdu et al., 2007; Parkhill et 
al., 2000).  
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Likewise, the genomes of the other sequenced C. jejuni strains, RM1221, 81-
176, and NCTC11828 also present with small sizes of 1,777,831; 1,594,651 and 
1,628,115 respectively,  and contain 25, 19, and 17 homopolymeric tracts 
respectively (Fouts et al., 2005; Hofreuter et al., 2006; Parker et al., 2006; 
Pearson et al., 2007). These homopolymeric tracts have the potential to cause 
multiple phase variation events, gene duplications and deletions, frameshift and 
point mutations, which are subsequently translated into the surface structures 
and may be responsible for the adaptation and persistence of C. jejuni in its 
hosts as well as manifestation of disease (Gilbert et al., 2002; Guerry et al., 
2002; Karlyshev et al., 2002; Karlyshev et al., 2005; Linton et al., 2000b). 
Phase variation, which is a heritable, though reversible, ³RQDQGRII´ELRORJLFDO
switch that regulates the expression of a gene or an operon, results in a 
heterogenic phenotype of a clonal bacterial population, in which some cells do 
express the phase-variable protein(s) whilst others do not (van der Woude & 
Baumler, 2004; Young et al., 2007). In other instances a clonal population may 
express one of multiple antigenic forms of the protein causing antigenic 
variation. This phenomenon is well noted in Campylobacter (Gilbert et al., 
2002; Guerry et al., 2002; Karlyshev et al., 2002; Karlyshev et al., 2005; Linton 
et al., 2000b). 
Of the 1,643 predicted coding sequences of C. jejuni, at least 20 appear to be 
pseudogenes, with 94.3% of the genome coding for proteins. Despite its small 
genome size functional information is known for only 77.8% of C. jejuni 
sequences, whereas 13.5% have similarity with genes of unknown function, 
with 8.7% having no database match or any functional information (Gundogdu 
et al., 2007; Parkhill et al., 2000). The small genome size has been cited as the 
likely explanation for the requirement of complex growth media, and the 
inability of C. jejuni to ferment carbohydrate or degrade complex substances 
(Griffiths & Park, 1990). 
Due to its natural competence, C. jejuni is able to take up DNA in the 
environment, allowing genetic exchange and recombination between strains to 
generate the extensive genetic diversity associated with the organism (de Boer et 
al., 2002; Wilson et al., 2003). This horizontal transfer of genetic material has 
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been shown to occur both in vivo and in vitro, indicating the importance of 
natural transformation in the spread of adaptive factors such as antibiotic 
resistance among strains (Avrain et al., 2004). Although it is believed that DNA 
transfer is more likely to occur between different strains of C. jejuni than 
between different species, Sheppard et al. has recently reported patterns of 
genetic exchange that show that C. jejuni and C. coli are converging as a 
consequence of recent changes in gene flow (Sheppard et al., 2008; Wilson et 
al., 2003). Although the mechanisms are yet to be fully elucidated, it is believed 
that natural transformation in C. jejuni requires some components of type II 
secretion system, some components of a plasmid encoded type IV secretion 
system, a putative DNA-processing enzyme, a homologue of H. pylori DprA, as 
well as genes involved in N-linked glycosylation and LOS biosynthesis (Bacon 
et al., 2000; Fry et al., 2000; Larsen et al., 2004; Takata et al., 2005). Recently 
Jeon et al. reported the likely involvement of yet two additional genes in C. 
jejuni natural transformation, Cj1211 and Cj0011c, defined as probable integral 
membrane protein and possible non-specific DNA binding protein respectively 
(Jeon & Zhang, 2007; Jeon et al., 2008). 
It has often been reported that genes from Campylobacter species are difficult to 
clone and subsequently analyze, an observation which is believed to be due to 
several possible factors, including the high AT content, which results in 
promoter-like sequences, the lack of required accessory factors in Escherichia 
coli or both, as well as different patterns of methylation or codon usage and the 
frequent changes in the hypervariable G tracts present in the genomes (Pearson 
et al., 2007; Taylor et al., 1992). Strain NCTC11828 is, however, thought to be 
fairly stable due to the presence of fewer hypervariable G tracts (Pearson et al., 
2007). 
1.4 Epidemiology of Campylobacter jejuni 
The Gram-negative bacterium, Campylobacter jejuni, is a major cause of 
zoonotic bacterial gastroenteritis in the world, the leading cause of bacterial 
gastroenteritis in most developed countries and has therefore become an 
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important public health problem worldwide (Samuel et al., 2004; Young et al., 
2007; Zilbauer et al., 2008). 
A population based cohort study undertaken in England in 1999 to identify the 
causative microorganisms in infectious diarrhoea reported Campylobacter 
species as the commonly isolated organism among 12.2% of 2893 cases 
(Tompkins et al., 1999). Likewise, Campylobacter species was the most 
frequently reported pathogen in a similar study in Scotland (Noone et al., 2000). 
In the United Kingdom as a whole, epidemiologic and microbiologic data 
indicate that C. jejuni accounts for 93% of the cases of campylobacteriosis, with 
C. coli constituting 7%, C. lari <1%, and C. fetus <1%. Epidemiologic data 
from the Caribbean also indicate that C. jejuni constitutes 63.6% of isolates 
from stools whereas C. coli constituted 31.8% (Gillespie et al., 2002; Workman 
et al., 2006). 
The risk factors for Campylobacter enteritis, as identified by case-control 
studies and outbreak reports, are numerous and varied but contaminated food is 
a common source of human infection, with consumption or handling of poultry 
considered as the single most important route of infection, at least in developed 
countries (Gormley et al., 2008; Nichols, 2005; Stern et al., 2001). Generally, it 
is believed that most veterinary sources are reservoirs of pathogenic 
campylobacters since populations of veterinary and human isolates overlap 
(Danis et al., 2009; Manning et al., 2003). Based on circumstantial evidence 
such as the low infective dose and the ubiquitous nature of the organism, the 
isolation of Campylobacter from flies has led to the hypothesis that the latter 
could be major carriers of small quantities of materials infected with the 
organism onto foods (Ekdahl et al., 2005; Szalanski et al., 2004; Wright, 1983). 
However, the consumption of inadequately cooked poultry, both at home and in 
restaurants, barbecued meats, untreated water, unpasteurized milk, contact with 
pets, particularly puppies, and occupational and recreational exposure to farm 
animals remain the major known  risk factors (Danis et al., 2009; Nichols, 2005; 
Rushton et al., 2009; Stern et al., 2001; Verhoeff-Bakkenes et al., 2008). Travel 
abroad and swimming have been associated with some incidences of 
campylobacteriosis (Allos, 2001; Studahl & Andersson, 2000). Nevertheless, a 
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large proportion of sporadic cases remain unexplained by these commonly 
recognized risk factors (de Mattos et al., 2002). 
Cases of campylobacteriosis are higher in the warmer months in most developed 
countries, and between April and July in developing tropical countries 
indicating the propensity for infection in warmer months (Asrat et al., 1999; 
Banmali et al., 2006). It is more common in young children and young adults 
and affects more men than women (Banmali et al., 2006; Unicomb et al., 2008). 
Within England and Wales over 45,000 laboratory-confirmed 
campylobacteriosis cases are reported annually, whereas an estimated 500,000 
community cases are reported in England alone per annum (Tam et al., 2006a). 
An estimated 2 million people were infected with Campylobacter species in the 
United States each year during the period 1996-1999 (Samuel et al., 2004). 
 
 
Figure 1. 5 | The Ecological cycle of Campylobacter jejuni. Wild birds, livestock and chicken 
constitute the major reservoirs of C. jejuni. It colonizes the gastrointestinal mucosa of chicken in 
high numbers, from where it is passed between chicks within a flock through the faecal±oral 
route or enters the water supply. C. jejuni infect humans directly through drinking of 
contaminated water or the consumption of contaminated animal products, such as unpasteurized 
milk or meat, particularly poultry. In humans, C. jejuni invades the intestinal epithelial layer, 
resulting in inflammatory diarrhoea [Adopted with permission from Young et al., 2007; Nat Rev 
Microbiol 5, 665-679). 
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Although the incidence of campylobacteriosis has declined in both the UK and 
the USA in recent years, it still remains a major cause of bacterial diarrhoea 
affecting around 1% of their populations which underscores the need to better 
understand the pathogenesis of the disease (Konkel et al., 2005; Samuel et al., 
2004). Likewise, the incidence of campylobacteriosis in the European Union has 
declined in the last five years, an observation which although encouraging still 
warrants that attention is given to this organism and its pathogenesis (Janssen et 
al., 2008). 
In 2007 New Zealand reportedly had one of the highest incidences of human 
campylobacteriosis of 396 cases per 100,000 persons, whereas the United States 
reported one of the lowest cases of 12.7 cases per 100,000 persons (Ailes et al., 
2008; Baker et al., 2007). This clearly shows that the global incidences of 
Campylobacter cases differ from country to country. But with little or no data 
from several countries especially developing ones, this might also be a 
reflection of differences in reporting in different countries (Janssen et al., 2008; 
WHO, 2001). 
 
Figure 1. 6 | Number of Campylobacter cases in the European Union until 2003. Data after 
2003 are not shown because several new European Union (EU) member states with a high 
reported incidence of campylobacteriosis joined the European Union (Table 1) [Adopted from 
Janssen et al., 2008; Clin Microbiol Rev 21, 505-518]. 
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This same epidemiological picture is depicted by the number of human 
campylobacteriosis cases reported per 100,000 persons within the European 
Union which also differs widely among the countries averaging 51.6 as shown 
in Table 1 (EFSA, 2006). 
Country No. of confirmed cases No. of cases/100,000 
Austria  5,065  61.7 
Belgium  6,879  65.8 
Czech Republic  30,268   302.7 
Denmark  3,677  68 
Estonia  124  9.2 
Finland  4,002   76.4 
France  2,049  3.3 
Germany  62,114  75.3 
Hungary  8,288  82.1 
Ireland  1,794  43.7 
Lithuania  694  20.3 
Luxembourg  194  42.6 
Malta  91  22.6 
The Netherlands  3,761  46.2 
Poland  47  0.1 
Slovakia  2,204  40.9 
Spain  5,513  2.8 
Sweden  5,969  66.2 
United Kingdom  52,686  88.5 
Total  195,419   51.6 
Table 1. 1 | Country-specific campylobacteriosis cases in the European Union in 2005 
[Modified from Janssen, et al. 2008; Clin Microbiol Rev 21, 505-518]. 
1.5 Isolation, culture and storage of Campylobacter 
There are two main methods for the isolation of Campylobacter species. The 
first involves selective filtration of specimen through membrane filters with 
pore sizes of 0.45 µm, 0.65 µm and 0.8 µm as initially described by Dekeyser 
and Butzler (Butzler et al., 1973; Dekeyser et al., 1972). This is based on the 
principle that Campylobacter cells are very small and highly motile, and thus 
are capable of penetrating these membranes. The filtrate is then inoculated onto 
selective media and incubated in microaerophilic atmosphere containing both 
elevated CO2 and H2 concentrations and at a temperature of around 42-43°C. 
The second method involves plating of specimen directly unto a selective 
medium as initially described by Skirrow (Skirrow, 1977) 6NLUURZ¶V PHGLXP 
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contained 10 µg/ml of vancomycin, 2.5 IU/ml of polymyxin B and 5 µg/ml of 
trimethoprim. The inoculated plates are then incubated at 43°C in an atmosphere 
of 5% oxygen, 10% carbon dioxide, and 85% hydrogen (Skirrow, 1977). 
Following this breakthrough by Skirrow, several selective media have been 
described containing different supplements at different concentrations, but none 
of these supports the growth of all the Campylobacter species (Aspinall et al., 
1993; Butzler et al., 1983; Goossens et al., 1986; Goossens et al., 1989; 
Griffiths & Park, 1990; Griffiths, 1993). 
It must, however, be stated here that there is no gold standard for the isolation of 
campylobacters, but the predominant species of human infections, C. coli and C. 
jejuni, can be readily cultured on selective media under microaerophilic 
conditions without the addition of H2 (Butzler et al., 1983). It has been 
suggested that all 18 serogroups of C. coli and C. jejuni, could even be cultured 
on solid media in an atmosphere of 10% CO2 in moist air at a relative humidity 
of 99%, thus minimizing the cost of isolation of the organism (Fraser et al., 
1992). Similarly, it has been shown that buffered peptone water (BPW) 
supplemented with blood and antibiotics could be used in the isolation of both 
C. jejuni and C. coli (Oyarzabal et al., 2006). Campylobacter can best be grown 
and propagated in/on Mueller-Hinton broth/agar and for laboratory storage 
purposes high cell concentrations could be mixed with 10% glycerol or dimethyl 
sulfoxide (DMSO) and stored at -80°C (Davis & DiRita, 2008). 
Whereas Campylobacter grows best at 42-43°C, Helicobacter thrives best at 
37°C both under microaerophilic conditions, but Arcobacter is highly aero-
tolerant and thermo-intolerant differentiating the three related genera from each 
other (Davis & DiRita, 2008; Hamill et al., 2008; Jalava et al., 1998; Sainsus et 
al., 2008; Skirrow, 1977). Although of limited value in routine diagnostics, 
analysis of respiratory quinones has been used in differentiation of 
Campylobacter strains from Helicobacter and Arcobacter until the recent 
development of new methods such as polymerase chain reaction (PCR), 
sequencing and PCR-restriction fragment length polymorphisms (Gonzalez et 
al., 2006; Hill et al., 2006; Neubauer & Hess, 2006; Quinones et al., 2007; 
Samie et al., 2007). 
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1.6 Identification of Campylobacter species 
The importance of identifying a strain up to species and subspecies levels 
cannot be underestimated due to the enormous diversity within campylobacters. 
This importance ranges from estimation of the prevalence and significance of 
different species to source tracing and clinical management (Babiker et al., 
2001). 
Two main forms of identification are available; phenotypic tests such as 
biochemical tests, fatty acid or protein profiling and genotypic tests such as 
DNA fingerprints, sequencing, pulsed-field gel electrophoresis (PFGE), 
polymerase chain reaction (PCR) and microarray-based methods (Keramas et 
al., 2004; Wassenaar & Newell, 2000). 
Following isolation and culture under the conditions described above, 
Campylobacter species produce non-haemolyitc spreading, droplet-like colonies 
on blood agar whilst producing grey, moist, flat-spreading colonies on improved 
blood-free agar, with some strains having a green hue or a dry appearance with 
or without a metallic sheen (Cheesbrough, 2006). Under light microscopy, a wet 
mount of Campylobacter species would exhibit the typical darting and 
corkscrew motility whilst a Gram-stain would show the typical spiral 
morphology (Butzler et al., 1973; Butzler & Skirrow, 1979). Campylobacter is 
oxidase and catalase positive and hydrolyzes hippurate to benzoate (Harvey, 
1980; Krausse & Ullmann, 1985). 
1.6.1 Typing Methods 
Since the advent of the development of novel culture techniques for their 
isolation, several phenotypic and genotypic methods have been developed to 
identify Campylobacter to the species level. 
i. Serotyping 
The widely used phenotypic method is serotyping. Several agglutination 
techniques have been described, involving haemagglutination, slide 
agglutination, and latex agglutination using antisera generated against various 
Campylobacter strains and species and which could be used to test unknown 
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strains (Hodinka & Gilligan, 1988; Lior et al., 1981; Miller et al., 2008; 
Nachamkin & Barbagallo, 1990; Penner & Hennessy, 1980). These are all 
based on two main serological schemes developed in the 1980s in Canada; the 
Penner scheme, developed by John Penner of the University of Toronto, is 
based on a passive haemagglutination serological technique using soluble 
antigen extracts of  Campylobacter isolates to raise specific antisera that 
detect the heat-stable (HS) or somatic O antigens of C. jejuni and C. coli; and 
the Lior VFKHPHGHYHORSHGE\+HUP\ /LRU DW&DQDGD¶VQDWLRQDO /DERUDWRU\
for Enteric Pathogens in Ontario, is based on a slide agglutination serology, 
which uses live bacteria together with absorbed and unabsorbed antisera to 
detect heat-labile (HL) or flagellar antigens of Campylobacter strains (Lior et 
al., 1981; Penner & Hennessy, 1980). 
The HS or O antigen was originally thought to be the C. jejuni 
lipooligosaccharide or lipopolysaccharide, but was subsequently shown to be 
the previously unrecognised capsular polysaccharide antigen by Karlyshev 
and co-workers (Karlyshev et al., 2000; Preston & Penner, 1987). Although 
flagella was suggested to be the major antigenic determinant of some Lior HL 
serotypes including LIO5, LIO6, LIO7 and LIO17,  it has also been shown 
that non-flagella antigen may be the serodeterminant for this scheme (Alm et 
al., 1991; Wenman et al., 1985; Yoshida et al., 1987). 
The Penner scheme, which comprises 65 serotypes, including 48 serotypes of 
C. jejuni and 17 serotypes of C. coli, was modified in the UK to comprise of 
118 serotypes for use in the Laboratory of Enteropathogens (LEP) of the 
Public Health Laboratory Service (Frost et al., 1998). In this modification, 
specific antisera are used to detect antigens by direct bacterial agglutination of 
heated suspensions in microtiter plates. 
A comparative analysis of the serotyping results of 9,024 sporadic human 
isolates of C. jejuni using the Penner and Lior schemes revealed conserved 
associations between specific HS (O) and HL antigens (O/HL serovars), 
making the case for the combined use of O and HL serogrouping as a practical 
and phylogenetically valid method for investigating the epidemiology of 
sporadic C. jejuni infection (Jackson et al., 1998). 
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Using C. jejuni polyclonal antibodies, Hochel et al. developed an indirect 
competitive ELISA for detection of somatic antigen O:23 of C. jejuni in foods 
with high sensitivity (Hochel et al., 2004). 
ii. Cellular Fatty Acid Profiling 
The identification of bacteria could also be achieved through the profiling of 
their cellular fatty acid (CFA) and whole-cell protein using mass spectrometry 
(MS) (On, 2005). Using matrix-assisted laser desorption ionization time-of-
flight (MALDI-TOF) MS or Pyrolysis MS (Py-MS), specific moieties from 
intact bacteria or pyrolysed Campylobacter cells could be separated by their 
mass to charge ratio and the results presented in a dendrogramatic form 
alongside that of known taxa (On, 2005). Identification is made on the basis of 
cluster analysis. 
iii. Phage Typing 
The lytic activity of some Campylobacter phage has long been shown to differ 
in different species of the organism (Bryner et al., 1970; Bryner et al., 1973). 
This selective lysis by bacteriophage derived from C. jejuni, C. coli and other 
Campylobacter species has been employed in the identification of unknown 
strains in what is referred to as phage typing (Grajewski et al., 1985). Several 
Campylobacter phage types have been identified that can be used in further 
characterization of various strains, notably C. jejuni and C. coli (Frost et al., 
1999; Khakhria & Lior, 1992; Salama et al., 1990). Phage typing of 
Campylobacter strains, alongside serotyping, lends a further level of 
discrimination that enhances the epidemiological typing of Campylobacter 
species (Frost et al., 1999). 
iv. Pulsed Field Gel Electrophoresis 
With the advancement of molecular biology techniques, pulsed field gel 
electrophoresis (PFGE) became a gold standard in epidemiological studies of 
pathogenic organisms, proving superior to the conventional agarose gel 
electrophoresis in separating larger DNA fragments, and providing invaluable 
information for molecular genotyping of Campylobacter (Fitzgerald et al., 
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2001; Karenlampi et al., 2007; Klein et al., 2007; Ribot et al., 2001). This 
involves the cleavage of chromosomal DNA using selected restriction 
enzymes, such as SmaI, SalI, ApaI, KpnI, XhoI and BssHII, that cut DNA 
infrequently, and the resultant fragments which are generally very large, 
separated by agarose gel electrophoresis under special conditions (Wassenaar 
& Newell, 2000). This produces genotypic profiles that could be interpreted to 
identify the species of an unknown strain. 
Scientists have also made use of the high variability of the flanking regions of 
rRNA gene loci coding for 5S, 16S and 23S rRNA, as well as the strong 
conservation of portions of some non-rRNA genes in the identification of 
Campylobacter species (Wassenaar & Newell, 2000). Following restriction 
digestion of genomic DNA with one or two of the enzymes PstI, HaeIII, 
HindIII or PvuII and agarose gel electrophoresis, southern blot hybridization 
is done with probes specific for rRNA genes to produce ribotype profiles akin 
to PFGE in high level species identification (Denes et al., 1997). 
v. Polymerase Chain Reaction 
Of equally significant value in the species identification of Campylobacter is 
the use of polymerase chain reaction (PCR) in amplification of conserved 
portions of specific genes which are unique to a particular species (Burnett et 
al., 2002). In this regard, several genes, including flaA, mapA, ceuE, pflA, 
gyrA, flgE and hipO as well as some variable regions of the 16S rRNA/rDNA 
have been identified as being unique to particular species and have been 
utilised in that manner (Harmon et al., 1997; Klena et al., 2004; Oyarzabal et 
al., 1997; Waegel & Nachamkin, 1996). Using randomly designed 10-mer 
primers, several polymorphic genes could be amplified in a single assay 
known as the multiplex PCR in the species identification of strains (Burnett et 
al., 2002; Klena et al., 2004; Wesley et al., 1997). 
Furthermore, fluorescently labelled PCR oligonucleotide probes designed to 
match the highly variable DNA segment within the flaA short variable region 
(SVR) of Campylobacter jejuni or C. coli could be used to identify a 
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Campylobacter strain to the species level in a LightCycler-based assay in what 
is referred to as real-time PCR (Jensen et al., 2005; Ridley et al., 2008). 
The presence of several unique genes of Campylobacter species could be 
detected in an ordered arrangement on a microarray glass slide. This involves 
the PCR amplification of specific regions in the target genes, such as fur, glyA, 
cdtABC, ceuB-C, and fliY, followed by microarray-based analysis of these 
amplified DNAs (Volokhov et al., 2003). 
vi. Restriction Fragment Length Polymorphism 
An extension to the PCR methods of typing is the use of rare-cutting 
restriction enzymes in the digestion of resultant amplicons, called restriction 
fragment length polymorphism (RFLP) or PCR-RFLP (Takahashi et al., 
2006). Nachamkin et al. described the observation of 18 RFLP patterns 
following digestion of the amplified flaA gene with the restriction enzyme 
Ddel, whilst Zorman et al. observed 12 RFLP patterns when same gene was 
digested with CfoI (Nachamkin et al., 1993; Zorman et al., 2006). Other 
restriction endonucleases that have been successfully used to type 
Campylobacter strains are MboI, MseI, and AluI (Fujimoto et al., 1997). 
vii. Amplified Fragment Length Polymorphism 
A variation of the RFLP which has become important in speciation of 
campylobacters is the amplified fragment length polymorphism (AFLP) which 
involves restriction digestion of the genomic DNA of a strain, followed by 
ligation of adaptors to the sticky ends of the restriction fragments (Wassenaar 
& Newell, 2000). A subset of the restriction fragments are then amplified 
using radioactively or fluorescently labelled primers complementary to the 
adaptor and part of the restriction site fragments (Fang et al., 2006; Koene et 
al., 2008). Using the SVR of flaA and 16S rRNA it has now become possible 
to detect and enumerate specific Campylobacter strains in mixed populations 
using a novel molecule-based method, that uses strain- and genus-specific 
oligonucleotide probes (Elvers et al., 2008). 
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viii. Multi-Locus Sequence Typing 
Despite the extensive variability of the SVR of the flaA gene and the 
invaluable information it provides in species identification following PCR and 
restriction digestion, direct nucleotide sequencing of PCR amplicons of 
specific portions of this and some other genes of Campylobacter strains have 
proven to be superior to RFLP or AFLP giving birth to the current state-of-
the-art multi-locus sequence typing (MLST) technique (Kinana et al., 2007; 
Levesque et al., 2008; Price et al., 2006). This involves profiling a 
Campylobacter strain based on the DNA sequences of short sequences at a 
number of loci within selected housekeeping genes (Al Amri et al., 2007; 
Dingle et al., 2001). 
ix. Biosensor 
Moving even further in the typing of Campylobacter, Ivnitski et al. described  
an ion-channel biosensor based on supported lipid bilayer membrane for direct 
and fast detection of Campylobacter species (Ivnitski et al., 2000). This 
system incorporated C. jejuni antibodies in an artificial lipid bilayer 
membrane covering the sensing element of the biosensor, which served as 
channel forming proteins in detecting Campylobacter species. Wei and co-
workers have also recently described the development of a surface plasmon 
biosensor based on antigen-antibody binding using C. jejuni polyclonal 
antibodies for the rapid identification of C. jejuni (Wei et al., 2007). 
1.7 Pathogenesis of Campylobacter jejuni Infection 
Despite being recognized as the leading cause of bacterial gastroenteritis in 
developed countries, the pathogenic mechanisms of C. jejuni are still far from 
being well-understood (Samuel et al., 2004; Young et al., 2007; Zilbauer et al., 
2008). To establish an infection sufficient to cause disease, the organism would 
have to survive the physiological stresses associated with external and internal 
environments such as temperature fluctuations, variations of pH, different hosts, 
host immunity, oxidative stress and limited nutrient supply (Snelling et al., 
2005).  
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Like all other enteropathogenic bacteria, Campylobacter species have evolved 
attributes, many of which are virulence determinants that have helped them to 
circumvent the innate host defences of humans and other mammalian and avian 
hosts (Finlay & Falkow, 1997; Guerry, 2007). 
This section looks at the general features and virulence factors that determine 
the course of a Campylobacter disease. 
1.7.1 General Features of Campylobacter Pathogenesis 
i. Adhesion and Colonization 
The role of adhesins, flagellae, cellular and extracellular matrix proteins, and a 
host of other factors as observed in other bacteria such as Salmonella, Yersinia 
species, Shigella and Escherichia coli cannot be overlooked in C. jejuni 
pathogenesis (Falkow et al., 1992; Finlay & Falkow, 1997). Adhesion to host 
cells, colonization and invasion of host cells are needed in order for several 
bacterial pathogens to successfully establish infection and induce diseases, 
whereas others may employ toxins to induce disease (Finlay & Falkow, 1997). 
In the case of C. jejuni adhesion and invasion of mammalian cells have been 
demonstrated in vitro and are considered to be important factors in its 
pathogenicity in vivo (Coutte et al., 2003; Grant et al., 1993; Ketley, 1997). 
Furthermore, motility, chemotaxis, iron acquisition, quorum sensing as well as 
host immune evasion also play various roles in C. jejuni pathogenesis (Elvers 
& Park, 2002; Ketley, 1997). 
ii. Invasion 
Following colonization of the human intestinal mucus layer C. jejuni invades 
the intestinal epithelial cells where it may modify the signal transduction 
pathways of its host, thus, aiding entry and easy passage through the epithelial 
monolayer (Konkel et al., 2005). This invasion is thought to be initiated by 
signaling events on the surface of the host cell, coupled with a unique 
caveolae-dependent entry pathway and downstream signals that trigger 
microfilament and microtubule depolymerization and subsequent membrane 
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ruffling and internalization of the bacterium (Hu et al., 2006b; Watson & 
Galan, 2008; Wooldridge & Ketley, 1997). 
This theory is buttressed by recent studies in which depolymerization or 
stabilization of microfilaments and microtubules [see Figure 1.7], as well as 
inhibition of host cell tyrosine kinases, receptor-mediated endocytosis, 
endosome acidification, and phosphatidylinositol-3-kinases, resulted in 
reduction in or inhibition of, invasion by C. jejuni (Biswas et al., 2000; 
Biswas et al., 2003; Oelschlaeger et al., 1993; Wooldridge et al., 1996).  
It has also been observed that epithelial cell membrane pseudopods, which are 
known to contain microtubules, do extend towards and envelope C. jejuni 
(Biswas et al., 2000; Hu & Kopecko, 1999; Kopecko et al., 2001).  
 
Figure 1. 7 | Illustration of the current working model of Campylobacter jejuni pathogenesis. 
(1) Initial adhesion of C. jejuni is believed to start at the apical cell surface at the peri-
junctional region. (2) Where it secretes SXWDWLYHµLQYDVLRQ¶HIIHFWRUVLQWRWKHKRVWFHOO, which 
in turn trigger phosphorylation of host proteins and the release of Ca2+ from intracellular 
stores. (3) Host signalling cascades trigger a localized disruption of cortical actin filaments 
and an extension of microtubules (MTs) to form a membrane protrusion to meet the adjacent 
bacterium. (4) Host-pathogen interaction at caveolae leads to an endocytosis of the bacterium 
via membrane invagination. (5) The engulfed C. jejuni within a membrane-bound vacuole 
moves via dynein along MTs to the basolateral surface for exocytosis (6), and then re-enter 
the epithelium basolaterally (7). (8) Infected epithelial cells secrete interleukin (IL)-8 
basolaterally, which leads to proliferation of lymphocytes from the lamina propria. (9) C. 
jejuni apparently survive in macrophages/monocytes for several days, which aids their local 
dissemination [Adopted with permission from Kopecko, et al. 2001; TRENDS in Microbiology 9, 
389-396].  
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Also, there have been reports of the involvement of caveolae, which are non-
clathryn-coated small invaginations, 50-100 nm in diameter, found in the 
plasma membrane of many vertebrate cell types, in the internalization of C. 
jejuni (Schnitzer et al., 1994; Wooldridge et al., 1996). Transport across 
caveolae is known to be inhibited by filipin III, a sterol-binding agent, and this 
phenomenon has been demonstrated in Caco-2 cells co-cultured with C. jejuni 
(Schnitzer et al., 1994; Wooldridge et al., 1996).  
Although, this model of caveolae-mediated, microtubule-dependent epithelial 
cell invasion has become well accepted, there have been other reports which 
seek to suggest that C. jejuni gut invasion via other mechanisms could also 
result in dysentery (Kopecko et al., 2001).  
For instance, there have been previous reports in which inhibition of 
endosome acidification, phosphatidylinositol-3-kinases or protein kinase-C 
did not inhibit C. jejuni invasion of epithelial cell lines, although the same 
studies reported some of the observations above (Biswas et al., 2000; 
Oelschlaeger et al., 1993). The question that arises is, should we ignore these 
contradictory reports? Another study that used the same inhibitors as above to 
inhibit the various structures and processes found no involvement of any of 
microfilaments, microtubules or clathryn-coated pits in C. jejuni invasion of 
epithelial cell lines (Russell & Blake, 1994). Recently, van Alphen and co-
workers reported a cell entry mechanism involving active and rapid migration 
of the pathogen into the epithelial sub-FHOOXODU VSDFHV WHUPHG ³subvasion´), 
followed by bacterial invasion at the cell bases (van Alphen et al., 2008). 
Although, these contradictory reports may be possibly due to the differences 
between different strains in terms of how they elicit cellular invasion they still 
leave us with no clear explanation of the mechanisms involved in the 
pathogenesis of Campylobacter infection. 
iii. Intracellular Survival 
Immediately following the unique caveolae-dependent entry or invasion, C. 
jejuni-containing vacuoles appear to roll along microtubules towards the 
perinuclear region of the epithelial cell through interactions with dynein, thus, 
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deviating from the canonical endocytic pathway, and hence avoiding delivery 
into lysosomes (Hu & Kopecko, 1999; Watson & Galan, 2008). The bacterium 
remains largely confined to membrane bound vacuoles, although some have 
been observed freely in the cytoplasm (Konkel et al., 1992a; Russell et al., 
1993). Infected epithelial cells exhibit cytoplasmic swelling, loss of microvilli 
and premature apoptosis due to the cytotoxic effect of surviving C. jejuni, and 
are finally exfoliated into intestinal lumen, disrupting the intestinal epithelium 
(Konkel et al., 1992a; Russell et al., 1993). 
iv. Trans-Epithelial Translocation 
Using polarized Caco-2 cell monolayers grown on micro-porous membrane 
filters, Konkel and co-workers showed that C. jejuni is actively translocated 
across the epithelial monolayer, a process that can be inhibited by 
chloramphenicol (Konkel et al., 1992b). Whereas some studies have shown 
that trans-epithelial translocation is aided by an overall reduction in the trans-
epithelial electrical resistance and disruption of the cellular tight junctions, 
others have shown that none of these changes do occur (Bras & Ketley, 1999; 
Chen et al., 2006; MacCallum et al., 2005b).  This translocation of C. jejuni 
across the intestinal epithelial cell barrier to the lamina propria is considered 
important in C. jejuni pathogenesis as it leads to tissue damage and 
inflammation (Wine et al., 2008; Wooldridge & Ketley, 1997). The organism 
continues to proliferate in the lamina propria, eliciting an inflammatory 
response that disrupts the normal function of the intestinal cells causing 
diarrhoea (MacCallum et al., 2005b). 
1.7.2 Virulence Factors 
It is generally accepted that most bacterial virulence factors are located on the 
cell surface or are secreted (Finlay & Falkow, 1997; Wilson et al., 2002). 
Several adhesins of C. jejuni have been identified, and although adhesion is 
known to be the first step in the invasion process, the involvement of these 
adhesins in pathogenesis has been a subject of much research (Finlay & 
Falkow, 1997; Min et al., 2009). Adhesins that have been firmly characterized 
are the 28-kDa protein Pei, Ellison and Blaser one (PEB1), encoded by the 
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peb1 gene (Leon-Kempis et al., 2006; Pei & Blaser, 1993), the 46-kDa 
Campylobacter adhesion to fibronectin (CadF) protein encoded by the cadF 
gene (Konkel et al., 1997; Konkel et al., 2005; Mamelli et al., 2006), the 46-
kDa pore-forming major outer membrane protein (MOMP), encoded by the 
porA gene (Schroder & Moser, 1997), the 42.3-kDa protein JlpA, encoded by 
the jlpA gene (Jin et al., 2001; Jin et al., 2003), and a lipoprotein 
autotransporter adhesin, CapA (described later), encoded by the capA gene 
(Ashgar et al., 2007). Two putative fibronectin-binding proteins as well as 
three other PEB adhesins have also been described (Asakura et al., 2007; 
Fouts et al., 2005; Min et al., 2009; Rangarajan et al., 2007).  
i. The Flagella 
Like all other bacterial flagella, the basic structure of the C. jejuni flagellum 
consists of at least three parts, namely a basal body, which is embedded within 
the matrix of the cell wall and which constitutes the motor of the flagellum, a 
hook, which functions as a universal joint and an outer filament which 
functions as a propeller [see Figure 1.8] (Minamino et al., 2008). The motor, 
which is capable of both clockwise and counterclockwise rotation is driven by 
proton or sodium ion motive force across the cell membrane (Minamino et al., 
2008).  
The flagellar export apparatus consists of six integral membrane proteins 
(FlhA, FlhB, FliO, FliP, FliQ and FliR or its homologues), three soluble 
components (FliH, Flil and FliJ), and cytoplasmic chaperone proteins which 
together facilitate the export of substrates in an injectisome manner akin to the 
type III secretion system (TTSS/T3SS) involved in translocation of virulence 
factors into host cells (Minamino et al., 2008). 
Equipped with a single unsheathed flagellum at one or both ends, 
Campylobacter is rendered highly motile, which aids the organism in 
overcoming intestinal peristalsis and facilitate entry into the mucous layer  
(Guerry, 2007). The C. jejuni flagellum is composed of two 59-kDa, highly 
homologous flagellins, FlaA and FlaB, and reguODWHGE\ı28 (encoded by fliA) 
WKURXJK WKH VHQVRU NLQDVH )OJ6 DQG ı54 (encoded by rpoN) through the 
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response regulator FlgR respectively, as well as a two-component regulatory 
system (Guerry et al., 1991; Hendrixson & DiRita, 2003; Nuijten et al., 1990; 
Poly et al., 2007b).  
Phase variation, which is a common feature of both C. jejuni and C. coli, is 
also observed in the expression of the flagellins through slip-strand mismatch 
repair (Caldwell et al., 1985; Hendrixson, 2006; Park et al., 2000). 
 
 
Figure 1. 8 | Schematic representation of bacterial flagellum. Flagellar components are 
synthesized in the cytoplasm and then transported to the periplasmic space, the outer 
membrane, or the extracellular space where their assembly occurs. Apart from FlgA, which is 
proposed to be a periplasmic chaperone for the P-ring assembly, and two other proteins, the 
external component proteins are translocated into the central channel and to the distal end of 
the growing flagellar structure through type III export apparatus (see later).  The C. jejuni 
flagella are not only important in motility but are also employed in the secretion of virulence 
proteins [Adopted from Minamino et al., 2008; Mol. BioSyst., 4, 1105-1115]. 
It has long been documented that motility is important in C. jejuni 
colonization and invasion of intestinal epithelial cells (Nachamkin et al., 1993; 
Wassenaar et al., 1991). However, C. jejuni flagella are not only important in 
motility but are also employed in the secretion of virulence proteins, notably, 
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CiaB, FlaC and FspA, as well as in chemotaxis, autoagglutination, 
microcolony formation and evasion of host immune responses (Guerry, 2007).  
Evasion of host immune responses is aided by the absence of Toll-like 
receptor 5 (TLR 5) recognition sites in the C. jejuni flagella, whereas the 
glycosylation of the flagellin at 19 serine or threonine residues mediate 
autoagglutination and microcolony formation (Andersen-Nissen et al., 2005; 
Guerry et al., 2006; Jeon et al., 2003; Misawa & Blaser, 2000). 
Furthermore, several non-flagellar genes such as Cj0040, Cj0062c, Cj0428 
and Cj0977c have been identified to be up-regulated in very virulent and 
actively motile strains of C. jejuni and have been confirmed to be regulated by 
WKH VDPH IODJHOOLQ VLJPD IDFWRUV ı28 DQG ı54, leading to the hypothesis that 
they may be involved in virulence (Carrillo et al., 2004; Guerry, 2007). In 
fact, the flagelOLQVLJPDIDFWRUVı28 DQGı54, play an important role in C. jejuni 
pathogenesis since they are also involved in secretion of Cia proteins 
(Fernando et al., 2007). 
ii. Lipooligosaccharide and Capsular Polysaccharide 
Like all other mucosal pathogens, C. jejuni expresses two classes of surface-
located glycolipid: lipo-oligosaccharide (LOS) and capsular polysaccharide 
(CPS) (Linton et al., 2001). C. jejuni LOSs are unique in the sense that they 
are the only known bacterial LOSs capable of mimicking human gangliosides 
structurally and capable of eliciting immune reactions, the antibodies of which 
can cross-react with host gangliosides causing Guillain-Barré syndrome and 
Miller Fisher syndrome (Ang et al., 2002; Yuki et al., 2000).  
Phase variations within one of the LOS locus genes, cgtB (also known as 
wlaN), encoding a galactosyltransferase involved in LOS biosynthesis, is 
known to cause changes in LOS ganglioside mimicry, whilst mutants of its 
homologue in C. jejuni 81-176, cgtA encoding an N- 
acetylgalactosaminyltransferase, has also been implicated in the adhesion and 
invasion of host epithelial cells and increased protection from complement-
mediated killing (Guerry et al., 2002; Kordinas et al., 2005; Linton et al., 
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2000). A recent study, however, found no association between these genes and 
adhesion or invasion (Muller et al., 2007). 
Again, the capsule is a common feature on bacterial surfaces and is important 
in bacterial survival and persistence in the environment, whilst its 
polysaccharides often contributed to pathogenesis (Roberts, 1996). CPSs are 
known to exhibit structural variation, host antigen mimicry as well as 
providing resistance to phagocytosis and complement-mediated killing. In C. 
jejuni, CPSs were previously described as high molecular weight 
³OLSRSRO\VDFFKDULGHV´ +0: /36VXQWLO WKH LQLWLDWLRQRI WKH ILUVW JHQRPH-
sequencing project, that led to the identification of kps genes involved in 
capsule biosynthesis and subsequent identification in other C. jejuni strains 
(Karlyshev et al., 1999; Karlyshev et al., 2001; Karlyshev & Wren, 2001). 
CPSs were again confirmed as the major antigens in the Penner serotyping 
scheme (Karlyshev et al., 2000). However, our understanding of the role of C. 
jejuni CPS in protecting the organism against host immune mechanisms 
remains poor. Whereas some studies of capsule-deficient mutants of 81-176 
and 81116 strains exhibited reduced adherence, invasion or virulence, both in 
vitro and in vivo, other studies found no significant differences between the 
wild type and the mutants (Bachtiar et al., 2007; Bacon et al., 2001).  
$JDLQ LQ D VWXG\ RI WKH EDFWHULFLGDO HIIHFW RI HSLWKHOLDO ȕ-defensins on C. 
jejuni, it was demonstrated that the presence or the absence of the bacterial 
polysaccharide capsule did not have any effect on the innate immune 
responses induced by C. jejuni or the survivability of the organism in 
recombinant ȕ-defensins, thus casting more doubt on the role of CPS in 
protecting C. jejuni (Zilbauer et al., 2005a). However, it must be stated that C. 
jejuni CPS may not be involved in its survival inside the host since the main 
role of the capsule is to prevent bacterial desiccation (Zilbauer et al., 2008).  
iii. Adhesins 
PEB1, also known as cell-binding factor 1 (CBF1), is a homologue of the 
amino acid ATP-binding cassette (ABC) transporters, and has been confirmed 
to bind specifically to aspartate and glutamate (Pei & Blaser, 1993; Pei et al., 
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1991). Although it is a periplasmic protein, PEB1 is believed to be surface 
exposed due to the presence of signal peptidase II recognition site, a motif 
akin to that seen in surface-localized lipoproteins, coupled with its 
identification in some culture supernatant (Leon-Kempis et al., 2006). Other 
PEB variants are PEB3 and PEB4 (Gundogdu et al., 2007; Parkhill et al., 
2000).  
CadF, which is thought to be similar to outer membrane protein A (OmpA) of 
E. coli, is believed to be required by C. jejuni for maximal adherence and 
invasion at the basolateral surface of intestinal epithelial cells (Monteville & 
Konkel, 2002; Monteville et al., 2003). JlpA is a surface-exposed lipoprotein 
and KDVEHHQGHPRQVWUDWHGWRELQGWRKHDWVKRFNSURWHLQ+VSĮOHDGLQJ
to the activation of p38 mitogen-activated protein (MAP) kinase and  nuclear 
factor-kappa B (NF-ț%(Jin et al., 2001; Jin et al., 2003).  
In contrast to other autotransporters, CapA is believed to be retained on the 
cell surface, the mutant of which was reported to have led to reduced ability 
by C. jejuni to associate with and invade Caco-2 cells in vitro (Ashgar et al., 
2007). Lastly, a periplasmic glycoprotein, encoded by Cj1496c, has been 
shown to mediate C. jejuni invasion of human epithelial cells (Kakuda & 
DiRita, 2006). Other putative adhesins include a collagen-binding surface 
protein, SpaP, an outer membrane adhesin that is believed to be involved in 
iron acquisition and a putative periplasmic adhesin which is also believed to 
function as initial receptors in ABC transport of metal ions (Fouts et al., 2005; 
Gundogdu et al., 2007). 
iv. Toxins 
The most well-characterized C. jejuni toxin is the cytolethal distending toxin 
(CDT), named after the morphological changes of cytoplasmic distension 
associated with its action (Johnson & Lior, 1988). CDT, which has three 
subunits, CdtA, -B and -C, is encoded by three adjacent genes, cdtABC, with 
the B subunit being the active component of the toxin (Young et al., 2007). 
CDT is involved in eukaryotic cell maturation arrest in the G2/M phase of the 
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cell cycle leading to epithelial cell death (Abuoun et al., 2005; Asakura et al., 
2008; Carrillo et al., 2004; Kalmokoff et al., 2006; Muller et al., 2006).  
The effect of CdtB is mainly in the nuclear compartment of the host cell and it 
has been demonstrated that it is delivered into the host cell through the 
binding of CdtA and CdtC to the host cell (Lee et al., 2003). Furthermore, 
being membrane bound protein, CDT has been demonstrated to induce 
interleukin-8 (IL-8) secretion in polarized human intestinal epithelial cells 
(Zheng et al., 2008). Several studies have confirmed the involvement of CDT 
in C. jejuni disease pathogenesis (Jain et al., 2008; Kalischuk et al., 2007). 
Recently, it has been demonstrated that CDT may have carcinogenic potential 
in vivo (Ge et al., 2008; Kalischuk et al., 2007). 
Historically, physiological and immunological relatedness has been 
demonstrated between a C. jejuni enterotoxin, the Vibrio cholerae enterotoxin, 
and the heat-labile cholera-like Escherichia coli enterotoxin. However, 
nucleotide sequence similarity between C. jejuni DNA and either the toxA, 
toxB, eltA or eltB genes remained to be shown (Calva et al., 1989; Collins et 
al., 1992; Klipstein & Engert, 1985). Recently, Albert and co-workers have 
demonstrated that this cross-reactivity with cholera toxin is embedded in the 
C. jejuni major outer membrane protein, which could be explored as a vaccine 
candidate (Albert et al., 2008). 
v. Chemotaxis 
Chemotaxis is a necessary phenomenon in all bacteria and other unicellular 
organisms in directing their movements according to certain chemicals in their 
ecology and associated processes (Frymier et al., 1993; Parkinson et al., 
2005). The acidic environment of the gastrointestinal tract (GIT), and the 
numerous chemicals secreted therein means that C. jejuni uses chemotaxis to 
move towards or away from chemicals (Takata et al., 1992). Thus, chemotaxis 
is important in the pathogenesis of C. jejuni and this has been demonstrated 
via the investigation of phenotypic changes in non-chemotactic mutants in 
vivo, one of which in a mouse model showed that chemotactic mutants failed 
CHAPTER ONE 
 
 
Harry H Abruquah | Identification of host-pathogen interacting molecules of Campylobacter jejuni  
PhD Thesis | Microbiology | March 2009 
30 
 
to colonise the intestines (de Melo & Pechere, 1990; Hendrixson & DiRita, 
2004; Takata et al., 1992). 
Most features of C. jejuni chemotaxis have been likened to chemotaxis 
systems in E. coli and Bacillus subtilis based on genome wide analysis 
(Marchant et al., 2002). Firstly, based on chemotaxis systems in E. coli and 
Bacillus subtilis twelve methyl-accepting chemotaxis proteins (MCPs) or 
chemoreceptors can be identified from the C. jejuni genome, namely, 
Cj0019c, Cj0144, Cj0246c, Cj0262c, Cj0448c, Cj0923c, Cj0924c, Cj0951c, 
Cj1110c, Cj1190c, Cj1506c and Cj1564, previously referred to as transducer-
like proteins (Tlp) (Gundogdu et al., 2007; Marchant et al., 2002). However, 
only two of these, Cj0019c (DocB) and Cj0262c, have so far been shown to 
have an effect on chicken colonization (Hendrixson & DiRita, 2004).  
Furthermore, C. jejuni motility has been shown to be dependent on two energy 
taxis or aerotaxis proteins, CetA (Tlp9/Cj1190c) and CetB akin to E. coli 
HAMP domain (named for the presence of histidine kinases, adenylyl 
cyclases, 46 methyl-accepting chemotaxis proteins and phosphatases) and 
PAS domain (named after three proteins Per, ARNT and Sim) (Gundogdu et 
al., 2007; Hendrixson et al., 2001). The PAS domain is believed to interact 
directly with the HAMP domain to transmit an energy taxis signal parallel to 
the inner membrane through detection of redox changes in the electron 
transport system or cytoplasm when the bacteria enter or leave a hypoxic 
microniche (Taylor, 2007; Watts et al., 2008). Recently, it has been 
demonstrated that whilst CetA and CetB interact to provide energy for 
motility, only CetA contributes to C. jejuni invasion of human epithelial cells 
(Elliott & Dirita, 2008; Elliott et al., 2008). 
Additionally, three genes, cheA, cheV and cheY, have also been shown to 
encode polypeptides of response regulator domain characteristics, the CheY of 
which has long been predicted to interact with the flagellar motor to influence 
the direction of rotation (Baker et al., 2006; Marchant et al., 2002; Yao et al., 
1997). Although the roles of CheA and CheV have not been fully elucidated in 
C. jejuni, they are believed to play a role in adaptation, where CheA may 
phosphorylate CheY or the presence of multiple response regulator domains 
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may serve as a ³SKRVSKDWH VLQN´ WR UHPRYH SKRVSKDWH JURXSV IURP &KH<
(Marchant et al., 2002; Young et al., 2007). 
It has long been known that C. jejuni migrate towards some components of 
mucus as well as towards amino acids in the chicken GIT (Hugdahl et al., 
1988). Recently, it has been shown that C. jejuni utilizes MUC2, the most 
abundant of the secreted mucins in the human intestine, as an environmental 
cue for the modulation of expression of genes with various functions including 
colonization and pathogenicity (Tu et al., 2008). Again, the regulation of the 
CmeABC multidrug efflux pump is believed to be mediated by the presence of 
bile salts through CmeR (Lin et al., 2005a; Lin et al., 2005c). 
vi. Iron Acquisition 
The importance of iron in C. jejuni pathogenesis cannot be overemphasised 
given that it is an essential nutrient for bacterial growth and survival playing a 
major role in the catalysis of many biochemical reactions (Andrews et al., 
2003). Bacteria, including C. jejuni, are known to access iron that is present in 
the body fluids of its mammalian host that are complexed to high affinity iron-
binding proteins (van Vliet et al., 1998). The serum iron is present in 
complexes with haemoglobin (in small amounts from lysis of erythrocytes) or 
transferrin, while iron exists as a complex with lactoferrin in secretions on 
mucosal surfaces (Payne & Finkelstein, 1978). It was previously thought that 
C. jejuni did not utilise iron from these sources, but recent developments have 
shown that C. jejuni is capable of utilizing lactoferrin-bound and transferrin-
bound iron (Miller et al., 2008; Tom-Yew et al., 2005). 
Three iron-uptake systems have been described in C. jejuni: (i) a 
haemin/haemoglobulin uptake system called chuABCD; (ii) a periplasmic 
binding-protein-dependent transport (PBT) system for the uptake of a ferric 
enterochelin (cfrA and ceuBCDE); and (iii) a ferric siderophore uptake system, 
cfhuABD (Galindo et al., 2001; Palyada et al., 2004; Richardson & Park, 
1995; Ridley et al., 2006). Two uncharacterized iron uptake systems, Cj1658-
Cj1663 and Cj0173c-Cj0178 have also been predicted (Parkhill et al., 2000). 
Though not extensively characterised, the C. jejuni genome also encodes an 
CHAPTER ONE 
 
 
Harry H Abruquah | Identification of host-pathogen interacting molecules of Campylobacter jejuni  
PhD Thesis | Microbiology | March 2009 
32 
 
iron transporter operon akin to the E. coli feoAB operon. Recently, Naikare et 
al. demonstrated that FeoB is actually involved in ferrous iron acquisition in 
C. jejuni, contributing significantly to colonization of the gastrointestinal tract 
during both commensal and infectious relationships, contradicting the 
previous assertion by Raphael and Jones that this operon played no role in iron 
acquisition (Naikare et al., 2006; Raphael & Joens, 2003).  
The response of the organism to environmental changes in iron concentrations 
is regulated by another gene, the ferric uptake regulator (fur) gene (Holmes et 
al., 2005; van Vliet et al., 1999; Wooldridge et al., 1994). Furthermore, the 
lipoprotein component of the ceuBCDE operon, encoded by ceuE, is thought 
to confer a haemolytic phenotype thus complicating our understanding of iron 
acquisition in C. jejuni (Park & Richardson, 1995).  
vii. Other virulence Genes/Proteins 
Several other Campylobacter virulence genes have been identified such as 
thermotolerance gene, dnaJ, and the structural gene for a phospholipase A, 
pldA involved in hemolysis (Grant et al., 1997; Konkel et al., 1998). Carvalho 
and co-workers reported the identification of an invasion-associated marker 
(IAM) using random amplified polymorphic DNA (RAPD) techniques, which 
was later found to be encoded by the iam gene (Carvalho et al., 2001; Konkel 
et al., 1999b). Another gene, virB11, carried by the virulence plasmid pVir, 
was reported to be involved in Campylobacter disease pathogenesis (Bacon et 
al., 2000).  
However, whilst we may think of invasion as being mediated by ciaB, pldA, 
iamA and virB11, the presence of all these putative virulence genes in a 
Campylobacter species does not guarantee successful colonization and 
invasion in vivo since some of these genes, notably virB11 gene, have been 
found to be absent in some invasive Campylobacter isolates (Talukder et al., 
2008; Zheng et al., 2006). The virB11 gene is strongly associated with 
antibiotic resistance rather than with invasion (Bang et al., 2003; Bang et al., 
2004). 
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DksA, a well known bacterial regulatory protein involved in the transcription 
of rRNA and control of expression of virulence genes in pathogenic bacteria, 
was recently reported to also play an important regulatory role in numerous 
metabolic events and the virulence of C. jejuni, with a C. jejuni DksA-like 
protein mutant exhibiting a decreased ability to invade intestinal cells or 
induce IL-8 secretion from intestinal cells (Yun et al., 2008). Again, CmeR, 
which is known to be a transcriptional repressor regulating the expression of 
the CmeABC multidrug efflux pump, is believed to also regulate the 
expression of multiple genes with diverse functions and is required for 
Campylobacter adaptation in the chicken host (Guo et al., 2008; Lin et al., 
2005a; Lin et al., 2005c). 
Furthermore, C. jejuni is known to secrete a set of eight proteins called 
Campylobacter invasive antigens (Cia) A-H, the CiaB of which has been well-
characterized as a 73.1-kDa protein and believed to be required for the 
invasion of cultured epithelial cells as well as colonization of the chicken gut 
(Konkel et al., 1999b; Ziprin et al., 2001).  
The mechanism of secretion of these Cia proteins and their role in cellular 
invasion have been likened to type III secretion systems (TTSS/T3SS) where 
the effector proteins are injected directly into host cells (Guerry, 2007; Konkel 
et al., 1999c). It is believed that the secretion of CiaB, as well as the other Cia 
proteins, is mediated by the flagellar export apparatus, emphasizing the 
importance of the flagella in C. jejuni pathogenesis (Konkel et al., 1999c; 
Konkel et al., 2004b; Song et al., 2004).  
Recently, it has been shown that two additional virulence proteins, a 26.6-kDa 
FlaC protein, and a 15.5-kDa FspA protein, are also secreted through the 
flagellar filament (Poly et al., 2007a; Song et al., 2004). 
1.7.3 Protein Glycosylation in Campylobacter 
Post-translational glyco-conjugation of protein has long been recognised as 
essential in eukaryotic cellular biology, modulating protein structure and 
function, including sorting, targeting, localization, stability, and antigenicity 
(Kelly et al., 2006). There are two forms of glycosylation: O-linked and N-
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linked, the former involving attachment of glycans to the hydroxyl groups of 
serines or threonines and the latter involving the attachment of glycans to 
amino groups of asparagines in the sequon Asn-Xaa-Ser/Thr, where Xaa is 
any amino acid except for proline (Benz & Schmidt, 2002; Messner & 
Schaffer, 2003; Szymanski et al., 2005). 
This post-translational protein modification was first identified in bacteria in 
C. jejuni flagellin by Logan and co-workers (Logan et al., 1989), with 
Szymanski demonstrating that an N-linked glycosylation is responsible for the 
synthesis of a conserved bacillosamine-containing heptasaccharide that 
modifies over thirty secreted Campylobacter proteins (Szymanski et al., 1999; 
Szymanski et al., 2003).  
Despite the predominance of N-linked glycosylation in bacteria, current data 
indicate that C. jejuni contains both N- and O-linked glycosylation systems 
[see Figure 1.9], with the latter responsible for the addition of pseudaminic 
acid and related sugars to the immunodominant C. jejuni flagellin protein, 
FlaA (Szymanski et al., 2003). 
 
 
Figure 1. 9 | A cross-sectional view of C. jejuni cell wall. The photo depicts the flagellum, 
capsule, outer membrane protein and its associated lipooligosaccharides, and the O- and N-
linked glycans [Adopted with permission from Young et al., 2007; Nat Rev Microbiol 5, 665-
679]. 
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The precise functions of these glycosylations are yet to be elucidated but there 
is evidence that loss of the conserved heptasaccharide of the N-linked 
glycosylation results in changes in antigenicity, reduction in in vitro adherence 
and invasion, loss of in vivo colonization, and loss of type IV protein complex 
assembly and DNA uptake, whereas the high variability of the O-linked 
glycosylation suggests a role in immune evasion (Kelly et al., 2006; 
Szymanski et al., 2003).  
Furthermore, Guerry and co-workers have demonstrated that alterations in the 
glycosylation of Campylobacter flagellin proteins result in reduced adherence 
and invasion (Guerry et al., 2006). 
1.7.4 Host Factors in C. jejuni infection 
Infection with C. jejuni is usually self-limiting but has varied manifestations 
depending on the KRVW DQG WKH KRVW¶V JHRJUDSKLFDO ORFDWLRQ WKXV SURPSWLQJ
the importance of host immune responses in determining disease outcome 
(Blaser et al., 1980; Zilbauer et al., 2008). Fucosylated sugars in breast milk 
have been demonstrated not only to inhibit C. jejuni binding and infection but 
also prevent diarrhoea in infants, whilst the bactericidal effect of human serum 
has long been demonstrated, underlining the importance of host innate 
responses in containment of infection with C. jejuni (Blaser et al., 1985b; 
Morrow et al., 2004; Ruiz-Palacios et al., 2003). 
Following ingestion, C. jejuni does not only have to survive the acidic 
environment of the stomach, but also has to bypass the mucus lining of the 
intestinal epithelium which are important barriers, the depletion of which leads 
to increased susceptibility to Campylobacter infection (Doorduyn et al., 2008; 
Neal et al., 1996; Tu et al., 2008). The epithelial lining plays a crucial role in 
microbial sensing to initiate appropriate innate immune responses such as the 
production of chemokines, cytokines, and antimicrobial peptides (Eckmann, 
2005; Zilbauer et al., 2005b)(SLWKHOLDOȕ-defensins, a family of host-defence 
peptides known to be modulated during C. jejuni infection and which have 
been demonstrated to be also present in the avian intestinal tract, play a very 
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crucial role in mucosal innate defence through their chemotactic and 
bactericidal activity (Byrne et al., 2007; Ganz, 2003). 
Initiation of innate immunity is known to be mediated by the interaction of 
host pattern-recognition receptors (PRRs) with conserved microbial signature 
motifs called pathogen-associated molecular patterns (PAMPs) (Akira et al., 
2006; Sanderson & Walker, 2007). The phylogenetically conserved Toll-like 
receptors (TLRs), which are expressed at the basolateral surface of the 
intestinal epithelium, constitute one of the commonest PRRs involved in 
flagella recognition and activation of host NF-ț% a family of mammalian 
proteins that regulate transcription of pro-inflammatory genes involved in 
early host immunity against infection (Gewirtz et al., 2001; Ghosh et al., 
1998; Hayashi et al., 2001). 
One of the early immunological challenges encountered by infecting C. jejuni 
is presumably the presence of these TLRs, which are present in most 
vertebrates including humans and chickens (Takeda et al., 2003; Young et al., 
2007). The stimulation of innate immune responses through TLR5 and TLR9, 
which are responsible for the recognition of primary flagellin structure and 
unmethylated CpG dinucleotides respectively, is known to be deficient in C. 
jejuni (Andersen-Nissen et al., 2005; Dalpke et al., 2006; Johanesen & 
Dwinell, 2006; Watson & Galan, 2005). However, a recent demonstration that 
mice deficient in MyD88, an important molecule downstream of TLRs, are 
more susceptible to C. jejuni infection has rekindled the belief that TLRs are 
important in the pathogenic mechanisms of campylobacters, providing host-
immune defences (Watson et al., 2007). This assertion is supported by 
previous but recent reports that NF-ț%LVUHDGLO\DFWLYDWHGLQ in vitro models 
and that NF-ț%-gene deficient mice are also highly susceptible to C. jejuni 
infection (Chen et al., 2006; Fox et al., 2004; Jin et al., 2003; Johanesen & 
Dwinell, 2006; Jones et al., 2003; Zilbauer et al., 2005b). Also, innate 
immunity has been shown to be partly mediated by other PRRs such as the 
nucleotide-binding oligomerization domain one (NOD1), and the natural 
resistance-associated macrophage protein one (Nramp1) (Watson et al., 2007; 
Zilbauer et al., 2007). 
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The interaction of C. jejuni with intestinal epithelial cells also results in the 
activation of MAP kinases, which in turn induce host responses such as the 
induction of interleukin 8 (IL-8) production by p38MAP kinases and 
extracellular regulated kinases (ERK) (MacCallum et al., 2005a; Watson & 
Galan, 2005). The interaction of C. jejuni surface protein, JlpA, with the heat 
shock protein 90 (Hsp90) of epithelial cells leads to the activation of both 
p38MAP and NF-ț%(Jin et al., 2003). In addition to TLR-mediated activation 
of NF-ț% Eacterial adhesion and invasion and the presence of CDT can 
stimulate IL-8 production (Hickey et al., 1999; Hickey et al., 2000; Zheng et 
al., 2008). 
The release of IL-8, and other pro-inflammatory cytokines such as interferon 
JDPPD ,)1Ȗ WXPRXU QHFURVLV IDFWRU DOSKD 71)Į ,/-2 and IL-ȕ LQ
response to bacterial infection is not only considered to be crucial in bacterial 
clearance but also in the development of diarrhoea, through recruitment of 
polymorphonuclear leukocytes (PMNs), especially neutrophils to the site of 
local inflammation, recruitment of activated macrophages, inhibition of the 
absorptive functions of the intestinal epithelium and disruption of its cellular 
tight junctions (Al-Banna et al., 2008; MacCallum et al., 2005b; Zilbauer et 
al., 2008). However, the degree of IL-8 induction has been shown to vary in in 
vitro models of infection and correlates well with pathological changes (Al-
Banna et al., 2008; MacCallum et al., 2006). 
The interaction of neutrophils (PMN) with infecting C. jejuni leads to 
phagocytosis of the bacterium resulting in the production of reactive oxygen 
species which, may lead to bacterial killing depending on the level of 
induction (Wooldridge & Ketley, 1997). Monocytes and macrophages have 
long been shown to internalize and kill infecting C. jejuni, with the killing 
mediated by reactive nitrogen species (Al-Banna et al., 2008; Iovine et al., 
2008; Wassenaar et al., 1997; Wooldridge & Ketley, 1997). However, some 
studies have also demonstrated that a significant proportion of C. jejuni-
infected monocytes do undergo apoptosis (Hickey et al., 2005; Siegesmund et 
al., 2004). Furthermore, C. jejuni has been shown to survive in porcine and 
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murine peritoneal macrophages for days, and this survival is attributed to the 
production of catalase by the bacterium (Day et al., 2000). 
Recently, C. jejuni has been shown to also induce specific cell-mediated 
immune responses in vitro leading to the maturation of dendritic cells and 
secretion of associated pro-inflammatory cytokines (Hu et al., 2006a; 
Johanesen & Dwinell, 2006; Rathinam et al., 2008). Johanesen et al. 
demonstrated an increased expression of CCL20, a chemo-attractant cytokine 
of dendritic cells, following exposure of T84 epithelial cell line to C. jejuni, 
which goes to buttress the involvement of cell-mediated immunity in C. jejuni 
pathogenesis (Johanesen & Dwinell, 2006). In another study, Jones et al. have 
shown that maturation of dendritic cells is bacterial LOS-dependent and that it 
leads to internalization of C. jejuni (Jones et al., 2003). Also, in an in vivo 
study by Fox and co-workers, it was demonstrated that IgG2a is produced in 
response to both the wild-type strain and a cdtB C. jejuni mutant, through Th1, 
and was responsible for clearance of the bacterium from infected mice (Fox et 
al., 2004). $OWKRXJK WKH VLJQLILFDQFH RI WKH SURWHFWLYH HIIHFW RI Ȗį 7-cells 
against Campylobacter infection is not known, it has been reported that non-
protein extracts of Campylobacter can induce in vitro expansion of these (Van 
Rhijn et al., 2003). 
Several studies have described humoral immune responses following human 
infections with C. jejuni (Blaser & Duncan, 1984; Blaser et al., 1985a; Blaser 
et al., 1986; Lane et al., 1987; Martin et al., 1989; Mizuno et al., 1985). 
Likewise, similar responses have been reported in several animal models 
including monkeys, rabbits, hamsters and mice (Humphrey et al., 1985; 
Russell et al., 1989). This immune response has been attributed to some 
components of the bacterium, such as the flagella, MOMP, LOS, CDT and 
outer membrane proteins (Omps) (Abuoun et al., 2005; Guerry et al., 2000; 
Huang et al., 2007; Mills & Bradbury, 1984; Nachamkin & Yang, 1989).  
Infection with C. jejuni has also been reported to generate a secretory 
immunoglobulin A (sIgA) in both humans and experimental rabbits (Burr et 
al., 1988). In infants, C. jejuni infections result in the generation of low levels 
of IgA, IgG and IgM, which is thought to be due to the presence of maternal 
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antibodies (Ruiz-Palacios et al., 1990; Young et al., 2007). Antibodies 
produced as a result of C. jejuni infection have long been shown to be 
protective (Black et al., 1988; Dolby & Newell, 1986; McSweegan et al., 
1987; Ruiz-Palacios et al., 1990). A pentaglobulin preparation containing C. 
jejuni specific IgM is reported to have been used to successfully treat 
hypoglobulinemic patients who were suffering from chronic 
campylobacteriosis (Borleffs et al., 1993). Children in developing countries 
and persons who consume high amounts of raw milk tend to have high levels 
of IgG which is thought to protect them against bloody diarrhoea (Blaser et 
al., 1985a; Blaser et al., 1986; Blaser et al., 1987). Following infection, the 
level of IgG is thought to persist longer than IgA or IgM levels, which affirms 
the superior protective effect of the former (Cawthraw et al., 2002; Russell et 
al., 1989). 
1.7.5 Mechanisms of Campylobacter Diarrhoea 
Whereas gastroenterologists define diarrhoea as the passage of more than 200 
g of stool per day, many patients and doctors describe diarrhoea in terms of 
increased stool frequency, with lose or watery consistency (Boon et al., 2006). 
Following passage through the human gastrointestinal tract (GIT) by 
Campylobacter, the illness that may ensue could and has been described as 
diarrhoea, which could be either watery or bloody (Janssen et al., 2008). 
Following a thorough review of available literature four mechanisms can be 
said to be responsible for the induction of diarrhoea based on clinical 
syndromes and intestinal biopsies:  
i. adherence and colonization of Campylobacter to the intestine 
(Byrne et al., 2007; Smith et al., 2008; Tu et al., 2008; Van Deun 
et al., 2008; Wine et al., 2008) 
ii. production of toxins (Ge et al., 2008; Jain et al., 2008; Kalischuk et 
al., 2007; Wassenaar, 1997; Zheng et al., 2008) 
CHAPTER ONE 
 
 
Harry H Abruquah | Identification of host-pathogen interacting molecules of Campylobacter jejuni  
PhD Thesis | Microbiology | March 2009 
40 
 
iii. invasion of intestinal epithelial cells (Kakuda & DiRita, 2006; 
Louwen et al., 2008; van Alphen et al., 2008; Watson & Galan, 
2008) and 
iv. initiation of an inflammatory response (Al-Banna et al., 2008; 
Borrmann et al., 2007; Hu et al., 2006a; Li et al., 2008; 
MacCallum et al., 2006; Zheng et al., 2008; Zilbauer et al., 2007). 
For infection to ensue, Campylobacter must first adhere to the intestinal 
epithelium, which is believed to be achieved through a number of adhesins 
including the CadF (Konkel et al., 1997; Konkel et al., 2005; Mamelli et al., 
2006), JlpA (Jin et al., 2001; Jin et al., 2003), PEB1 (Leon-Kempis et al., 
2006; Pei & Blaser, 1993), several outer membrane proteins including MOMP 
(Schroder & Moser, 1997), CPS and a host of other secreted proteins such as 
Cia proteins (Konkel et al., 1999b; Ziprin et al., 2001), CapA (Ashgar et al., 
2007), FlaC and FspA (Poly et al., 2007a; Song et al., 2004) as discussed 
previously.  
This initial adherence results in the immediate disturbance of the intestinal 
micro flora, a time-dependent decrease in trans-epithelial electrical resistance, 
a redistribution of the protein occludin, which is the major component of the 
epithelial tight junctions,  resulting in malabsorption and hence diarrhoea 
(Chen et al., 2006; MacCallum et al., 2005b). Colonization is aided by these 
proteins which also help the Campylobacter cells to adhere to each other 
through biofilm formation further disturbing the intestinal micro flora and 
initiating activation of NF-ț% 0$3 NLQDVHV and IL-8, leading to 
malabsorption and hence diarrhoea (Chen et al., 2006; Fields & Thompson, 
2008; Hanning et al., 2008; Joshua et al., 2006). 
Cytolethal distending toxin (CDT) has been extensively proven to be a major 
factor in the pathogenesis of Campylobacter enteritis, although some other 
toxins have been mentioned in the past (Jain et al., 2008; Poly & Guerry, 
2008). The production of this toxin results in apoptosis-like cell death, due to 
developmental arrest in the G2/M phase of the intestinal cell cycle (Lara-
Tejero & Galan, 2001). 
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Furthermore, it has long been known that Campylobacter cells invade 
intestinal epithelial cells (van Spreeuwel et al., 1985). This internalization of 
C. jejuni into cells is aided by Campylobacter secreted proteins on one hand 
and host-cell depolymerization of microtubule and microfilaments on the 
other (Biswas et al., 2003). Also, it is believed that the interaction between 
Campylobacter cells and intestinal caveolae results in membrane ruffling and 
subsequent phagocytosis (Wooldridge & Ketley, 1997). Although 
Campylobacter cells are thought to be confined to membrane-bound cell 
vesicles once inside the cell, some have been observed in the cytoplasmic 
space (Russell et al., 1993). 
The three processes described, namely, adherence and colonization, toxin 
production, and invasion would inadvertently elicit an immune response that 
may result in inflammatory diarrhoea (Hu & Hickey, 2005; Mamelli et al., 
2006; Smith et al., 2008; Zheng et al., 2008). The end result is mucoid 
diarrhoea that could be bloody, with leucopenia. 
1.8 Clinical Significance of Campylobacter jejuni 
Campylobacter jejuni has been known to be a causative agent of gastroenteritis 
in both humans and animals for several decades (Blaser et al., 1979; Butzler & 
Skirrow, 1979; Karmali & Fleming, 1979; King, 1957; Skirrow, 1977; White, 
1967) and is still considered a major cause of the disease in the 21st century 
(Butzler, 2004; Danis et al., 2009; French et al., 2009; Hariharan et al., 2009; 
Huang et al., 2009; Taylor et al., 2009; Wesley et al., 2009; Yoda & Uchimura, 
2006; Young et al., 2007; Zilbauer et al., 2008). 
The first well-documented case of human infection with C. jejuni is reported to 
have taken place in Illinois in 1938 which involved a milk-borne outbreak of 
diarrhoea in 355 inmates of two adjacent institutions (Levy, 1946). In 1947 
Vinzent and co-workers isolated the organism from the blood of three pregnant 
women admitted with pyrexia of unknown origin, two of whom later aborted 
(Vinzent et al., 1947). Then in 1957 Elizabeth King described a vibrio of human 
origin with similar features as the one described by Vinzent and proposed the 
QDPH³UHODWHG9LEULRV´(King, 1957)%\RQO\FDVHVRI³UHODWHGVibrio´
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infections had been reported in literature comprising of seven infants, two 
children and three adults (Butzler, 2004).  
The story is different now, and there is no doubt that C. jejuni is the commonest 
cause of bacterial enteritis in the world, with the rate of infection in some 
developed countries exceeding 400 per 100,000 persons (Baker et al., 2007). 
7KH :RUOG +HDOWK 2UJDQLVDWLRQ¶V ODVW UHSRUW RQ WKH KHDOWK LPSDFW RI
Campylobacter infections recognizes the tremendous increase in the incidence 
of human campylobacteriosis in the last two decades and estimates 
Campylobacter mortality at 30 days post-infection to be as high as 4 deaths per 
1000 infections (WHO, 2001). Guillain-Barré Syndrome (GBS), a debilitating 
autoimmune disorder of the peripheral nervous system characterized by 
symmetrical leg weakness has become a clearly recognised sequelae of  C. 
jejuni enteritis, and C. jejuni is the inducing antecedent infection in 
approximately 15% and 30% of cases of GBS in the UK and the US 
respectively (Nachamkin, 2001; Smith, 2002; Tam et al., 2003). 
C. jejuni has also been implicated in post-infectious musculoskeletal disorders 
such as reactive arthritis and Miller Fisher syndrome, which is a milder form of 
GBS (Hannu et al., 2002; Hannu et al., 2004a; Koga et al., 2005). Furthermore, 
the involvement of C. jejuni in irritable bowel syndrome as well as immuno-
proliferative small intestinal diseases has been well-documented (Lecuit et al., 
2004; Malinen et al., 2005). 
As all foodborne infections could be potentially hazardous to both the mother 
and the fetus in pregnancy, C. jejuni bacteraemia during pregnancy may also 
result in intrauterine infection of the fetus, with a resultant abortion, stillbirth, or 
early neonatal death and even death of the mother (Meyer et al., 1997; Smith, 
2002). Neonatal enteritis, bacteraemia, and/or meningitis have resulted from 
Campylobacter infection of an infant during parturition or shortly after (Fujihara 
et al., 2006; Simor et al., 1986; Smith, 2002). 
Although gastroenteritis remains the main presentation of C. jejuni infection, 
there have been reports of other presentations such as osteitis of the foot (Pedler 
& Bint, 1984), severe bacteraemia in immunocompromised persons (Manfredi 
et al., 1999), osteomyelitis (Vandenberg et al., 2003), myelitis (Aberle et al., 
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2004), uveitis (Hannu et al., 2004b), cellulitis (Monselise et al., 2004), and 
myocarditis (Braun et al., 2008; Reda & Mansell, 2005). With reports of 
aortoiliac aneurysms infected with C. fetus (Cochennec et al., 2008; Yano et al., 
2008), it makes sense to suggest that C. jejuni could pose a similar risk. 
In England and Wales, the estimated cost of treatment of a case of 
Campylobacter enteritis is £315 which is higher than the average cost of 
treatment of other infectious intestinal disease estimated at £253 (Edwards et al., 
2000). It is therefore obvious that the clinical significance of Campylobacter 
jejuni and hence the economic impact of campylobacteriosis cannot be 
overlooked. 
1.8.1 Campylobacter Enteritis 
The main route of infection in humans is the oral route. Gastroenteritis 
remains the most common end-presentation of Campylobacter infection 
(Blaser, 1997). Although birds could invariably remain asymptomatic even in 
the face of heavy infestations of up to 109 Campylobacter organisms, human 
disease could ensue with as few as 102 (Black et al., 1988; Robinson, 1981). 
The mode of infection of this organism is binding and colonization of the 
distal ileum and jejunum of the gastrointestinal tract, inducing diarrhoea 
which may be indistinguishable from diarrhoea caused by other 
enteropathogens such as Salmonella and Shigella (Nachamkin, 2002). 
Generally, a large proportion of the ingested organisms may be killed, but the 
few that may survive the transit through the GIT would then adhere to the 
intestinal epithelia causing the diarrhoea observed or lead to an asymptomatic 
carrier state (Cabrita et al., 1992). 
There are two main manifestations of the disease, based on epidemiological 
studies; bloody, mucoid diarrhoea which is usually self-limiting is the 
common presentation among young adults in the developed world, whereas in 
developing countries it manifests as non-inflammatory watery diarrhoea 
mostly in children (Blaser et al., 1980). 
 
CHAPTER ONE 
 
 
Harry H Abruquah | Identification of host-pathogen interacting molecules of Campylobacter jejuni  
PhD Thesis | Microbiology | March 2009 
44 
 
1.8.1.1 Clinical Features of Campylobacter Enteritis 
The clinical features of Campylobacter enteritis caused by C. jejuni may not 
be sufficiently different from that caused by other campylobacters or other 
bacterial pathogens such as Salmonellae to allow for easy and reliable 
diagnosis without laboratory tests (Gascon, 2006; Nachamkin, 2002).  
However, it is believed that within 24-72 hours of exposure to C. jejuni, an 
acute diarrhoeal illness could ensue, followed by a non-specific syndrome of 
fever, chills, myalgia and headache (Blaser, 1997). Individuals may have 8-
10 diarrhoeal bouts in a day and the stool may be loose, watery and/or 
bloody, with associated faecal leucocytes and erythrocytes in the majority of 
cases (Young & Mansfield, 2005). 
The disease is usually associated with nausea, but only a small proportion of 
patients actually vomit (Janssen et al., 2008; Pacanowski et al., 2008). The 
diarrhoea may subside within 3-5 days but carriage of the organism may 
persist even during convalescence for well over 30 days (Kapperud et al., 
1992). 
Although diarrhoeal diseases constitute a major risk among infants and older 
children in developing countries, C. jejuni infection is yet to be considered a 
major causative organism, since asymptomatic shedding of the organism has 
been reported in children two years and older (Megraud et al., 1990; 
Pazzaglia et al., 1991). However, where inflammatory enteritis ensues, there 
is often significant morbidity and mortality associated with 
campylobacteriosis among infants than among adults (Young & Mansfield, 
2005). 
Whereas C. jejuni may pass unnoticed in the stools of most adults in the 
developing world, in advanced countries young adults are the most common 
group with disease (Cabrita et al., 1992; Robinson et al., 2004). 
Nevertheless, asymptomatic carriage has been reported in 0.75% of adults 
studied in the United Kingdom (Wheeler et al., 1999). 
This differential expression of the disease between developed and 
developing countries could be attributed to the early acquisition of immunity 
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in childhood following hyperendemic and/or polymicrobial exposure, which 
persists into adulthood (Calva et al., 1988; Mansfield et al., 2003). 
1.8.1.2 Campylobacter Infection in Animals 
The course of infection of Campylobacter in most domesticated animals 
cannot be likened to that in humans, since in most animals colonisation can 
occur without significant pathology. Several experiments have described the 
course of infection as the same following inoculation of C. jejuni by various 
routes in pigs (Babakhani et al., 1993; Mansfield et al., 2003), rabbits 
(McSweegan et al., 1987), dogs (Prescott et al., 1981) and chickens 
(Meinersmann et al., 1991). However, natural infections with C. jejuni in 
which enteritis has ensued have also been reported in a wide range of 
domesticated animals ranging from weaning ferrets and juvenile macaques 
(Bell & Manning, 1990; Fox et al., 1986b; Russell et al., 1993) to cats and 
dogs (Fox et al., 1986a; Fox et al., 1988). However, infection is more 
common and more pronounced in puppies and kittens, as it is in infants (Fox 
et al., 1986a; Young & Mansfield, 2005). 
The clinical signs and symptoms following infection with C. jejuni are 
obvious, and are usually watery to bloody mucoid, bile-stained diarrhoea 
lasting 5-15 days, with associated fever and leucopenia (Young & 
Mansfield, 2005). 
Asymptomatic carriage of the organism in healthy domesticated animals has 
also been documented (Cave et al., 2002; Hackett & Lappin, 2003), with 
several studies reporting that over 50% of commercially raised pigs excrete 
C. jejuni suggesting early exposure (Moore et al., 2002a; Moore et al., 
2002b). In pigs therefore, it is believed that this early exposure confers some 
level of acquired immunity to C. jejuni, with diarrhoea resulting only in co-
infection with other pathogens such as Trichuris suis or bacteria (Babakhani 
et al., 1993). 
Most domesticated animals could therefore be considered as significant 
sources of C. jejuni. However, it is believed that inoculating gnotobiotic or 
colostrum-deprived piglets with C. jejuni would result in clinical signs and 
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symptoms akin to that observed in acute infections in humans (Babakhani et 
al., 1993). 
Although C. jejuni is known to also cause diarrhoea in sheep and cattle late-
pregnancy abortion has been the commonest presentation of infection 
(Delong et al., 1996; Varga et al., 1990a; Varga et al., 1990b). This is not a 
unique occurrence in sheep or cattle as C. jejuni is reported to have been 
isolated in the vaginal discharge of three German Shepherd bitches after 
late-pregnancy abortions (Odendaal et al., 1994). 
Although birds are known to have a higher carriage and infection rate than 
other animals, Campylobacter jejuni rarely causes any disease in them 
(Pearson et al., 1993; Young & Mansfield, 2005). This is true of free-living 
birds such as gulls, waterfowls and crows (Maruyama & Katsube, 1990), as 
well as domesticated poultry, especially chickens, which constitute a major 
reservoir of C. jejuni causing 50-70% of human infections (Adak et al., 
1995; Allos, 2001). That said, C. jejuni infestation of pet birds such as 
parrots and finches has a high morbidity and mortality rate resulting from 
anorexia, weight loss, lethargy, hepatitis and associated yellow diarrhoea 
(Young & Mansfield, 2005). 
1.8.2 Campylobacter Reactive Arthritis or ǯ 
5HDFWLYHDUWKULWLV5H$RIWHQWLPHVUHIHUUHGWRDV5HLWHU¶VV\QGURPHUHIHUVWR
the development within 2-4 weeks of sterile inflammatory arthritis as a sequel 
to a distant infection, most commonly gastrointestinal or genitourinary 
infections involving Campylobacter, Salmonella, Yersinia, Shigella and 
Chlamydia (Hannu et al., 2006; Hill Gaston & Lillicrap, 2003). In the strictest 
VHQVH5HLWHU¶VV\ndrome is characterized by a triad of arthritis, conjunctivitis, 
and urethritis, but in reality not all three symptoms occur in all affected 
individuals due to the post-infectious nature of the onset of the arthritis and 
the two terms are used interchangeably (Dworkin et al., 2001; Hill Gaston & 
Lillicrap, 2003). 
ReA has been classified as part of the group of spondyloarthritide (SpA) 
diseases that share common features such as an association with HLA-B27, 
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the absence of rheumatoid factor, a tendency towards family aggregation and 
the typical non-articular manifestations of urethritis, iritis, conjunctivitis, 
enthesopathy (McColl et al., 2000). This group of SpA includes ankylosing 
spondylitis (AS), sacroiliitis, oligoarthritis, psoriasis arthropathy, and 
inflammatory bowel disease-associated arthritis (Rudwaleit et al., 2001). 
1.8.2.1 Clinical Features of Campylobacter Reactive Arthritis 
Reactive arthritis typically involves inflammation of one joint 
(monoarthritis) or four or fewer joints (oligoarthritis), preferentially 
affecting those of the lower extremities; the pattern of joint involvement is 
usually asymmetric (Rudwaleit et al., 2001). Inflammation is common at 
enthuses (places where ligaments and tendons attach to bone), especially the 
knee and the ankle (Rudwaleit et al., 2001). 
1.8.2.2 Pathogenesis of Campylobacter Reactive Arthritis 
As indicated earlier, there exists an association between reactive arthritis and 
the human leukocyte antigen (HLA) B27 genotype, the major 
histocompatibility complex in humans (Hill Gaston & Lillicrap, 2003). 
These proteins displayed on the surfaces of nucleated somatic cells with 
high concentrations in white blood cells, are thought to affect the 
HOLPLQDWLRQ RI WKH LQIHFWLQJ EDFWHULD RU DQ LQGLYLGXDO¶V LPPXQH UHVSRQVH, 
thus, becoming a predisposing factor in reactive arthritis (Barth & Segal, 
1999). Although HLA-B27 is not responsible for the initial predisposition to 
the infection itself, it is believed to increase the risk of developing arthritis 
that is more likely to be severe and prolonged, a risk that is slightly greater 
for Salmonella and Yersinia-associated arthritis than with Campylobacter 
(Hill Gaston & Lillicrap, 2003). 
1.8.3 Guillain Barré Syndrome  
Guillain-Barré Syndrome (GBS) is a debilitating autoimmune disorder of the 
peripheral nervous system that is characterized by a symmetrical ascending 
paralysis (Boon et al., 2006). Evolving over a period of several days to weeks 
it has become a clearly recognised sequela of  C. jejuni enteritis, and is the 
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inducing antecedent infection in approximately 15% and 30% of cases of GBS 
in the UK and the US respectively (Nachamkin, 2001; Smith, 2002; Tam et 
al., 2003). 
1.8.3.1 Clinical Features of Guillain Barré Syndrome 
The illness initially presents as weakness in the lower limbs that may spread 
to the upper limbs and the face in an ascending order, along with complete 
loss of deep tendon reflexes (Boon et al., 2006). 
Frequently, the lower cranial nerves may be affected which results in bulbar 
weakness and its accompanying dysphagia and respiratory difficulties that 
may warrant hospitalization, with nearly 20-30% requiring ventilatory 
assistance (Nachamkin et al., 1998b). Sensory loss, which usually takes the 
form of loss of proprioception (position sense) is a common finding, 
alongside deep aching pain in the weakened muscles akin to overexercising 
(Boon et al., 2006). There may be bladder dysfunction in severe cases but 
this is usually transient. 
Although GBS is largely self-limited and the progressive weakness may be 
followed by partial or complete recovery, about 15-20% of patients may be 
left with permanent neurologic deficits (Hiraga et al., 2005; Hughes & 
Cornblath, 2005). Two forms of treatment exist, namely, the administration 
of high-dose intravenous immunoglobulins (IV-Ig) or plasmapheresis, which 
LQYROYHVWKHUHPRYDORISDWLHQW¶VEORRGIRUVHSDUDWLRQRIFHOOXODUDQGSODVPD
components and re-administration of the cellular components back into the 
patient in artificial plasminate (Nachamkin et al., 1998a). 
Based on the target of the immune response, GBS could be classified into 
three groups, namely, an acute inflammatory demyelinating polyneuropathy 
(AIDP) which is the common type, a more severe variant involving both 
motor and/or sensory fibres called acute motor axonal neuropathy/acute 
motor-sensory axonal neuropathy (AMAN/AMSAN) or a milder form that 
involves only sensory fibres called the Miller-Fisher syndrome (MFS) 
(Nachamkin et al., 1998a). The MFS manifests as a descending paralysis in 
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the reverse order of AIDP and is characterized by an acute onset of ataxia, 
areflexia and ophthalmoplagia (Davidson & Abbott, 1987). 
1.8.3.2 C. jejuni Infection and Guillain Barré Syndrome 
Although GBS had long been known to be an important sequel of many 
infections, especially viral upper respiratory infections, it was not until 1982 
that the first case of its association with Campylobacter was reported in a 
45-year old man who developed severe GBS following Campylobacter 
enteritis (Rhodes & Tattersfield, 1982). Several reports later described cases 
in which C. jejuni infection has been the preceding infection in GBS 
(Hagensee et al., 1994; Isaacson, 1998; Mishu et al., 1993; Rees et al., 1995; 
Speed & Kaldor, 1985). New cases of GBS that could be directly linked to 
an infection with C. jejuni continue to be reported (Kopyta & Wardak, 
2008). 
Several studies that have analysed antecedent infections to cases of GBS 
have concluded that C. jejuni plays a major role in the onset of disease and 
that C. jejuni-associated GBS can even be more severe and more likely to be 
of the AMSAN variant (Sinha et al., 2007; Tam et al., 2006b; Yuki & Koga, 
2006). Again, considering the time course of C. jejuni infection in relation to 
the time of onset of the neurological symptoms of GBS, it is obvious that 
immunopathogenic mechanisms were in play (Nachamkin et al., 1998a). 
Other studies have also demonstrated that patients with the Guillain-Barré 
syndrome are more likely than controls to have serologic evidence of C. 
jejuni infection in the weeks before the onset of neurologic symptoms (Ho et 
al., 1995; Mishu et al., 1993). In a case-control study by Sinha and co-
workers in which they sought to confirm the association between 
campylobacteriosis and GBS using both culture and PCR diagnostics, it was 
observed that 19% of the GBS subjects were positive for C. jejuni whereas 
none of the control subjects was (Sinha et al., 2004). In another study in 
Japan that spanned a period of 13 years involving 378 hospitals and 1,049 
sufferers of GBS, culture results of 11% were positive for C. jejuni whereas 
serotyping showed further that there is a high prevalence of HS:19 strain in 
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AIDP as opposed to the prevalence of HS:02 in MFS (Takahashi et al., 
2005) $JDLQ LQ .XZDEDUD¶V VWXG\ XVLQJ (/,6$ WR PHDVXUH C. jejuni 
antibodies he observed that 14% of 159 GBS sufferers were positive for C. 
jejuni (Kuwabara et al., 2004). Tam et al., estimated that 15% of all 157 
GBS cases reported between 1 April 2000 and 31 March 2001 in England 
were attributable to symptomatic C. jejuni infection (Tam et al., 2003). 
Again, using the General Practice Research Database, he estimated the 
incidence of GBS in a cohort of patients presenting with Campylobacter 
enteritis to be 1.17/1000 person-years, a rate 77 times greater than that in the 
general population (Tam et al., 2006b). 
1.8.3.3 Anti-ganglioside Antibodies and Guillain Barré Syndrome 
Representing nearly 10% of the total lipid content of the peripheral and the 
central nervous systems, gangliosides are a heterogeneous family of 
glycosphingolipids with one or more sialic acid(s) linked to an oligoglycosyl 
backbone attached to a ceramide base (Mocchetti, 2005). Synthesised in 
neuronal somata, they are transported to specific sites of neuronal function 
such as synapses and nodes of Ranvier (Nachamkin et al., 1998a).  
The number of sialic acid residues in a ganglioside is used to classify the 
different species, with one sialic acid designated by M (monosialo), two by 
D (disialo), giving rise to names such as GM1 
(monosialotetrahexosylganglioside), GM2 and GM3 (Mocchetti, 2005). 
Ganglioside localization studies have shown that GM1-like epitopes are 
concentrated at the nodal regions and the paranodal myelin loops whereas 
GM1 are abundant in the motor nerve myelin of the human sensory and 
motor nerves (Ogawa-Goto et al., 1992; Sheikh et al., 1998).  
Again, myelin-associated glycoprotein occurring on the adaxonal surface of 
Schwann cells are known to bind to the axolemma through GT1b and GD1a 
(Yang et al., 1996). 
The identification of antibodies to these gangliosides in both AMAN and 
AIDP patients has been unequivocal suggesting the involvement of anti-
ganglioside antibodies in the pathogenesis of GBS (Ilyas et al., 1992; 
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Kornberg et al., 1994; Pestronk et al., 1994a). Although less than 50% of 
Chinese AMAN sufferers have been found to be positive for IgG anti-GM1, 
it is believed that its identification is more specific for AMAN cases than it 
is in AIDP cases and is even rarely found in other anomalies lending further 
support to this theory (Ho et al., 1995; Kornberg et al., 1994).  
Furthermore, the identification of IgG and complement in the nodal region 
as well as the paranodal myelin loops of autopsied AMAN patients is more 
than enough proof of the role of anti-ganglioside antibodies in the 
pathogenesis of this debilitating disease (Griffin et al., 1996; Hafer-Macko 
et al., 1996). 
1.8.3.4 Is GBS the Result of Molecular Mimicry? 
Following the strong epidemiological data that linked GBS to previous C. 
jejuni infection, scientists were eager to elucidate the association and in 
1993 Yuki and co-workers reported that their gas-liquid chromatography-
mass spectrometric analysis of acute-phase sera from patients with GBS 
after C. jejuni infection has shown that the purified LOS contained Gal, 
GalNAc, and NeuAc [see Table 1.2], which are sugar components of GM1 
ganglioside (Yuki et al., 1993). 
The following year they further isolated C. jejuni from 2 patients with 
Miller-Fisher syndrome subsequent to enteritis and then extracted and 
separated crude lipo-oligosaccharide fractions from the bacteria by thin-
layer chromatography. Using monoclonal antibodies to GQ1b ganglioside 
(GMR13 and 7F5) they showed that both lipo-oligosaccharide fractions 
reacted to the anti-GQ1b antiganglioside antibodies, indicating that the lipo-
oligosaccharides bear the GQ1b epitope (Yuki et al., 1994b).  
These were the first reports and probably the first evidence of molecular 
mimicry between neural tissue components and the often associated 
antecedent infectious agents of AIDP and MFS. A further work illustrated 
that anti-GM1 and anti-GD1a antibodies reacted with the LOSs of serotypes 
HS:01, HS:04, and HS:19 (Yuki et al., 1994a). 
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Ganglioside Mimic Structure 
  
GM1 Gal (E1-4)GalNAc(E1-4)Gal (E1-4)Glc(E1-4)-Ceramide 
                                          Į-3) 
                                          NeuNAc 
 
GD1a Gal (E1-4)GalNAc(E1-4)Gal (E1-4)Glc(E1-4)-Ceramide 
 Į-3)                               Į-3) 
 NeuNAc                           NeuNAc 
 
GD1b Gal (E1-4)GalNAc(E1-4)Gal (E1-4)Glc(E1-4)-Ceramide 
      Į-3) 
                                          NeuNAc 
                                          Į-3) 
                                          NeuNAc 
 
GT1a Gal (E1-4)GalNAc(E1-4)Gal (E1-4)Glc(E1-4)-Ceramide 
Į-3)                                Į-3) 
NeuNAc         NeuNAc 
Į-8) 
NeuNAc 
 
GT1b Gal (E1-4)GalNAc(E1-4)Gal (E1-4)Glc(E1-4)-Ceramide 
 Į-3)        Į-3) 
NeuNAc                          NeuNAc 
      Į-8) 
      NeuNAc 
 
GQ1b Gal (E1-4)GalNAc(E1-4)Gal (E1-4)Glc(E1-4)-Ceramide 
 Į-3)        Į-3) 
NeuNAc                            NeuNAc 
 Į-8)         Į-8) 
NeuNAc                            NeuNAc 
 
GM2 
                        GalNAc(E1-4)Gal (E1-4)Glc(E1-4)-Ceramide 
                                          Į-3) 
                                          NeuNAc 
 
GD3 
                        Gal (E1-4)Glc(E1-4)-Ceramide 
                                          Į-3) 
                                          NeuNAc 
                                          Į-8) 
       NeuNAc 
 
GM4 
                        Gal (E1-4)-Ceramide 
                                          Į-3) 
                                          NeuNAc 
 
 
 
Table 1. 2 | Structures of different gangliosides with terminal saccharide structures. 
These are the reported variants for isolates of C. jejuni (Courtesy: Nachamkin et al. 
1998). 
In 1994, a further collaborative work between Aspinall and Penner 
elucidated the structure of the core oligosaccharide regions of C. jejuni 
strains HS:04, and HS:19 and concluded that they mimic human 
gangliosides in structure (Aspinall et al., 1994a; Aspinall et al., 1994b). In 
that same year, other reports of the immunological mimicry of C. jejuni 
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were published sparking intense research into C. jejuni-associated GBS 
(Kornberg et al., 1994; Pestronk et al., 1994a; Pestronk et al., 1994b). 
Sensitization of female guinea pigs with lipo-oligosaccharides from serotype 
HS19 of C. jejuni has been shown to result in increased titres of anti-GD3 
antibodies and subsequently cause decreases of nerve conduction velocity 
and conduction block (Shu et al., 2007). These anti-GD3 antibodies can also 
block transmission in neuromuscular junctions of spinal cord-muscle cell 
cocultures and thus are thought to be involved in the development of 
Guillain-Barré syndrome (Seigo Usuki, 2006). Again, axonal degeneration 
has also been observed with the expression of ganglioside-mimicking 
structures of C. jejuni lipooligosaccharides and is considered essential for 
the induction of antiganglioside antibodies that lead to Guillain-Barré 
syndrome (Xiao Mei Shu, 2006). 
Now it is known that C. jejuni sialyltransferase gene cst-II, which functions 
in the biosynthesis of ganglioside-like LOSs, determines the transferase 
activity and that a mutation of asparagine to threonine at amino acid position 
51 (Asn-51-Thr) leads to the expression of GM1 and GD1a epitopes, 
whereas GBS patients infected with cst-II (Thr51) strains have anti-GM1 or 
anti-GD1a IgG antibodies (Yuki, 2007; Yuki & Kuwabara, 2007). 
1.9 Management and Control of C.  jejuni  Infection 
C. jejuni infections are usually self-limiting and treatment may not be necessary 
except in severe diarrhoeal and/or vomiting cases where replacement of fluid 
and electrolytes may be warranted (Boon et al., 2006; Poly & Guerry, 2008; 
Zilbauer et al., 2008). 
However, the long-term consequences of infections caused by this organism can 
be potentially dangerous for some individuals. Bacteraemia, toxic megacolon, 
haemolytic uraHPLF V\QGURPH 5HLWHU¶V V\QGURPH *XLOODLQ-Barré syndrome, 
Miller-Fisher syndrome and reactive arthritis (ReA) are the most serious known 
long-term consequences of C. jejuni infections (Nachamkin, 2002). 
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1.9.1 Chemotherapy 
On this backdrop, it is imperative that antimicrobial treatment is instituted to 
hasten the clearance rate of the organism and reduce the period of 
asymptomatic shedding, although this does not lead to immediate cessation of 
the disease process itself (Janssen et al., 2008). Again, antibiotics are 
recommended in severe cases or in cases where the disease becomes 
protracted with prolonged enteritis and/or septicaemia (Zilbauer et al., 2008). 
The first choice of antibiotic for confirmed cases of C. jejuni infection is the 
macrolide antibiotic, erythromycin, whereas ciprofloxacin, a fluoroquinolone, 
KDVEHHQXVHGLQVXVSHFWHGWUDYHOOHUV¶GLDUUKRHD(Boon et al., 2006). Nalidixic 
acid, doxycycline as well as tetracycline are also effective in the treatment of 
Campylobacter enteritis (Boon et al., 2006). It has recently been shown that 
the newer macrolides such as azithromycin and clarithromycin are equally 
effective and that the efficacy of azithromycin compares with 
fluoroquinolones (Allos, 2001; Sanders et al., 2007). 
In serious bacteraemia and other systemic infections due to Campylobacter, 
intravenous aminoglycosides are recommended (Aarestrup & Engberg, 2001). 
Meropenem has also been successfully used in the treatment of a severe case 
of Campylobacter meningitis (Burch et al., 1999). 
1.9.2 Education 
The main goal of the public health physician is in reduction of transmission 
through public education of the dangers of unpasteurised milk, the necessity of 
proper food handling practices, an awareness of the potential for cross-
contamination in the kitchen, the importance of thoroughly cooking meat and 
the vigilant attention to personal hygiene with particular regard to hand-
washing before eating, after contact with pets and after using the toilet (Allos, 
2001; Crushell et al., 2004; Humphrey et al., 2001). 
1.9.3 Farm-To-Fork Strategies 
Despite the complex nature of the transmission dynamics, coupled with the 
relative contribution of different sources in C. jejuni infections it is still 
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reasonably clear that food-producing animals such as poultry, cattle and sheep 
remain the important routes through which organisms could enter the food 
chain (Allen et al., 2007; Corry & Atabay, 2001; Gormley et al., 2008; 
Nichols, 2005). This means that the incidence of campylobacteriosis could be 
dramatically reduced by enhanced on-farm biosecurity or preventing food-
borne transmission. 
The most promising control strategy suggested by leading scientists is 
³VFKHGXOHGSURFHVVLQJ´ZKLFh involves keeping colonised and non-colonised 
flocks apart during slaughter (Wagenaar et al., 2006). The Campylobacter-free 
meat can be supplied as fresh meat to the meat market, whilst the 
Campylobacter-infected meat is treated to reduce the Campylobacter 
concentration before supplying to the market. In a study in Belgium that 
sought to obtain insight into the effect of food practices on Campylobacter 
transmission, it was reported that unskinned chicken meat preparations had an 
almost 2.2-fold probability of being positive for Campylobacter, while 
chicken meat preparations made from frozen meat, or partly containing pre-
frozen meat, had a significantly lower probability of being positive for 
Campylobacter (Sampers et al., 2008). 
Chlorate- and nitro-containing salts employed in the feed and water of various 
farm animals have proven efficacious in reducing concentrations of 
Campylobacter as well as E. coli and Salmonella in the gut of cattle, sheep, 
swine, and poultry (Anderson et al., 2005). This technology is based on the 
ability of Enterobacteriaceae to catalyze the reduction of chlorate to the lethal 
chlorite. Again, the use of caprylic acid supplement in feeds has also been 
shown to be effective in reducing C. jejuni colonisation of chickens (Solis de 
Los Santos et al., 2008). 
C. jejuni colonisation of chicken can be inhibited by feeding freshly hatched 
chicken with some strains of Campylobacter in what is referred to as 
competitive exclusion (Barrow & Page, 2000; Zhang et al., 2007a). The first 
commercially available competitive exclusion product, broilact, has proven to 
be efficacious in preventing colonisation of several enteric pathogens 
including Campylobacter (Hakkinen & Schneitz, 1999). Whereas some 
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scientists have argued that this effectiveness of competitive exclusion is 
dependent on the bird strain, others also argue about the safety of this method 
(Laisney et al., 2004; Wagner, 2006). 
Recently, the experimental treatment of Campylobacter colonized broiler 
flocks with bacteriophage has proven effective in the control of transmission 
at the poultry farm level (Bigwood et al., 2008; Havelaar et al., 2007). 
1.9.4 Vaccines 
Although the use of vaccine in the prevention of transmission has been an 
option in the minds of many scientists, the setback has been the theoretical 
risk of triggering GBS in recipients (Crushell et al., 2004). Several attempts 
have been made using previously known approaches for vaccine development, 
such as the demonstration by Rollwagen et al. of the immune response and 
protective effect following the oral administration of killed Campylobacter in 
mice (Rollwagen et al., 1993). Similarly, Baqar and co-workers demonstrated 
the immunogenicity and protective efficacy of a prototype Campylobacter 
whole-cell killed vaccine in mice and non-human primates (Baqar et al., 
1995a; Baqar et al., 1995b). Guerry and co-workers described the 
development of a recA mutant C. jejuni for inclusion in live-attenuated 
vaccines   (Guerry et al., 1994). Recently, it was demonstrated that feeding 
ferrets with inactivated whole cell C. jejuni led to prevention of disease (Burr 
et al., 2005). Subunit vaccine, containing truncated FlaA flagellin of 
Campylobacter coli VC167 was shown to induce a protective sIgA when 
administered intranasally (Lee et al., 1999). 
In a rather twisted development, a novel approach in which a live-attenuated 
vaccine of Salmonella typhimurium harbouring PEB1 of C. jejuni was tested, 
significant levels of anti-PEB serum IgG were induced, but no protection was 
observed when recipients were challenged with oral administration of C. jejuni 
(Sizemore et al., 2006). 
Through proteomics, Prokhorova and co-workers have recently identified 
eight C. jejuni surface proteins, which showed high protective efficacies 
following expression in E. coli and immunization of mice (Prokhorova et al., 
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2006). With all these promising developments, the question that still remains 
is who should be vaccinated? Vaccination of poultry is probably a more likely 
prospect. 
1.10 Campylobacter and Antibiotic Resistance 
Antibiotic resistance in pathogenic bacteria has always been a threat to both the 
clinician and the patient, and threatens to curtail the euphoria that came with the 
discovery of these drugs in the early 1900s. Bacterial antibiotic resistance 
evolves over time through the acquisition of chromosomal mutations that are 
passed on to daughter cells (Cirz et al., 2005). Campylobacter species are 
known to possess the genetic machinery for natural transformation and 
conjugation; hence, acquired antibiotic resistance genes are easily transferred 
between strains (Jeon & Zhang, 2007; Jeon et al., 2008; Kim et al., 2008).  
The re-annotation of the C. jejuni NCTC11168  genome has revealed the 
presence of 12 antibiotic resistance genes; three of them have been described as 
multidrug efflux pump CmeABC, another three predicted to encode for an 
efflux pump CmeDEF, two additional putative efflux pumps Cj0035c/Cj1687, a 
putative periplasmic ȕ-lactamase Cj0299, a putative acetyltransferase Cj1715, 
and two hypothetical proteins Cj1296/ Cj1297 (Gundogdu et al., 2007). 
The result of acquisition of these antibiotic resistance genes is the development 
of one or more of several mechanisms that lead to reduced uptake of the 
antibiotic into the cell, active efflux of the antibiotic from the cell,  modification 
of the antibiotic target to eliminate or reduce binding, overproduction of the 
antibiotic target (titration), sequestration of the antibiotic by protein binding, 
binding of specific immunity proteins to the antibiotic, and inactivation of the 
antibiotic by enzymatic modification (Davies, 1994). Three of these 
mechanisms appear to be involved in antibiotic resistance in C. jejuni, namely, 
efflux of the antibiotic, mutation of the target site, and protection of the target 
site (Alfredson & Korolik, 2007; Taylor & Tracz, 2005). 
Three main groups of antibiotics are important in Campylobacter treatment and 
control, namely, the fluoroquinolones (ciprofloxacin, nalidixic acid, etc), the 
macrolides (erythromycin, azithromycin, etc), and the tetracyclines (Allos, 
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2001; Coker et al., 2002). Resistance to these antibiotics as well as other 
antibiotics that could be used in the treatment of Campylobacter infections has 
become a major public health concern globally for some time now (Nachamkin 
et al., 2002). C. jejuni resistance to various antibiotics including 
fluoroquinolones, macrolides and lincosamides, tetracyclines, aminoglycosides, 
chloramphenicol, cotrimoxazole, W\ORVLQH DPSLFLOOLQ DQG RWKHU ȕ-lactams has 
been reported (Moore et al., 2006). Of major importance in the emergence of 
resistance to these antibiotics by Campylobacter is their usage in food-
producing animals and the subsequent transmission of these antibiotic resistant 
Campylobacter strains to humans (Alfredson & Korolik, 2007). 
1.10.1 Fluoroquinolone Resistance 
DNA gyrases and/or topoisomerase IV are the sole targets of fluoroquinolone 
action where binding results in altered enzyme conformation, causing 
fluoroquinolone-mediated complexes with the two enzymes to impede DNA 
re-ligation after cleavage during DNA replication, transcription, 
recombination and maintenance of genomic stability (Drlica, 1999; Tse-Dinh, 
2007). Resistance to fluoroquinolone is mediated by single nucleotide 
polymorphisms of Ala-70, Thr-86, or Asp-90 within the quinolone resistance-
determining region (QRDR) of the gyrA sequence encoding the enzyme DNA 
gyrase (Drlica, 1999; Hooper, 2001; Luo et al., 2003; Payot et al., 2006). Thr-
86-Ile substitution in the DNA Gyrase A protein is the commonest mutation 
and is associated with a higher level of resistance to ciprofloxacin and 
nalidixic acid in both C. jejuni and C. coli (Jesse et al., 2006; Kinana et al., 
2006). 
The involvement of the multidrug efflux pump, CmeABC, encoded by the 
cmeABC operon (Figure 1.10), in C. jejuni resistance to fluoroquinolone as 
well as other antibiotics has also been well documented, paving way for its 
inhibition as a promising approach in curbing antibiotic resistance of 
Campylobacter in both humans and animals (Berggard et al., 2002; Martinez 
& Lin, 2006; Yan et al., 2006). Despite the existence of several efflux pumps 
among bacteria, the CmeABC is the only well-documented efflux pump in 
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Campylobacter that is known to mediate antibiotic drug resistance (Ge et al., 
2005; Luo et al., 2003). A mention has been made of a second efflux pump, 
CmeDEF, which is described as being uniformly distributed among multiple 
strains of fluoroquinolone resistant C. jejuni but its involvement in 
antimicrobial resistance is yet to be proven (Lin et al., 2005b; Payot et al., 
2006). Recently, a mutation frequency decline (mfd) gene, which encodes a 
transcription-repair coupling factor involved in DNA repair, was found to 
promote the emergence of spontaneous fluoroquinolone resistant mutants and 
the development of fluoroquinolone resistance in C. jejuni in contrast to its 
previously known function in the decline of mutation frequency in other 
bacterial organisms (Han et al., 2008; Park et al., 2002b; Selby & Sancar, 
1993).  
Fluoroquiniolone resistance in campylobacters has been noted since the early 
1990s (Acar et al., 1993; Adler-Mosca & Altwegg, 1991; Endtz et al., 1990; 
Nachamkin et al., 2002; Rautelin et al., 1991; Reina & Alomar, 1990). In his 
review, Engberg noted that due to the then increased incidences of 
fluoroquinolone resistance among Campylobacter isolates erythromycin and 
other macrolides should remain the drugs of choice across the globe (Engberg 
et al., 2001).  
 
Figure 1. 10 | Genomic organization of the operon coding for CmeABC efflux system. The 
figure also shows features of the intergenic region between cmeR-cmeABC. ORFs are 
indicated by boxed arrows. The start codon (ATG) of the cmeA gene is in bold italics, and the 
sequences that form the inverted repeats are highlighted in bold and indicated by dashed 
arrows. The predicted ±10, ±16, and ±35 regions of PcmeABC are overlined. The nucleotide 
deleted in a laboratory-selected efflux mutant, showing an over-expression of CmeABC efflux 
system, is indicated by an asterisk [Courtesy: Gibreel & Taylor, 2006]. 
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In a survey in the United Kingdom, foreign travel was strongly associated with 
the acquisition of ciprofloxacin resistant C. jejuni (Collaborators, 2002). 
Likewise, in 2006 Norstrom reported increased ciprofloxacin resistance 
among Campylobacter isolates from persons returning from foreign travel 
than among isolates from local broilers (Norstrom et al., 2006). Since the 
recognition of antibiotic resistant Campylobacter among humans, the efficacy 
of ciprofloxacin is far discouraging than that of erythromycin (Wardak et al., 
2007). Nevertheless, erythromycin resistance has also been reported in isolates 
from humans and animals, as well as food (Saenz et al., 2000). 
The situation has not been much different in isolates from cattle, pigs or 
poultry, with reports of quinolone resistance as high as 89.3% among cattle in 
a Washington state farm (Bae et al., 2005; Humphrey et al., 2005; Taylor et 
al., 2008). 
1.10.2 Macrolide Resistance 
The mechanism of action of the macrolides is based on inhibition of bacterial 
protein synthesis whereby the antibiotic binds reversibly to the 50S subunit of 
the bacterial ribosome, to inhibit translocation of peptidyl tRNA (Nakajima, 
1999). In high antibiotic concentrations this action, which is mainly 
bacteriostatic, can also be bactericidal. Macrolides tend to accumulate within 
leukocytes, and are therefore transported to the site of infection (Nakajima, 
1999). Three main mechanisms of macrolide resistance in bacteria have been 
described, namely, (i) target modification mediated by rRNA methylases, 
specific point mutations in the 23S rDNA and/or alteration of the 50S 
ribosomal proteins, (ii) enhanced efflux of the antibiotic from the organism, 
and (iii) macrolide hydrolysis by esterase or phosphorylation mediated by the 
genes, ere and mph, respectively leading to inactivation/degradation of the 
antibiotic (Gibreel & Taylor, 2006; Nakajima, 1999; Payot et al., 2006). 
Although a previous study by Yan et al., ruled out the involvement of any of 
the above three mechanisms in macrolide resistance in Campylobacter, a 
recent study by Caldwell and co-workers has come to confirm the role of the 
above in erythromycin resistance (Caldwell et al., 2008; Yan & Taylor, 1991). 
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Caldwell et al. reported that point mutations in domain V of the 23S rRNA 
target gene of A2074C or A2075G akin to A2058G or A2058C in E. coli 
(Figure 1.11) correlated well with high erythromycin resistance and 
inactivation of CmeABC efflux pump led to increased sensitivity to 
erythromycin (Caldwell et al., 2008). This serves as further evidence in 
support of previous studies that demonstrated the involvement of CmeABC 
efflux pump in both intrinsic and acquired resistance to erythromycin among 
C. jejuni as well as C. coli strains (Corcoran et al., 2006; Mamelli et al., 2005; 
Payot et al., 2004a). It is believed that cmeB over-expression may be 
associated not just with erythromycin resistance, but rather a  multidrug 
resistance phenotype of C. jejuni (Payot et al., 2006). 
Again, Gibreel et al. demonstrated that there was no significant association 
between macrolide resistance and alterations in the 50S ribosomal subunit 
proteins L4 and L22, which are portions of the exit tunnel within the 70S 
ribosome, but a recent study by Caldwell et al. asserts the reverse as true 
(Caldwell et al., 2008; Gibreel et al., 2005). Again, Corcoran et al. has 
described the presence of the characteristic A2075G polymorphism alongside 
one or more amino acid substitutions in both L4 and L22 in 13 Campylobacter 
isolates (Corcoran et al., 2006). These findings suggest that the mechanism of 
macrolide resistance is multifactorial and that the involvement of each of the 
above factors may be independently selected by macrolide levels, with one 
factor modifying or increasing the effect of the other. 
Macrolide, specifically erythromycin, resistance in Campylobacter has been 
reported since the 1970s (Brunton et al., 1978; Karmali et al., 1980; Walder & 
Forsgren, 1978). However, the increasing incidence of macrolide resistance in 
Campylobacter in both developed and developing countries, with the situation 
worsening in developing countries, makes it a public health concern (Engberg 
et al., 2001; Moore et al., 2006; Payot et al., 2004b). 
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Figure 1. 11 | The peptidyl-transferase loop in domain V of the C. jejuni/coli 23S rRNA. This 
is the secondary structure showing positions 2058 and 2059 (based on E. coli numbering) as 
the location of the mutations associated with erythromycin resistance [Adopted with 
permission from Gibreel & Taylor, 2006; J Antimicrob Chemother, 58(2):243-55]. 
1.10.3 Tetracycline Resistance 
There are two main ways through which tetracyclines produce their antibiotic 
effect on bacteria; the atypical tetracyclines such as anhydrotetracycline 
produce their effect by disrupting bacterial cell membranes, whereas the 
typical tetracyclines such as tetracycline and minocycline produce their effect 
by binding to bacterial ribosome to inhibit binding of the aminoacyl transfer 
RNA (aa-tRNA) to the ribosomal A site, thereby preventing the elongation 
phase of protein synthesis (Chopra & Roberts, 2001; Oliva et al., 1992; 
Rasmussen et al., 1991). 
Bacterial resistance to tetracycline is achieved through the disruption of the 
ribosomal binding site of tetracycline by ribosomal protection proteins (RPPs) 
and through efflux pumps (Chopra & Roberts, 2001; Connell et al., 2002). 
There are, however, other mechanisms through which resistance could also be 
achieved such as enzymatic degradation of tetracycline as described in 
Bacteroides and mutations in the 16S rRNA gene as described in H. pylori and 
Propionibacterium acnes (Gerrits et al., 2002; Speer et al., 1992; Trieber & 
Taylor, 2002). 
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In both C. jejuni and C. coli, resistance to tetracycline is mediated by an RPP 
named Tet(O), which is encoded by a self-transmissible plasmid tet(O) gene 
(Aarestrup & Engberg, 2001). This gene, which is mainly located on a 
plasmid, may also be carried on the chromosome of Campylobacter strains 
lacking plasmids (Gibreel et al., 2004b). An insertion element, IS607*, akin to 
that found in H. pylori, has been reported in tet(O)-carrying plasmids in C. 
jejuni, prompting the belief that mobile genetic elements other than 
transmissible plasmids may be involved in the acquisition and transfer of 
tet(O) (Gibreel et al., 2004a). 
Tetracycline resistance in C. jejuni was first reported in the 1970s by Butzler 
et al., and it still continues to be a major setback in the poultry industry as 
resistance among strains could reach as high as 100% in one production cycle 
(Butzler et al., 1974; Luangtongkum et al., 2008). 
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1.11 Aims and Objectives of Study 
It is now generally accepted that bacterial pathogenesis is often dependent on 
the panoply of proteinaceous virulence factors which are either transported to 
the bacterial cell surface or released into the external environment (Finlay & 
Falkow, 1997; Wilson et al., 2002). The interactions of these bacterial proteins 
with host cellular molecules, including the extracellular matrix proteins, are 
important in the pathogenesis of many bacterial infections (Casadevall & 
Pirofski, 2001; Patti et al., 1994). Understanding the molecular basis of 
interactions between these proteins and host cells is necessary in understanding 
and controlling infections. Although previously identified adhesins and other 
virulence determinants of C. jejuni have added to our understanding of the 
pathogenesis of campylobacteriosis, our understanding of the molecular basis 
still lags behind that of other enteric pathogens (Poly & Guerry, 2008; Zilbauer 
et al., 2008). Again, with the increasing incidence of campylobacteriosis around 
the globe and increasing antibiotic resistance, there is a need to fully understand 
the molecular basis of Campylobacter disease pathogenesis to enable us control 
these infections. One important approach to this lies in the inhibition of the 
initial adhesion and colonization, which requires an extensive knowledge of the 
adhesins involved. 
It is highly likely that as yet unidentified C. jejuni surface proteins interact with 
host proteins in a number of ways which contribute to colonisation and 
pathogenesis. Indeed, over 20% of the 1,643 coding sequences of the C. jejuni 
NCTC11168 genome are still uncharacterized including 150 putative membrane 
proteins, 105 putative periplasmic proteins, over 50 putative surface structures 
and several uncharacterized secreted proteins, coupled with the fact that new 
information on previously characterized genes or proteins continues to emerge 
(Gundogdu et al., 2007; Parkhill et al., 2000). 
This study seeks to screen the genome of C. jejuni NCTC 11168 to identify 
additional genes that may code for other adhesins to key components of host 
extracellular matrix molecules such as, collagen, fibronectin, fibrinogen, 
vitronectin, laminin and heparin sulphate, as well as host-secreted proteins such 
as lactoferrin/transferrin given that they are abundant and directly involved in 
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many bacterial processes in the ecological niche of C. jejuni in its human host 
(Patti et al., 1994). One approach to finding such genes is to utilise phage 
display technology. 
Molecular and proteomics approaches in the study of host-pathogen 
interactions, combined with host and pathogen driven epidemiological findings 
are important in elucidating the pathogenesis of Campylobacter infection for 
effective control strategies to be developed. 
1.11.1 Main Objective 
The main aim of this work was to identify Campylobacter jejuni surface 
proteins that may contribute to the pathogenesis of campylobacteriosis in its 
human host. 
1.11.2 Specific Objectives 
The specific objectives of this work were: 
 To construct a phage display DNA library of Campylobacter jejuni 
NCTC11168. Such a library will provide an important resource for 
future research. 
 To pan the resultant library against host cell protein ligand(s) known to 
be involved in the processes of Campylobacter jejuni pathogenesis, 
specifically lactoferrin and/or transferrin. 
 To identify the Campylobacter jejuni DNA sequences responsible for 
the peptides that may bind to the host protein ligand(s) as stated above. 
 To analyse the identified sequences based on available data for their 
possible roles in the pathogenesis of Campylobacter infection. 
 To identify putative autotransporter proteins from the genome 
sequence of Campylobacter jejuni NCTC11168 using in silico 
analyses. 
 To attempt expression of one of the identified proteins for further 
characterization in the future. 
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CHAPTER TWO 
2.0 Construction of a Phage Display Library of 
Campylobacter jejuni NCTC11168  
2.1 Introduction 
The involvement of proteinaceous virulence factors, that are either transported 
to the bacterial cell surface or released into the external milieu, has long been 
generally accepted in the early mechanisms of bacterial pathogenesis (Finlay & 
Falkow, 1997). Understanding the molecular basis of the interactions between 
these proteins and host cells is not just necessary in understanding the disease 
but also in controlling infections. Phage display offers a molecular link between 
surface proteins and their genetic coding sequences, thereby allowing the 
experimental phenotype to be directly linked to an encapsulated genotype 
through sequencing (Wang et al., 2008). 
The superiority of phage display over traditional expression libraries in 
identifying virulence factors lies in the fact that the laborious screening 
procedure of the latter is replaced with affinity selection or panning, followed by 
amplification and repanning which results in enrichment of clones with the 
highest binding affinity to a specific ligand (Jacobsson & Frykberg, 2001b; 
Wang et al., 2008). 
This chapter describes the construction of a phage display library of 
Campylobacter jejuni NCTC11168, based on the filamentous phage M13. This 
library will be utilized to identify C. jejuni proteins that may be involved in 
binding to lactoferrin and fibronectin present in the host intestinal mucosa. 
2.2 Phage Display Technology 
First described in 1985 by GP Smith (Smith, 1985), phage display involves the 
incorporation of foreign DNA sequences into the genome of a filamentous 
phage resulting in the expression of the foreign peptide or protein in fusion with 
one of the coat proteins of the phage particle (Kay et al., 2001). A viable wild-
type phage particle expresses two kinds of coat proteins: the major and minor 
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coat proteins. The M13 coat is composed of 2,700 copies of the major coat 
protein pVIII encoded by its gene 8 (g8) and 5 copies each of four minor coat 
proteins (pIII, pVI, pVII, pIX) (Webster, 1996). Thus, a foreign peptide/protein 
LQ IXVLRQ ZLWK RQH RI WKH FRDW SURWHLQV FDQ EH VHOHFWHG RU ³SDQQHG´ IRU E\
allowing the phage particles to interact with selected ligands immobilized on an 
appropriate surface (Mullen et al., 2006; Siegel, 2008). 
Two types of phage display library exist, random peptide libraries (RPLs) and 
natural peptide libraries (NPLs). Whereas the peptides displayed in RPLs are 
encoded by synthetic degenerate oligonucleotide inserts (Cwirla et al., 1990; 
Lundin et al., 1996), NPLs display natural peptides encoded by random 
fragments of genomic DNA from selected organisms especially pathogenic ones 
(Azzazy & Highsmith, 2002; Kehoe & Kay, 2005). They are therefore preferred 
since they are more successful in eliciting specific antibody response to the 
native intact pathogen than those of RPLs and hence are useful in the 
identification of vaccine candidates and bacterial adhesins (Jacobsson et al., 
2003; Matthews et al., 2002; Siegel, 2008). 
2.3 The Filamentous Phage 
Bacteriophages are viruses that infect a variety of Gram-negative bacteria using 
mainly pili as receptors, but can also use other surface molecules such as 
lipopolysaccharides, teichoic acid, outer membrane proteins or even flagella  
(Azzazy & Highsmith, 2002; Häusler, 2006). The Ff filamentous phage 
constitutes a type of bacteriophage which is rod-like or filament-shaped and 
infect E. coli strains that carry the F episome or sex pilus (Azzazy & Highsmith, 
2002; Häusler, 2006). The best characterized filamentous phage are the M13, f1 
and fd strains whose genome sequences have approximately 98% identity 
(Webster, 1996). 
2.3.1 Structure of the M13 Virion 
The wild-type M13 filamentous phage is a long cylindrical virion, about 930 
nm in length and 6.5 nm in diameter,  containing a covalently closed 6,407-
base single-stranded DNA (ssDNA) genome encased in a protein coat as 
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depicted in Figure 2.1 (Kehoe & Kay, 2005; Webster, 1996). The genome 
consists of eleven genes encoding five structural proteins, which form the viral 
coat, and six non-structural proteins which are involved in DNA replication 
and assembly (Kehoe & Kay, 2005). 
 
 
 
Figure 2. 1 | A Schematic Representation of the M13 Filamentous Phage. The dimensions, 
architecture, and copy numbers of each of the structural proteins are shown 
[Redrawn/Modified from Mullen et al, 2006 and Kehoe & Kay, 2005]. 
2.3.2 The Life Cycle of the M13 Virion 
Unlike the lysis induced in bacteria following infection with lytic phage such 
as T4, infection of E. coli with the M13 filamentous phage induces a state in 
which the infected bacterium produces and secretes phage particles 
indefinitely without cell lysis albeit in reduced numbers over time (Azzazy & 
Highsmith, 2002). As depicted in Figure 2.2, the infection process is initiated 
by the attachment of pIII to the F pilus of a male E. coli strain such as E. coli 
TG1 (Azzazy & Highsmith, 2002; Kehoe & Kay, 2005). The pilus then 
retracts to bring the phage particle to the surface of the bacterium, with pIII 
binding through the E. coli membrane protein, TolA (Riechmann & Holliger, 
1997). The phage particle then transfers its ssDNA genome into the host cell, 
with its outer coat fusing with the bacterial membrane (Nakamura et al., 
2003). The DNA replication enzymes of the host bacterium initiate conversion 
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RIWKHSKDJH¶VVV'1$JHQRPHLQWRWKHGRXEOH-stranded (ds) replicative form 
(RF), which then serves as a template for the replication of ssDNA and 
V\QWKHVLVRI0¶VSURWHLQV (Azzazy & Highsmith, 2002; Kehoe & Kay, 
2005). 
Assembly of phage progeny begins as phage proteins and ssDNA accumulate 
within the bacterial cell. The structural proteins pIII, pVI, pVII, pVIII, and 
pIX have been reported to insert into the bacterial cell membrane whilst pV 
forms complexes with ssDNA for packaging and extrusion through a pIV-
gated pore in the bacterial cell membrane (Kehoe & Kay, 2005). The ssDNA 
is initially coated with nearly 2,700 copies of pVIII and 5 copies each of pVII 
and pIX at one end of the phage, whilst 5 copies each of pIII and pVI are 
incorporated at the opposite end as the phage is extruded (Feng et al., 1997; 
Rakonjac & Model, 1998). 
 
 
Figure 2. 2 | A Schematic Diagram of the Life Cycle of an M13 Filamentous Phage. Through 
the pIII coat protein, phage particle binds to the E. coli through the F pilus which retracts to 
bring the phage to the bacterial cell surface to interact with TolA. The ssDNA (+strand) viral 
genome is then injected into the bacterium (1), which is then converted to the dsDNA (RF) 
(2). This serves as a template for the synthesis of viral proteins and replication of ssDNA (3). 
Progeny components of the phage are assembled by pV and then extruded out of the bacterial 
cell without cell lysis [Redrawn/Modified from Mullen et al, 2006 and Kehoe & Kay, 2005]. 
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Whilst all five coat proteins of the phage particle have been utilized in phage 
display technology, the most common practice has been to fuse foreign 
sequences to the amino terminus of pIII and pVIII (Kehoe & Kay, 2005).  
Nevertheless, the possibility of peptide fusions to the carboxy termini of pVI, 
as well as an artificial pVIII and pIII have also been reported (Fuh & Sidhu, 
2000; Hufton et al., 1999; Weiss & Sidhu, 2000). Peptides or proteins in 
fusion with phage proteins are known to be completely exposed on the phage 
surface and could be present in each copy of its partner, thus, allowing 
interaction with other proteins (Kehoe & Kay, 2005). 
2.4 Phage Cloning Vectors 
It is clear from the life cycle of the M13 bacteriophage that viral DNA from the 
phage particle is single-stranded whereas that from an infected bacterium is 
double-stranded. Thus, dsDNA isolated from infected bacteria is usually used 
for cloning of a target DNA fragment, although cloning into ssDNA is also 
possible (Jacobsson & Frykberg, 2001b). 
Most vectors available for exogenous expression of a foreign peptide or protein 
have utilized both g3 and g8 (Kehoe & Kay, 2005). Phage vectors that 
incorporate foreign DNA sequences into either g3 or g8 are termed type 3 or 8 
respectively, as detailed in Figure 2.3 (Smith, 1993). Whereas pIII is known to 
tolerate a variety of proteins and short peptides, pVIII on the contrary, seems to 
be able to harbour only short inserts of five to six amino acids due probably to 
the closely packed nature of the viral surface (Greenwood et al., 1991; 
Kishchenko et al., 1994). Again, sequences may not be well-displayed on the 
surface of the phage due to defects in assembly which may ultimately affect 
viral stability and infectivity (Armstrong et al., 1996). This latter problem is 
compensated for in two other groups of vectors. 
In one group of vectors, an additional wild-type copy of the gene of interest is 
added to the recombinant genome. These are referred to as type 33 or 88 (Smith, 
1993). Infection of bacterial cells with these phage vectors results in phage 
particles displaying both the wild-type and the fusion copies of pIII or pVIII 
(Figure 2.3). 
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Termed 3+3 or 8+8, the third group of vectors contains the so-called phagemid-
based vectors. These are designed such that they carry only one copy of the gene 
of interest, and do not possess the viral machinery needed for the synthesis and 
packaging of new bacteriophages (Smith, 1993). Bacterial cells carrying these 
phagemids therefore require the assistance of an M13 helper phage, which 
carries the full machinery for the synthesis of the phage coat but is defective in 
replication, in order to secrete phage particles that will display both wild-type 
and the pIII or pVIII fusion protein of interest (Figure 2.3 f & g). This process is 
WHUPHG³SKDJHUHVFXH´ 
In contrast to the multivalency of the 8+8 vector system, the displayed peptide 
in the 3+3 vector system is mainly monovalent which is important in 
eliminating the avidity in protein-protein interactions. The peptide concentration 
in both systems is diluted by the presence of the wild-type copies contributed by 
the helper phage in spite of the fact that it is advantageous when the resultant 
phage particles are not stable or infectious (Armstrong et al., 1996).  
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Figure 2. 3 | Representative M13 phage display vectors and viral particles. The dark blue 
spheres depict the translation of the dark blue foreign DNA insert as a fusion protein with either 
pIII or pVIII respectively. Each vector is named based on the host viral gene. Type 3 or 8 
vectors have single copies of the viral genes (b & c), whereas type 33 or 88 vectors have two 
copies (d & e). Types 3+3 and 8+8 are phagemid-based (f & g), producing viral particles only 
when bacterial cells carrying the phagemid are infected with helper phage [Courtesy, Brian Kay; 
Redrawn]. 
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2.4.1 Phagemid Vector 
Phagemid cloning vectors, or simply phagemids, are hybrids of phage and 
plasmid vectors [see Figure 2.4]. They are designed to contain the origin of 
replication of both M13 and a plasmid origin of replication from E. coli. In 
addition to these, they include the bacteriophage gene to be fused to foreign 
DNA sequences, appropriate cloning sites to enable the insertion of foreign 
DNA sequences, and an antibiotic resistance cassette, but lack all the 
structural and non-structural genes required for the synthesis of a complete 
phage (Azzazy & Highsmith, 2002; Jacobsson & Frykberg, 1995; Jacobsson 
& Frykberg, 2001b). 
 
Figure 2. 4 | A schematic Diagram of a g8-based Phagemid vector, pG8SAET. The vector 
contains origin of replication of M13 and of E. coli, in addition to gene 8 and NcoI/SnaBI 
cloning sites for insertion of foreign DNA sequences. An ampicillin resistance cassette is also 
present in the vector sequence. This vector was used in the construction of the phage display 
library of C. jejuni NCTC11168 described in this study [Redrawn with permission from 
Jacobsson et al., 2003]. 
As with all phage vectors, the phagemid vector also allows the incorporation 
of foreign DNA sequences into its genome, the display of the said sequences 
as peptides or proteins on the surface of the phage or in the periplasmic space 
of the E. coli host cell, the recovery of the packaged gene encoding the said 
peptide and, more importantly, allows selective culture of phage-infected 
bacterial cells over uninfected ones (Azzazy & Highsmith, 2002). 
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2.4.2 Manipulation of Phagemids 
An important feature in phagemids is the presence of multiple restriction sites 
which enable foreign DNA sequences to be inserted into g3 or g8 (Azzazy & 
Highsmith, 2002). 
Phagemids have been designed such that the displayed peptide is separated 
from pIII or pVIII by short peptide linkers, the sequence of which is often a 
variation of GGGGS (Armstrong et al., 1996). Insertion of a proteolytic 
cleavage site between the displayed peptide and pIII or pVIII, such as Factor 
Xa cleavage site in M13mp18Xa, has also been utilized in some phagemids. 
This has been used to recover the displayed peptide (Nagai & Thogersen, 
1984). In addition, disruption of the g3 or g8 reading frames has been used to 
reduce the percentage of non-recombinant phage particles in phage libraries 
(Jacobsson & Frykberg, 2001b). This is achieved through introduction of 
frame-shifts in the stuffer sequences or restriction sites of the vector, the 
reading frame of which is restored when exogenous DNA sequences are 
inserted. 
Another important factor in the choice of phage display vector is the presence 
of a marker such as an antibiotic resistance cassette, antibody recognition tags, 
lacZ expression sequence or a stop codon, which are important in selecting 
recombinant phage (Jacobsson & Frykberg, 1998). Table 2.1 shows the names 
of published phage display vectors, with the gene of expression, restriction 
sites and markers. 
It is known that for infection to ensue, there must be an interaction between 
N1 terminal domain and TolA of E. coli and this is only achieved through a 
disruption of the two terminal domains, N1 and N2, of pIII (Lubkowski et al., 
1999). Thus, replacement of N1 with an exogenous sequence results in phage 
progeny which are not infectious. It is therefore possible to manipulate the 
phagemid vector by replacing the N-terminal domains of pIII with peptide- or 
protein-encoding DNA sequences such that the resultant phage particles are 
selectively infective (Crissman & Smith, 1984; Nelson et al., 1981). These 
vectors are engineered such that the missing N-terminal domains necessary for 
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infection are harboured in adaptor molecules made up of the ligand covalently 
coupled to the replacement DNA sequences. Following recovery, therefore, 
non-infective phage mixed with adaptor molecules restores infectivity to the 
phage particles that display peptides or proteins that can bind to the ligand 
which provides the missing N-terminal domains of pIII (Krebber et al., 1997). 
This selectively infective phage (SIP) has an advantage in selecting for high 
affinity binders. 
 
Vector Gene Rest Site Marker Reference 
fUSE1 III PvuII tetR Parmley and Smith, 1988 
fUSE2 III BglII tetR Parmley and Smith, 1988 
fUSE5 III SfiI tetR Scott and Smith, 1990 
pHEN1 III SfiI/NotI  ampR Hoogenboom et al., 1991 
Ȝ6XUI=DS III NotI/SpeI ampR Hogrefe et al., 1993 
p8V5 VIII BstXI ampR Affymax 
f88 VIII PstI/BamHI tetR Scott and Smith, 1990 
pG8SAET VIII SnaBI/NcoI ampR Jacobsson et al., 1998 
Table 2. 1 | Names of published phage display vectors, with gene of expression, restriction 
sites and markers. All of these vectors have been used successfully in the construction of 
phage display libraries as referenced in the table. 
Peptides and proteins attached to the domain 2 of pIII are more accessible, and 
hence this domain has become the preferred site of DNA insertion in phage 
display, such as the fusion of human growth hormone to a truncated form of 
pIII within amino acid position 198 to 406 (Armstrong et al., 1996; 
Lubkowski et al., 1999). 
Manipulating the phagemid vector to contain a signal sequence, Frykberg and 
co-workers developed a system that displays only exported bacterial proteins, 
thus enabling isolation of adhesin-encoded genes and genes of other exported 
proteins (Karlstrom et al., 2004; Rosander et al., 2002). The phage vector can 
WKHUHIRUHEHPDQLSXODWHGLQVHYHUDOZD\VWRVXLWRQH¶VDLPVDQGREMHFWLYHVLQ
any phage display library. 
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2.5 Construction of Phage-Display Libraries 
As depicted in Figure 2.5, the basic principle of the construction of a phage 
display library is the same irrespective of the type of library needed, although 
minor modifications of the procedures may be necessary. The foreign DNA 
fragments to be displayed as fusion peptides or proteins are introduced into a 
linearized vector DNA by ligation. The ligated fusion vector-DNA fragment is 
then introduced by electroporation into an appropriate E. coli strain and then 
amplified to produce a library (Jacobsson et al., 2003).  
In the construction of RPLs, double-stranded DNA fragments are usually 
obtained through the assembly of degenerate oligonucleotides  (Adey et al., 
1996). Whereas some researchers anneal only three oligos and then proceed to 
ligate into a vector (Cwirla et al., 1990), others may amplify these fragments by 
PCR, digest with restriction enzymes to obtain the desired ends, before ligating 
into a vector (Scott & Smith, 1990; Sparks et al., 1998). 
Phage display technology has been applied in many areas of research including 
the study of infectious diseases (Mullen et al., 2006). The principle of the 
construction of a phage library of a bacterial genome is very much the same as 
that described for random peptide libraries and antibody libraries. DNA 
fragments can be obtained through sonication of genomic DNA in what is 
referred to as the shot-gun phage display libraries (Jacobsson et al., 2003; 
Mullen et al., 2007b). The resulting fragmented DNA is separated by agarose 
gel electrophoresis and DNA in the required size range excised from the gel and 
purified for downstream applications (Jacobsson & Frykberg, 2001b). The 
disadvantages with this method lie in the fact that the blunt-ended ligation 
results in low insert yields, and that the inserted fragments are usually small. 
The percentage of insert following ligation can be improved by restriction 
digestion of the genomic DNA with an infrequent cutter such as Sau3AI (or its 
isoschizomer, BfuCI), which also gives DNA fragments with cohesive end-
termini. However,  using restriction digested DNA in this kind of library also 
has a big disadvantage since they can only cut where there are enzyme sites 
which means that some genes may never be represented  as expressed proteins 
in the library. 
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Figure 2. 5 | Schematic representation of phage display library construction.  Foreign DNA 
fragments, obtained from sonication or restriction digestion of chromosomal DNA or through 
the assembly of degenerate oligonucleotides, are ligated into linearized phagemid vector and 
then used to transform an appropriate E. coli host. Cells containing cloned foreign DNA 
fragments are then cultured in an amplification step. In order to secrete phage particles that 
will display both the wild-type and pIII or pVIII fusion proteins, the E. coli host cells are 
super-infected with helper phage in a phage rescue step [Drawing based on principles as 
described in literature]. 
2.5.1 Applications of Phage Display Libraries 
)ROORZLQJ 6PLWK¶V GHPRQVWUDWLRQ RI WKH GLVSOD\ RI IRUHLJQ SHSWLGHV RQ WKH
surface of bacteriophage, the technology has been used in the generation of 
several fusion proteins with phage capsid, the applications of which have been 
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numerous. Random peptide libraries have been shown to have the potential to 
mimic linear, conformational and non-proteinaceous epitopes (Smith, 1991).  
RPLs have been used to identify peptides that specifically bind to a wide range 
of targets such as antibodies (Scott & Smith, 1990), the lectin protein 
concanavalin A (Scott et al., 1992), streptavidin (Devlin et al., 1990), and 
ribonucleases (Smith et al., 1993). Phage display has been used to identify 
peptides that could be incorporated into conductive apatite layers in bone 
engineering to promote cell adhesion, proliferation and ultimately 
differentiation into bone tissue, leading to increased osteogenesis (Segvich et 
al., 2009). 
Through their binding activities, peptides identified through phage display 
have been shown to act as agonists or antagonists, whereas others that 
neutralize immunoglobulins have been employed as therapeutic agents in 
some autoimmune diseases (Blank et al., 1999; Doorbar & Winter, 1994; 
Goodson et al., 1994; van Groen et al., 2008). Panning a 12-mer phage display 
library against human hepatocellular carcinoma cell line HepG2, a novel 
peptide was identified by Zhu et al. which can be employed as a delivery 
carrier in target diagnosis or therapy in hepatocellular carcinoma (Zhu et al., 
2008). 
Cheng et al. showed that using phage display techniques amino acid 
sequences that are capable of affecting biologically significant protein-DNA 
interactions can be identified from random peptide libraries (Cheng et al., 
1996). Using a plaque dilution assay for affinity screening of their 23-mer 
random peptide library, they identified four groups of oligo-binding phage that 
showed preference for: (1) single-stranded oligos irrespective of sequence; (2) 
double-stranded oligos irrespective of sequence; (3) sequence-specific binding 
to single-stranded oligos; and (4) weak non-specific binding to all types of 
oligos tested. The beauty of the analysis of this was the identification of the 
consensus motifs responsible for the binding of the specific oligos. 
As knowledge in phage display technology increased, so did the length of 
DNA sequences cloned and several scientists attempted cloning longer 
peptides including functional peptides (Cwirla et al., 1990).  
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Antibodies became the first functional proteins to be displayed in this manner 
following several innovations using RPLs (McCafferty et al., 1990; Parmley 
& Smith, 1988). The technology was used to express fragments of various 
antibodies for epitope mapping and protein interaction studies (Chang et al., 
1991; Clackson et al., 1991). The technique can now be used to isolate high-
affinity antibodies, which are known to have several advantages over 
monoclonal antibodies generated by hybridoma technology (Azzazy & 
Highsmith, 2002). Cheng et al. have recently identified single chain antibodies 
specific for three of the four human Toll-like receptor-2 homologues using a 
phage display antibody library (Chen et al., 2009). 
In 1993, Kay and colleagues successfully constructed an M13 RPL displaying 
random 38-amino-acid peptides, the length of which led to intense interest in 
the display of functional peptides other than antibodies (Kay et al., 1993). The 
enzymes, alkaline phosphatase, trypsin, DQG ȕ-lactamase have since been 
expressed through this technology without any of them losing their catalytic 
activities (Corey et al., 1993; McCafferty et al., 1991; Siemers et al., 1996). 
2.5.2 Phage Display Technology in the study of Infectious Diseases 
As is clear now, interaction between bacterial adhesins and host cellular 
proteins are important in the events leading to the establishment of many 
bacterial infections (Finlay & Falkow, 1997; Patti et al., 1994). Phage display 
has long been thought of as a good system for displaying specific or random 
peptides of important infectious agents as antigens, which could lead to the 
development of cheap and effective vaccines, as well as in the identification of 
peptides or adhesins in pathogenic bacteria that are not easily grown in the 
laboratory, or for which genetic manipulations are not straightforward 
(Antonara et al., 2007; Greenwood et al., 1991; Willis et al., 1993). 
Campylobacter falls in the last two categories. 
By constructing phage display libraries of fragments of genomic DNA of 
pathogenic bacteria and panning against various ligands, Frykberg and 
Jacobsson identified several genes encoding bacterial proteins that were found 
to interact with host proteins (Jacobsson & Frykberg, 1995; Jacobsson & 
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Frykberg, 1996). Using phage display, Jacobsson and co-workers identified 52 
novel extracellular and transmembrane proteins from Lactobacillus reuteri, an 
organism routinely used in probiotics (Wall et al., 2003). Phage display 
technology was used in the identification and characterization of a 
plasminogen-binding protein B (PgbB) of Helicobacter pylori (Jonsson et al., 
2004), whilst the proteins FnBPA of Staphylococcus aureus (Ingham et al., 
2004), Embp, FnBPA and FnBPB of Staphylococcus epidermidis (Ingham et 
al., 2004; Williams et al., 2002), ScpB of Streptococcus agalactiae 
(Beckmann et al., 2002), DemA of Streptococcus dysgalactiae (Vasi et al., 
2000), and FnBP of Streptococcus equi (Lindmark & Guss, 1999), were all 
found to be adhesins that bind to fibronectin through phage display 
technology. 
In the same way, the proteins Fbe of Staphylococcus epidermidis (Nilsson et 
al., 1998), FgagV1, FgagV2 and FgagV3 of Streptococcus agalactiae 
(Jacobsson, 2003), and Fb1 of Staphylococcus lugdunensis (Nilsson et al., 
2004a), were also found to be adhesins that bind to fibrinogen through phage 
display technology. The F17a-G adhesin of bovine enterotoxigenic E. coli 
(ETEC) which is involved in the attachment of the bacterium to the intestinal 
epithelium was displayed as an amino-terminal fusion with the phage protein 
pIII and was found to elicit an IgG response against F17a-G after intra-
peritoneal immunisation of mice (Van Gerven et al., 2008). 
Phage display technology has also been employed in the identification of 
vaccine candidates against infectious diseases. In one study using a phage 
display cDNA library of Brugia malayi, the causative agent of lymphatic 
filariasis, five antigens were identified that bound to antibodies from infected 
persons, one of which was later proved to provide protection against infection 
in animal models of the disease (Gnanasekar et al., 2004). Again, phage 
libraries of single chain variable fragments have been used to identify 
potential vaccine candidates for infectious agents such as Clostridium difficile, 
Bacillus subtilis and the severe acute respiratory syndrome-associated 
coronavirus (SARS-CoV) (Deng et al., 2003; Knurr et al., 2003; Liu et al., 
2005). 
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2.5.3 Innovations in Phage Display Technology 
Following identification of proteins or peptides that bind to a particular ligand, 
the specific binding domains could be identified through an innovative 
approach to phage display where a single-gene phage display library is 
constructed from the fragments of the gene of interest. This innovation has 
been used to identify the IgG and albumin-binding domains of two novel 
receptors of group C streptococci as MAG and ZAG, whilst mapping the 
fibronectin-binding activity of Streptococcus equi to two C-terminal domains 
of FnBP (Jacobsson et al., 1997; Lindmark et al., 1996; Lindmark & Guss, 
1999). Zhang and co-workers also identified the binding domains of the Sbi 
protein of Staphylococcus aureus WR ,J* DQG ȕ2-glycoprotein through this 
method (Zhang et al., 1999). Using a RPL, Benedek and co-workers identified 
laminin-binding motifs of the Yersinia pestis plasminogen activator (Benedek 
et al., 2005). 
Another innovation in the use of phage display is the identification of bacterial 
proteins that bind to host proteins deposited on biomaterials of routinely used 
medical devices in clinical practice, such as intravenous catheters and 
prosthetic heart valves. By panning a genomic DNA library of Staphylococcus 
aureus against a freshly removed central intravenous catheter, several 
EDFWHULDOSURWHLQVZHUHLGHQWLILHGDVELQGLQJWRILEULQRJHQRUȕ2-glycoprotein I 
(Bjerketorp et al., 2004). 
2.5.4 Advantages and Disadvantages of Phage Display Technology 
Put simply, the benefits of phage display technology are therefore three-fold: 
(i) the ability to very effectively produce a large number of differing peptides 
and proteins (up to 1010 particles per ml of library) (ii) the ability to screen 
libraries expressing billions of unique peptides and proteins by way of binding 
to a ligand(s) and (iii) the capacity to maintain a molecular link between the 
displayed protein and the DNA sequence encoding it (Azzazy & Highsmith, 
2002; Mullen et al., 2006). 
However, it must be stated that phage display technology has its attendant 
drawbacks. For instance, very high phage titres containing large numbers of 
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clones are needed in NPLs since the majority of clones from such libraries are 
non functional. Furthermore, only one in eighteen clones would be in frame 
with the vector sequences as only one clone in three will start in frame with 
the coat protein, only one in three will end in frame with the coat protein, and 
one in two will be in the right orientation (Jacobsson & Frykberg, 2001b; 
Mullen et al., 2006). 
Clonal variation in the display levels of even closely related sequences is a 
known shortcoming of phage display technology, where differences in 
translation, transport, folding or stability of the fusion can negatively affect the 
expression levels of the recombinant protein (McCafferty, 1996). 
Furthermore, affinity selection is also affected by the number of recombinant 
phage particles present in any particular panning, where incubation of low 
numbers of phage particles results in about 34% of binding, with higher inputs 
yielding less (McCafferty, 1996). Therefore, careful optimization and strict 
adherence to the optimized protocol is required for panning of phage display 
libraries if consistent results are to be obtained. 
Post-translational protein modification is another important factor in phage 
display of proteins and peptides. In C. jejuni, glycosylation is known to play 
an important role in the functionality of many of its surface proteins (Young et 
al., 2007; Zilbauer et al., 2008) and its absence could be expected to affect 
interaction of phage expressed C. jejuni proteins with the appropriate ligands. 
Post-translational modification may therefore have a negative or a positive 
effect depending on the protein in question. 
Although E. coli remains one of the most widely used hosts for the production 
of heterologous eukaryotic proteins, the expression of toxic proteins could also 
be toxic to the host cells, thus, affecting propagation of phage clones 
containing such proteins. 
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2.5.5 Aims of The Work Described in This Chapter 
As stated earlier, this chapter describes the construction and validation of a 
phage display library of Campylobacter jejuni NCTC11168, based on the 
filamentous phage M13. This library will be utilized to identify C. jejuni 
proteins that may be involved in binding to lactoferrin and fibronectin present 
in the host intestinal mucosa. The phagemid vector, pG8SAET (Jacobsson & 
Frykberg, 2001a), will be utilized for this purpose. 
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2.6 Materials and Methods 
2.6.1 Bacterial Strains and Culture conditions 
The library was constructed using chromosomal DNA from wild type 
Campylobacter jejuni NCTC11168 obtained from a laboratory stock 
maintained in a 50:50 mixture of glycerol and Mueller-Hinton (MH) broth and 
stored at -80°C. C. jejuni NCTC11168 was grown at 42°C on charcoal-
cefoperazone-desoxycholate agar (CCDA) or in MH broth (Oxoid) with 
shaking, in a MACS VA500 Microaerophilic workstation (Don Whitley 
Scientific) in atmospheric conditions of 6% O2, 5% CO2, 3%H2 and 86% N2.  
E. coli TG1 electroporation-competent cells [supE thi-1 ǻ(lac-proAB) 
ǻ(mcrB-hsdSM)5 (rK± mK±) [F´ traD36 proAB lacIqZǻM15] (Stratagene) were 
used for the propagation of the phagemids, the construction of phage display 
libraries and the production of phage stocks. E. coli TG1 was grown at 37°C 
in Luria-Bertani (LB) broth (Fischer Scientific) with shaking or on LB agar 
(Fisher Scientific), that had been supplemented with 200 µg/ml of ampicillin 
or 50 µg/ml of kanamycin and 2% (w/v) filter-sterilized glucose when 
appropriate. 
2.6.2 Phagemids, Helper Phage and Plasmids 
The phagemid vector, pG8SAET (Figure 2.4), was used in the construction of 
the C. jejuni NCTC11168 phage display library (Jacobsson & Frykberg, 
2001a). This was a kind gift from Lisa Mullen, Division of Microbial 
Diseases, Eastman Dental Institute, University College London, London, UK. 
The vector was used with permission from its originators, Lars Frykberg and 
Karen Jacobsson, Department of Microbiology, Swedish University of 
Agricultural Sciences, Uppsala, Sweden. 
R408 helper phage (Promega) was employed for the packaging and secretion 
of the pG8SAET-chromosomal DNA hybrids as single-stranded DNA 
(ssDNA) viral particles.  
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The plasmid, pJMK30 (Figure 2.6), containing a kanamycin resistance gene, 
aphA-3,as well as an ampicillin resistance cassette (van Vliet et al., 1998), was 
XVHGWRSUHSDUH³LQVHUWPRGHOV´WRPLPLFWKHFKURPRVRPDO'1$LQVHUWV 
 
Figure 2. 6 | Schematic representation of the pJMK30 plasmid. The figure shows all 
restriction enzyme sites. The kanamycin resistance cassette was employed in the creation of 
insert mimics [Redrawn from van Vliet et al, 1998]. 
2.6.3 Antibiotic Supplements 
Ampicillin and kanamycin were obtained from Sigma-Aldrich. Stock solutions 
were prepared with distilled water to final concentrations of 100 mg/ml and 50 
mg/ml respectively, and then filter-sterilized with a 0.22-µl pore sterile 
Millex® filter unit (Millipore) before use. Antibiotic stocks were stored at 4°C 
until used. 
2.6.4 Culture Media 
i. CCDA Campylobacter Selective Agar (Skirrow) 
&&'$RWKHUZLVHNQRZQDV6NLUURZ¶V Campylobacter selective agar, obtained 
from Oxoid, was used in the culture of C. jejuni NCTC11168. This medium, 
which is designed to be used at 42°C for optimum selective effect, is based on 
CHAPTER TWO 
 
 
Harry H Abruquah | Identification of host-pathogen interacting molecules of Campylobacter jejuni  
PhD Thesis | Microbiology | March 2009 
87 
 
SkirrRZ¶VHDUO\UHFLSHWKDWFRQWDLQHG23 g/l of  special peptone, 1 g/l of  starch, 
5 g/l of NaCl and 10 g/l  of agar and supplemented with 10 µg/ml of vancomycin, 
2.5 IU/ml of polymyxin B, and 5 µg/ml of trimethoprim (Skirrow, 1977). 
ii. Mueller-Hinton Broth 
Mueller-Hinton (MH) Broth powder (Oxoid) suspended in distilled water 
DFFRUGLQJ WR PDQXIDFWXUHU¶V LQVWUXFWLRQs and autoclaved was used for liquid 
culture of C. jejuni NCTC11168. This microbiological media typically contains 
30% beef infusion, 1.75% of casein hydrolysate and 0.15% of starch. An addition 
of 1.7% of agar results in solidification of the medium to give Mueller-Hinton 
agar (Atlas, 2004). 
iii. SOC Media 
Super optimal broth with catabolite repression (SOC) is made from super 
optimal broth (SOB medium) by the addition of 0.3% glucose (Hanahan, 
1983). Premade SOC medium was obtained from Invitrogen, but was 
otherwise made up from 2% w/v bacto-tryptone (20g), 0.5% w/v bacto-yeast 
extract (5g), and 0.01 M NaCI (0.584g), 0.005 M KCI, and 0.02 M MgSO4 
(2.408g) or 10mM MgCl2 (0.952g), made up to a final volume of 1 litre in 
distilled water. The broth was sterilized by autoclaving, and stored at 4°C until 
required. Immediately prior to use, 0.02 M glucose (3.603 g/l), filter sterilized 
using 0.22 µm pore sterile Millex® filter unit (Millipore Corporation) was 
added. 
iv. LB Media 
Pre-made Luria-Bertani (LB) was obtained from Fischer Scientific of which a 
specified amount of its powder was suspended in distilled water according to 
PDQXIDFWXUHU¶V LQVWUXFWLRQV DQG DXWRFODYHG DV DSSURSULate. It was otherwise 
prepared according to the Miller recipe by dissolving 10 g of tryptone, 5 g of 
yeast extract and 10 g of NaCl in 1 litre of distilled water (Miller, 1972). The 
broth was then sterilized by autoclaving at 121°C, 15 lb. inch-2 for 15 min. 
LB agar was made in an identical fashion except for the addition of 1% (w/v) 
agar to LB broth prior to autoclave sterilization. Following cooling to 
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approximately 40°C, any necessary antibiotics were added and the agar 
transferred to Petri dishes. 
v. Soft Agar (Soft LB Agar) 
Soft agar was made by adding 0.05 % (w/v) of agar to LB broth prior to 
autoclave sterilization. Following cooling, bottles containing soft agar were 
kept at room temperature until required. This was used in the amplification of 
phage infected E. coli TG1 cells. 
vi. Luria-Bertani with Glucose 
Both LB broth and LB agar, fortified with glucose, were used in the 
propagation of phage-infected E. coli TG1 cells prior to amplification of these 
clones. LB-glucose was obtained by adding 2% (w/v) glucose, filter sterilized 
using 0.22 µm pore sterile Millex® filter unit, to either of LB broth or LB agar 
prior to use. 
2.6.5 Miscellaneous Buffers and Solutions 
i. 0.5 M EDTA 
0.5 M Ethylenediaminetetraacetic acid was prepared by adding 186.1 g to 900 
ml of distilled water and adjusting the pH to 8.0 using 10 M NaOH. The 
volume was made up to 1 litre and the solution sterilized by autoclaving at 
121°C, 15 lb. inch-2 for 15 min. 
ii. TAE Buffer 
Tris-acetate EDTA (TAE) buffer was routinely used in preparation of agarose 
gels. A 50 × TAE buffer was prepared by dissolving 242 g of Tris base [2-
amino-2-hydroxymethyl-propane-1,3-GLROŁ 2 M], 57.1 ml glacial acetic acid 
>Ł 1 M of 100% acetic acid],  and 100 ml 0.5 M Na2 EDTA (pH 8.0) in 1 litre 
of distilled water. 
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iii. Phosphate Buffered Saline 
Phosphate buffered saline (PBS) was prepared by dissolving 1 tablet of pre-
made PBS, obtained from Oxoid, in 100 ml distilled water >Ł 1× PBS] and 
sterilized by autoclaving at 121°C, 15 lb. inch-2 for 15 min. It was otherwise 
prepared from 8 g of NaCl, 0.2 g of KCl, 1.44 g of Na2HPO4 and 0.24 g of 
KH2PO4 dissolved in 1 litre of distilled water and the pH adjusted to 7.3. This 
was then sterilized by autoclaving. 
PBS-Tween 20 (PBS-T) was made by adding 200 µl of Tween 20 to 400 ml of 
1× PBS. 
iv. 3 M Sodium Acetate 
This was prepared by dissolving 40.8 g of sodium acetate salt in 90 ml of 
distilled water and adjusting the pH to 5.2 using glacial acetic acid and the 
volume made up to 100 ml. The resulting solution was then sterilized by 
autoclaving at 121°C, 15 lb. inch-2 for 15 min. 
v. Phenol-Chloroform-Isoamyl Alcohol 
Phenol: chloroform: isoamyl alcohol 25:24:1 was obtained from Sigma-
Aldrich and used routinely in the purification of DNA following ligation of C. 
jejuni NCTC11168 chromosomal DNA fragments into pG8SAET vector. 
2.6.6 Restriction Enzymes 
The restriction endonucleases/enzymes [SnaBI, BglII, BamHI, SmaI, EcoRV 
and BfuCI] were obtained from New England Biolabs, and were used 
DFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQVZLWKPLQRUPRGLILFDWLRQV 
2.6.7 DNA Modification Enzymes 
i. Antarctic Phosphatase 
Antarctic phosphatase (AP) was obtained from NEB and was used to catalyze 
the removal of the 5´ phosphate groups from linear DNA fragments, thus 
preventing self-ligation through the 5´ phosphoryl termini required by ligases 
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for ligation (Sambrook & Rusell, 2001). AP was used according to the 
PDQXIDFWXUHU¶V JXLGHOLQHV 7\SLFDO UHDFWLRQV FRQWDLQHG  O >Ł  8@ RI $3, 
approximately 10 µg of vector DNA, 12 µl of 10× AP buffer and nuclease-free 
deionised water to a final volume of 120 µl. This was incubated at 37°C for 15 
min. 
ii. Klenow Fragment 
Klenow Fragment (NEB) was employed to create blunt-ended chromosomal 
DNA fragments of C. jejuni 1&7& E\ ³ILOOLQJ-LQ´ 5´overhangs after 
sonication. A typical Klenow reaction contained 20 ȝg of fragmented 
chromosomal DNA8RI.OHQRZ>Ł8RI.OHQRZJRI'1$@ORI
mM dNTPs, 22 µl of 10× NEB buffer 2 and an appropriate amount of 
nuclease-free deionised water to a final volume of 220 µl. This was incubated 
at room temperature for 30 min, and then the reaction inactivated at 75°C for 
10 min. 
iii. T4 DNA Polymerase 
T4 DNA polymerase (NEB) was employed to complement the Klenow 
blunting of sonicated-chromosomal DNA of C. jejuni NCTC11168. Without 
cleaning the initial Klenow reaction mixture, 7 µl of T4 DNA polymerase was 
DGGHG >Ł8RI7'1$SRO\PHUDVHJRI '1$@ DORQJVLGHORI
mM dNTPs, 3 µl of 10× NEB buffer 2, 2.5 µl of 10× BSA, and an appropriate 
amount of nuclease-free deionised water to a final volume of 250 µl. This was 
then incubated at 12°C for 15 min, before the reaction was stopped by adding 
EDTA to a final concentration of 10 mM and inactivation at 75°C for 10 min. 
iv. T4 DNA Ligase 
T4 DNA ligase was employed in the ligation of chromosomal DNA fragments 
of C. jejuni NCTC11168 or insert models into linearized pG8SAET phagemid 
vector, by catalyzing the formation of a phosphodiester bond between 
juxtaposed 5´ phosphate and 3´ hydroxyl termini in DNA. 
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2.6.8 Polymerase Chain Reaction 
Polymerase chain reaction (PCR) was used for a variety of purposes during 
this work and was carried out using a Techne 96-well thermocycler, using 
either Taq DNA Polymerase or ([SDQG +LJK )LGHOLW\ 3&5 System. All 
primers used in this study are listed in Table 2.2 and were synthesized by 
Eurofins MWG GmbH (Germany). 
Table 2. 2 | Primers used in PCR amplification of vector and inserts. The restriction sites are 
highlighted in maroon. 
i. Taq DNA Polymerase 
Taq DNA polymerase (5 U/µl, Roche) was used for the amplification of the 
linear vector as well as the chromosomal DNA inserts. 
ii.  ?	System 
7KH ([SDQG High Fidelity (HiFi) PCR System (Roche) was used for high 
fidelity amplification of the pG8SAET vector as it gives a 3-fold yield, 
combined with higher fidelity and specificity compared with a conventional 
Taq DNA polymerase alone (Barnes, 1992; Barnes, 1994). 
2.6.9 DNA Extraction from Bacterial Cells 
Chromosomal DNA of C. jejuni NCTC11168 was isolated using the DNeasy 
WLVVXH NLW 4LDJHQ DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV )ROORZLQJ
three-day growth of C. jejuni NCTC11168 on one CCDA plate, cells were 
harvested using 1 ml of PBS and DNA extracted from this. DNA was eluted 
from the membrane using nuclease-free deionised water. 
Primer Sequence Amplification of 
 
  
pG8SAET_F1 
pG8SAET_F1 
5´ - GTACCCGGTGCGCCGGTGCCGTATCCG -3´ 
5´ - GTACTGCCATGGTCATCGTGTTGCGCAGC - 3´  
Linear vector with 
SnaBI site 
 
  
pG8SAET_F2  
pG8SAET_R2   
¶- GGAAGATCTCCCGGTGCGCCGGTGCCGTATCCG - ¶ 
¶- GGAAGATCTCTGCCATGGTCATCGTGTTGCGCAGC - ¶ 
Linear vector with 
BglII Site 
 
  
pG8SAET_F 
pG8SAET_R_Short 
pG8SAET_R_Long     
5´ - TATCTGGTGGCGTAACACCTGCT - 3´ 
5´ - GATCGTCACCCTCGGATCCCTAGG - 3´  
5´ - GTGAAATACCGCACAGATGCGTAA - 3´  
cDNA insert  
across SnaBI/ 
BglII bridge 
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Plasmid DNA was extracted using QIAprep spin miniprep kit (Qiagen) 
according to manufaFWXUHU¶V LQVWUXFWLRQV Single colonies of cells of interest 
were cultured overnight in 1.5 ml of LB broth containing appropriate 
antibiotics. Cells were harvested by centrifugation at 16,000 ×  g for 5 min and 
the pellet resuspended in the appropriate buffer for plasmid extraction. 
Plasmid DNA was eluted from the membrane using nuclease-free deionised 
water. 
2.6.10  Confirmation and Quantification of DNA 
i. Quantification of DNA by Spectrophotometer 
All DNA preparations were re-suspended in an appropriate volume of 
nuclease-free deionised water and quantified using the Nanodrop ND-1000 
Spectrophotometer (Thermo Scientific). 
ii. Agarose Gel Electrophoresis 
DNA fragments were resolved following DNA extraction, PCR, or restriction 
digestion using agarose gel electrophoresis. The agarose gel was prepared by 
dissolving 0.75% (w/v) agarose powder (Sigma) in an appropriate volume of 
1× TAE buffer. The mixture was then boiled, cooled and ethidium bromide 
added to a final concentration of 0.5 µg/ml. The gel was then cast with an 
appropriate comb and after solidification, placed in a running tank containing 
1× TAE buffer. 
DNA samples were prepared for electrophoresis by adding 1 µl of 10× loading 
buffer to 9 µl of sample. DNA samples were then loaded alongside an 
appropriate molecular marker, usually GeneRulerTM DNA Ladder 
(Fermentas). The gel was run at a constant voltage of 120 V/cm until the dye 
front had travelled through approximately 75% of the gel. DNA fragments 
were then visualized using ultra-violet light (290 nm) and photographed. 
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2.6.11 Purification of DNA 
i. Agarose Gel Extraction and Purification of DNA 
Purification of DNA fragments excised from agarose gels was done using 
4LDJHQ¶Vgel extraction NLW4LDJHQDFFRUGLQJWRPDQXIDFWXUHU¶VLQVWUXFWLRQV. 
DNA was eluted in 50 µl of nuclease-free deionised water by centrifugation at 
14,000 × g for 1 min. 
ii. Purification of DNA from PCR/Restriction Digests 
'1$ZDVSXULILHGXVLQJ4LDJHQ¶VPCR purification kit (Qiagen) according to 
PDQXIDFWXUHU¶V LQVWUXFWLRQV, following PCR reactions, restriction digests or 
other enzymatic reactions. DNA was eluted in 50 µl of nuclease-free deionised 
water by centrifugation at 14,000 × g for 1 min. 
iii. Phenol-Chloroform-Isoamyl alcohol Extraction of DNA 
Ligation reaction mixtures were purified using phenol-chloroform-isoamyl 
alcohol. Nuclease-free water was added to the reaction mixture to a final 
volume of 500 µl, if the initial volume was less than this. An equal volume of 
phenol-chloroform-isoamyl alcohol was then added and thoroughly mixed 
until solution became cloudy. This was then centrifuged at 14,000 × g for 30 
min, and 450 µl of the DNA-containing aqueous phase decanted into a fresh 
tube. To this, 0.7 volumes of 100% iso-propanol and 0.1 volumes of 3 M 
sodium acetate was added. 1 O>Ł10 µg/µl] of yeast tRNA (Sigma) was also 
added as a co-precipitant and samples incubated at -20°C for 30 min. The 
precipitated DNA was then pelletted by centrifugation at 14,000 × g for 30 
min at 4°C, and then washed with 1 ml of 70% ethanol and re-pelletted by 
centrifugation at 14,000 × g for 30 min. The purified DNA was then air-dried 
for 15 min and re-suspended in an appropriate volume of nuclease-free 
deionised water. 
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2.6.12 Linearization of Vector DNA 
2.6.12.1 Creation of Blunt-ended Linear Vector 
Two methods were used in creating blunt-ended linear vector in this study, 
namely, restriction digestion with dephosphorylation and PCR. 
i. SnaBI Restriction Digest of Circular Vector 
The circular phagemid vector was linearized by restriction digestion using 
SnaBI. A typical digestion reaction contained ca. 20 ȝg of vector DNA, 
100 U of SnaBI >Ł U of SnaBI/µg of vector DNA], in a final volume of 
100 µl in the recommended enzyme buffer and the mixture incubated at 
37°C overnight. A 1-µl aliquot of this digestion reaction mixture, 
containing ca. 200 ng of vector DNA, was analysed by agarose gel 
electrophoresis to ascertain complete cleavage. To the remaining 99 µl of 
digestion reaction mixture, 10 µl of 10 × loading buffer was added and 
subjected to electrophoresis on a 0.75% agarose gel to size-separate the 
completely digested vector. The band corresponding to the completely 
digested vector was excised and purified using Qiagen Gel purification kit 
as described above, and dephosphorylated using AP. 
ii. PCR of Digested Vector to Produce Blunt ends 
The SnaBI-digested vector was amplified using the ExpandTM HiFi PCR 
System and primers pG8SAET_F1 and pG8SAET_R1 (Table 2.2). The 
PCR reaction mixture contained 10 ng of SnaBI-digested vector DNA, 60 
pmol each of pG8SAET_F1 and pG8SAET_R1, 30 µl of 2 mM dNTPs, 30 
µl of 10 × PCR buffer containing 1.5 mM MgCl2, 15 U of ExpandTM HiFi 
PCR polymerase and nuclease-free deionised water to a final volume of 
300 µl. This master mix was divided into 6 aliquots of 50 µl each and 
placed in a thermocycler with the following settings: an initial 
denaturation at 95°C for 3 min, and 30 cycles of denaturation at 95°C for 
30 s, annealing at 54°C for 30 s, extension at 74°C for 4 min, and a single 
final extension at 74°C for 5 min. After PCR, the samples were pooled, 
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cleaned up using 4LDJHQ¶V 3&5 purification kit and eluted in 30 µl of 
nuclease-free deionised water, followed by dephosphorylation with AP. 
2.6.12.2 Creation of A-Tailed Linear Vector 
i. SnaBI-Digested/PCR Amplified Dephosphorylated Vector 
Blunt-ended and dephosphorylated linear vector was A-tailed to improve 
ligation efficiency. A typical A-tailing reaction contained 10 µg of blunt-
ended, dephosphorylated linear vector, 50 U of Taq polymerase [Ł8RI
Taq polymerase /µg of DNA], 10 µl of 10 × PCR buffer with 1.5 mM 
MgCl2, 10 µl of 2 mM dATP and nuclease-free deionised water to a final 
volume of 100 µl. The reaction mixture was incubated at 70°C for 1 h, 
cleaned up using 4LDJHQ¶V3&5SXULILFDWLRQNLW and quantified. 
ii. PCR with Taq Polymerase 
Using a Taq Polymerase (Roche), and primers pG8SAET_F1 and 
pG8SAET_R1 (Table 2.2), the linear vector was amplified using an 
aliquot of the SnaBI-digested vector as a template. This PCR took 
advantage of the low fidelity of the normal Taq polymerase, which results 
in the addition of an end A-tail to each single strand amplified. 
The PCR reaction mixture contained 10 ng of SnaBI-digested vector 
DNA, 60 pmol each of pG8SAET_F1 and pG8SAET_R1, 30 µl of 2 mM 
dNTPs, 30 µl of 10 × PCR buffer containing 1.5 mM MgCl2, 15 U of Taq 
polymerase and nuclease-free deionised water to a final volume of 300 µl. 
This master mix was divided into 6 aliquots of 50 µl each and placed in a 
thermocycler with the following settings: an initial denaturation at 95°C 
for 3 min followed by 30 cycles of denaturation at 95°C for 30 s, 
annealing at 54°C for 30 s, extension at 74°C for 4 min, and a single final 
extension at 74°C for 5 min. After amplification, the samples were pooled, 
FOHDQHG XS XVLQJ 4LDJHQ¶V 3&5 SXULILFDWLRQ kit and eluted in 30µl of 
nuclease-free deionised water. 
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2.6.12.3 Creation of Linear Vector with Cohesive End-termini 
Primers were designed to amplify the vector yielding a BfuCI/BglII 
recognition site. The PCR reaction mixture contained 10 ng of SnaBI-
digested vector DNA, 90 pmol each of pG8SAET_F2 and pG8SAET_R2 
(Table 2.2), 12 µl of 5 mM dNTPs, 30 µl of 10 × PCR buffer containing 
1.5 mM MgCl2, 42 U of ExpandTM HiFi PCR polymerase and an 
appropriate amount of nuclease-free deionised water in a final volume of 
300 µl. This master mix was divided into 6 aliquots of 50 µl each and 
placed in a thermocycler with the following settings: an initial denaturation 
at 95°C for 3 min followed by 30 cycles of denaturation at 95°C for 10 s, 
annealing at 54°C for 30 s, extension at 68°C for 5 min, and a single final 
extension at 68°C for 5 min. After amplification, the samples were pooled 
WRJHWKHUDQGFOHDQHGXSXVLQJ4LDJHQ¶V3&5SXULILFDWLRQkit and eluted in 
30 µl of nuclease-free deionised water. This was followed by a BglII 
restriction digest and then dephosphorylation. The BglII restrictions sites 
are highlighted in maroon in Table 2.2.  
A typical BglII digestion reaction contained 80 µl of PCR product (which 
typically yielded ca. 10 µg of phagemid DNA), 10 µl of BglII buffer, and 
10 µl or 100 U of BglII HQ]\PH >Ł 8RI HQ]\PHJRIYHFWRU '1$@. 
This was incubated at 37°C overnight. 
2.6.13 Preparation of Chromosomal DNA Inserts 
2.6.13.1 Creation of Blunt-ended Chromosomal DNA Fragments 
i. Sonication of Chromosomal DNA 
100 µg of C. jejuni NCTC11168 chromosomal DNA was adjusted to 400 
ȝl in nuclease-free deionised water. This was subjected to sonication in 2-4 
s pulses. Aliquots of 2 ȝO >Ł ca. 500 ng] were analysed by agarose gel 
electrophoresis after each sonication to determine the optimal conditions 
needed to yield DNA fragments in the size range of 50 and 4,000 bp.  
A portion of the sonicated-chromosomal DNA was used immediately in 
downstream applications, whilst the remainder was separated in one large 
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well of 0.75% agarose gel. The DNA smear corresponding to DNA 
fragment sizes of 50 to 4000 bp was carefully excised and replaced into a 
hole cut in an adjacent part of the gel. The orientation of current flow was 
reversed and the gel ran for an additional 15 min to re-focus the fragments 
prior to excision from the gel slice and purification carried out using 
4LDJHQ¶V*HOSXULILFDWLRQNLW 
ii. Polishing of Fragmented Chromosomal DNA 
Fragmented chromosomal DNA was subjected to polishing by the Klenow 
fragment, followed by further polishing with T4 DNA polymerase as 
described above. 
2.6.13.2 Creation of Chromosomal DNA Fragments with Cohesive 
End-termini 
i. Creation of T-tailed Chromosomal DNA Fragments 
Blunt-ended or polished fragments of C. jejuni NCTC11168 chromosomal 
DNA were T-tailed to improve ligation efficiency. A typical T-tailing 
reaction contained 10 µg of polished fragments of C. jejuni NCTC11168 
chromosomal DNA, 50 U of Taq polymerase [Ł8RITaq polymerase 
/µg of DNA], 10 µl of 10 × PCR buffer with 1.5 mM MgCl2, 10 µl of 2 
mM dTTP and nuclease-free deionised water to a final volume of 100 µl. 
Reaction mixtures were incubated at 70°C for 1 h, cleaned up using 
4LDJHQ¶V3&5SXULILFDWLRQkit and quantified. 
ii. BfuCI Digestion of Chromosomal DNA 
BfuCI, an isoschizomer of Sau3AI, was used to digest chromosomal DNA 
of C. jejuni NCTC 11168. A typical BfuCI restriction digest yielded DNA 
fragment sizes of between 50 and 4000 bp and contained ca. 10 µg of C. 
jejuni NCTC11168 chromosomal DNA, 10 µl of BfuCI >Ł 0.1 U of BfuCI 
i.e. 0.1U/µg of DNA], 5 µl of 10 × enzyme buffer, and nuclease-free 
deionised water to a final volume of 50 µl. This was incubated at 37°C for 
20 min. The products of several reactions were pooled to obtain sufficient 
quantities of DNA for gel purification. A portion was directly purified 
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using a PCR purification kit, and the remainder was size-purified by 
agarose gel electrophoresis. The smear corresponding to DNA fragments 
in the size range 300-4000 bp was carefully excised and replaced into a 
hole cut in an adjacent part of the gel. The orientation of current flow was 
reversed and the gel ran for an additional 15 min to re-focus the fragments 
prior to excision from the gel slice and purification XVLQJ 4LDJHQ¶V *HO
purification kit. 
2.6.14 Preparation of Chromosomal DNA Insert Models 
The plasmid, pJMK30 (Figure 2.5) was digested with EcoRV, SmaI and 
BamHI to create insert models. These insert models were used to mimic 
chromosomal DNA fragments in optimization of experimental conditions. 
2.6.14.1 Creation of Blunt-ended Insert Models 
A typical EcoRV and SmaI digestion reaction contained 10 µg of pJMK30 
plasmid DNA, 5 µl 10 × enzyme buffer, 5 µl eQ]\PH>Ł U of EcoRV or 
SmaI i.e. 5U of enzyme/µg of plasmid DNA], and nuclease-free deionised 
water to a final volume of 50 µl. The reaction mixture was incubated at 
37°C overnight and aliquots analysed by agarose gel electrophoresis to 
ascertain whether there was complete digestion of the plasmid.  
The remaining digests were separated by agarose gel electrophoresis and 
the ca. 3.1 kb fragment from the EcoRV digestion [pJMK30_EcoRV_Fr], 
and the ca. 1.4 kb fragment from the SmaI digestion [pJMK30_SmaI_Fr] 
containing the ampicillin and the kanamycin resistance cassettes 
respectively were FDUHIXOO\ H[FLVHG DQG SXULILHG XVLQJ 4LDJHQ¶V *HO
purification kit. 
To ensure that both chromosomal DNA fragments and pJMK30 fragments 
were subjected to the same conditions, the resulting DNA of the EcoRV or 
SmaI digestion of pJMK30 was polished by the Klenow fragment, 
followed by further polishing with T4 DNA polymerase as described 
above. 
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2.6.14.2 Creation of Insert Model with Cohesive End-termini 
i. Creation of T-tailed Insert Model 
The blunt-ended or polished DNA fragments from the EcoRV digestion 
[pJMK30_EcoRV_Fr] and the SmaI digestion [pJMK30_SmaI_Fr] were 
T-tailed to improve ligation efficiency. A typical T-tailing reaction 
contained 10 µg of polished fragments of pJMK30_EcoRV_Fr or 
pJMK30_SmaI_Fr, 50 U of Taq polymerase >Ł8RITaq polymerase/µg 
of DNA], 10 µl of 10× PCR buffer with MgCl2, 10 µl of 2 mM dTTP and 
nuclease-free deionised water to a final volume of 100 µl. This reaction 
mixture was incubated at 70°C for 1 h and thHQFOHDQHGXSXVLQJ4LDJHQ¶V
PCR purification kit, and quantified. 
ii. BamHI Digestion of pJMK30 Plasmid 
The pJMK30 plasmid DNA was digested with BamHI to yield DNA 
fragments with BfuCI-compatible end-termini. A typical digestion reaction 
contained 10 µg of pJMK30 plasmid DNA, 5 µl 10 × enzyme buffer, 5 µl 
eQ]\PH >Ł U of BamHI i.e. 5U of enzyme/µg of plasmid DNA], and 
nuclease-free deionised water to a final volume of 50 µl. The reaction 
mixture was incubated at 37°C overnight and an aliquot analysed by 
agarose gel electrophoresis to ascertain that there was complete digestion 
of the plasmid. 
The remaining digest was separated by agarose gel electrophoresis and the 
ca. 1.4-kb fragment [pJMK30_BamHI_Fr] containing the kanamycin 
resistance cassette was H[FLVHG DQG SXULILHG XVLQJ 4LDJHQ¶V *HO
purification kit. 
2.6.15 Ligation and Cloning 
Several test-ligations were carried out using various combinations of vector 
and insert prepared as described above, namely, 
i. Blunt-ended vector + Blunt-ended inserts 
ii. PCR generated Blunt-ended vector + Blunt-ended inserts 
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iii. A-tailed vector + T-tailed inserts 
iv. PCR generated A-tailed vector + T-tailed inserts 
v. PCR generated BfuCI ended vector + BfuCI-ended inserts 
Ligation reactions were set up with amounts of vector and insert DNA based 
on the calculation given in box 1. Following initial test ligations, a vector-
insert ratio of 1:3 was found to give the best results and was subsequently used 
in setting up ligation reactions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A typical ligation reaction, therefore, contained ca. 200 ng of linear pG8SAET 
phagemid vector, ca. 264 ng of cDNA/ Kanr_Fr, 1 µl T4 DNA lLJDVH>Ł 0.5 U 
of ligase/µg of vector DNA], 2 µl of 10× ligase buffer, 2 µl of 2 mM ATP, and 
nuclease-free deionised water to a final volume of 20 µl. The reaction mixture 
was mixed and incubated at room temperature for 2 hours, followed by an 
overnight incubation at 4°C. It was then purified using the phenol-chloroform-
isoamyl alcohol extraction method and then re-suspended in 10 µl of nuclease-
free deionised water, for transformation into E. coli TG1 cells. 
Box 1:  
Calculation of amounts of DNA needed in a ligation 
 
 ǡɖȋȌ  =  Amount of Vector DNA (ng) 
               Size of Insert DNA (kb)           Size of Vector DNA (kb) 
 ɖȋȌȏȀr_Fr ] = 200ng of pG8SAET 
                                           1.5 kb                   3.4 kb 
 
Î    ɖ ?88ng 
 
Where,  cDNA       Łthe average size of chromosomal DNA insert; ~1.5kb 
Kanr_Fr  Ł pJMK30_BamHI_Fr or pJMK30_SmaI_Fr; ~1.5kb 
 
Î   88ng of insert DNA needed in a ligation in a 1:1 vector-insert ratio. 
Î 264ng of insert DNA needed in a ligation in a 1:3 vector-insert ratio. 
Î 440ng of insert DNA needed in a ligation in a 1:5 vector-insert ratio. 
 
 
 
Source: Adopted from Technical Manual of Promega, Part# TM042, Revised 6/99, page 9; 
Optimizing Insert:Vector Molar Ratios. 
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2.6.16 Electrotransformation of E. coli TG1 Cells 
5 µl of each ligation was used to transform 50 µl of E. coli TG1 cells using a 
BioRad Gene Pulser at 1.7 kV and, UHVLVWDQFHDQGFDSDFLWDQFHRIȍDQG 
µFD respectively. Immediately following electroporation, 950 µl of SOC 
medium (Invitrogen), pre-warmed to 37°C, was added to the E. coli TG1 cells, 
which were allowed to recover at 37°C for 1 h. Portions of the recovered cells 
were plated onto LB agar containing 200 µg/ml of ampicillin (LB-Amp agar) 
or 200 µg/ml of ampicillin and 50 µg/ml of kanamycin (LB-Amp/Kan agar) as 
appropriate, and incubated at 37°C overnight. 
Viable colonies were counted manually, and the number of E. coli 
transformants and the percentage of recombinant colonies or ligation 
efficiency estimated. With regards to the insert model, Kanr_Fr, this was 
estimated by dividing the number of colonies counted on an LB-Amp/Kan 
agar plate by the number of colonies counted on LB-Amp agar plate and 
multiplied by 100%. 
2.6.17 Construction of C. jejuni NCTC11168 Phage Display Library 
The library was constructed to cover the whole genome of C. jejuni 
NCTC11168. The number of clones, and hence the adequate number of 
ligations needed in such an experiment was arrived at based on the 
calculations in box 2.  
Six ligation reactions were set up as described earlier. Following phenol-
chloroform-isoamyl alcohol purification and ethanol precipitation, each 
reaction mix was re-suspended in a final volume of 5 µl and used to electro-
transform 50 µl E. coli TG1 cells which were pooled and recovered in a total 
volume of approximately 6 ml SOC medium. 100 µl was plated for 
determination of the number of transformants and the percentage of 
transformants containing an insert. A number of colonies were selected for 
PCR analysis. The remaining 5.9 ml of culture was added to 60 ml of LB 
broth containing 200 µg/ml of ampicillin (LB-amp broth) in a 250 ml-flask 
and incubated at 37°C overnight. 
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The following day, this culture was divided into two portions and centrifuged 
briefly to pellet the cells. The supernatant from each portion was discarded 
and the pellets re-suspend in 5 ml of fresh LB-Amp broth each. 
Phage Rescue: The resulting culture was divided into 10 × 1 ml portions and 
each portion infected with R408 helper phage at a multiplicity of infection of 
100 (i.e. 100 µl of 1.3x1013 pfu/ml stock). Infection was allowed to proceed at 
room temperature for 1 h. 
Box 2:  
Calculation of number of Clones needed for a good 
Chromosomal DNA Library of C. jejuni NCTC11168 
 
A: Using simple reasoning based on  
   1. Estimated DNA fragment size of ca. 300 bp 
   2. Genome size of Cj11168 of 1,641,481 bp 
 
Î 1,641,481/ 300 = 5472 clones needed to cover genome. BUT in theory, 
only 1 in 18 clones will be in-frame. 
 
Î 5472 × 18 = 98489 (to make for 1 in 18 being in-frame) 
Î 10 × 98,489 = 984,890 (to make for good coverage of genome) 
Î ~ 1,000,000 Clones 
 
 
B: adopting the formula for calculation of above from Jacobsson et al 
(2003),    
 
                      N =   In (1 Ȃ P) 
        In (1 Ȃ a/b) 
Where,   P = probability that clone contains insert (0.8) 
   a = Average size of the DNA fragment (~300bp) 
   b = Size of genome (1,641,481 bp in Cj11168) 
This implies that the number of clones needed to cover whole genome is: 
    N =               ln (1-0.8)      =    -1.6094379 
            ln (1-300/1,641,481)                -0.0001827 
    
          N = 8810 
Î 8810 × 18 (to make for 1 in 18 being in-frame) = 158,580 
Î 158,580 × 10 (to make for good coverage of genome) = 1,585,800 
Î ~ 1,600,000 Clones 
 
C: A C. jejuni DNA library aimed at anything between 1,000,000 and 
1,600,000 clones would be of good genome coverage for the purpose of 
its construction. 
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To each 1 ml aliquot of R408-infected culture, 25 ml of molten soft agar, pre-
cooled to 45°C and containing 200 µg/ml of ampicillin, was added in 50 ml 
falcon tubes, mixed thoroughly and poured unto LB-Amp agar plates with 
approximate volume of 5 ml soft agar per plate. This was incubated at 37°C 
overnight. 
Following overnight incubation, the soft agar from the 50 plates was 
transferred into a 1 L flask containing 250 ml of LB-Amp broth (i.e. 5 ml 
broth per plate giving a total volume of 500 ml). This was incubated at 37°C 
for 4 hours with shaking at 200 rpm. This culture was then divided into two 
portions of 250ml each in centrifuge flasks and centrifuged at 20,000 × g for 
45 min, and the supernatant poured into fresh sterile tubes. 
The supernatant (ca. 400 ml) was filtered using 0.45 µl pore sterile Millex® 
filter unit (Millipore Corp) to remove any remaining bacterial cells. This 
rescued phage constituted the library and was stored as 1.5-ml aliquots at -
80°C.  
2.6.18 Determination of Library Indices 
i. Estimation of Number of E. coli Transformants/Transformation 
Efficiency 
)ROORZLQJDQKRXU¶VUHFRYHU\RIWKHWUDQVIRUPHGE. coli TG1 cells, containing 
g8-chromosomal DNA inserts in SOC medium, a 10-fold serial dilution of a 
100-µl aliquot of this culture was made to a final dilution of 10-5 and 90 µl of 
each dilution was plated on LB-Amp agar plates and incubated at 37°C 
overnight. 
The following day, colonies were counted and the number of E. coli 
transformants calculated. 
ii. Colony Analysis/Complexity of Library 
Several random colonies were selected from the LB-Amp agar plates for PCR 
analysis to confirm the presence or otherwise and the size of an insert for each 
clone [see Table 2.2].  
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Colony analysis PCR reaction mixtures contained 1 µl of 10× PCR buffer with 
1.5 mM MgCl2, 1 µl of 2 mM dNTPs, 0.1 µl of µl Taq polymerase, 0.2 µl 
each of primers pG8SAET_F1 and pG8SAET_RBORQJDFRORQ\>Ł~ 0.5 µl] 
and 6.5 µl nuclease-free deionised water to a final volume of 10 µl. 
The PCR machine was programmed for denaturation at 95°C for 2 min, then 
30 cycles of 95°C denaturation for 10 s, annealing at 55°C for 30 s, elongation 
at 72°C for 3 min, and further elongation at 72°C for 8 min. 
To increase sensitivity of this colony analysis, selected colonies were grown in 
1.5 ml of fresh LB-Amp broth at 37°C overnight. DNA was then extracted 
from these cultures XVLQJ4LDJHQ¶V0LQL3UHSNLWand eluted in a final volume 
of 50 µl nuclease-free deionised water. PCR was done as described above 
using 0.5 µl of a 1 in 100 dilution of each sample as a template. A positive 
control template of a vector without an insert and a negative control of water 
were used alongside samples. 
The resulting PCR product was resolved by agarose gel electrophoresis as 
described, and analysed for inserts and insert sizes. The percentage of colonies 
with inserts was calculated and multiplied by the number of E. coli 
transformants to reveal the complexity of the library. 
iii. Titration of Library 
A laboratory stock of E. coli TG1 was grown in fresh LB broth at 37°C until 
the optical density at 600 nm was between 0.5 and 0.6. A 90-µl aliquot of this 
culture was infected with 10 µl of rescued phage in an eppendorf tube. 
Infection was allowed to proceed at room temperature for 30 min. A 10-fold 
serial dilution of this was prepared and 90 µl of each dilution plated on LB-
Amp agar plates and incubated at 37°C overnight. 
The following day, colonies were counted and the number of E. coli 
transformants calculated.  
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2.7 Results 
2.7.1 Purification of DNA 
Two methods for DNA purification, phenol-chloroform-isoamyl alcohol with 
yeast tRNA and QIAquick PCR purification kit, were arrived at after 
evaluation of the percentage DNA recovered following various other 
purification procedures (Figure 2.7). QIAquick gel extraction kit was 
employed in size-selection of chromosomal DNA fragments. 
Purification of DNA using QIAquick PCR purification kit could lead to the 
recovery of up to 91% of the starting amount of DNA, whilst phenol-
chloroform-isoamyl alcohol with yeast tRNA led to the recovery of ca. 69% of 
the starting DNA. However, the use of phenol-chloroform-isoamyl alcohol 
was reserved for the purification of ligation reactions, prior to 
electrotransformation. This was based on the fact that the latter method 
eliminated silica which is usually present following column purification, as 
well as salt, following ligations thus preventing arcing during electroporation.  
 
 
 
Figure 2. 7 | Efficiency of DNA Purification Methods. DNA preparations were purified using 
ethanol or iso-propanol alone, phenol-chloroform-isoamyl alcohol without yeast tRNA 
(PhChIsAmyOH) or with yeast tRNA (YtRNA-PhChIsAmyOH), as well as with the 
commercial kit QIAquick PCR purification kit (Qiagen). The resulting DNA was quantified 
and compared with that of the starting DNA. 
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2.7.2 Linearization of Vector DNA 
Different types of the linear form of the vector, pG8SAET, were prepared and 
used in the preliminary stages of the study. The linear vector, pG8SAET_V5, 
was arrived at for the construction of the library following evaluation of the 
various forms. 
2.7.2.1 Creation of Blunt-ended Linear Vector [pG8SAET_V2] 
Two methods were used in creating blunt-ended linear vector in this study, 
namely, restriction digestion with dephosphorylation and then PCR. 
i. SnaBI Restriction Digest of Circular Vector 
The sequence of plasmid pG8SAET between nucleotides 283 and 336 is 
shown in Figure 2.8.  
 
 
Figure 2. 8 | SnaBI Recognition Sequence site in pG8SAET Vector. The DNA sequences 
used in the design of PCR primers are depicted in blue and red. Nucleotides between 
positions 1-295 constitute the staphylococcal protein A promoter sequence followed by 
the signal peptide of the E-tag sequence from position 283 to 336. Between the 
staphylococcal protein A promoter sequence and the E-tag sequence are two enzyme 
recognition sites, a SnaBI site and an NcoI site. Digestion of the circular vector with 
SnaBI, therefore, yielded a blunt-ended linear vector and provided a site for insertion of a 
foreign DNA sequence [Modified from Jacobsson et al., 2003]. 
Following SnaBI digestion of pG8SAET, the linearized vector DNA was 
dephosphorylated and/or gel purified as described above. The efficiency of 
digestion was assessed by self-ligating various preparations of the vector 
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and using these to electro-transform E. coli TG1 cells. After plating 
aliquots of the electrotransformed E. coli cells on LB-Amp agar plates and 
incubating overnight, plates were described as either having colonies (+ve) 
or not (-ve) the results of which are given in Figure 2.9.  
Although, the use of 5 U of SnaBI enzyme/µg of vector DNA was 
considered as yielding the best digest based on the appearance of the 
product on agarose gel, this yielded a large number of background 
colonies in all transformations. 
To reduce the level of background colonies gel purification of digested 
vector was employed. This procedure reduced the number of background 
colonies but it appeared to reduce the ligation efficiency of the vector 
(Table 2.3). 
Furthermore, analyses of a number of individual clones revealed that only 
10-15% of them had inserts [see Table 2.5 further in text]. The highest 
percentage of colonies with insert obtained following further optimization 
was 44%. 
Sample Description No. of Colonies 
(Column Purified) 
No. of Colonies 
(Gel Purified) 
Controls 
 
1 Undigested pG8SAET [+ve Control] Confluent Confluent 
2 No DNA                      [-ve Control] 0 0 
3 pJMK30 EcoRV Fragment 0 0 
Ligations  
4 Digested, non-Dephosph Phagemid + Ligase 1260 161 
5 Digested, non-Dephosph Phagemid - Ligase 720 70 
  
6 Digested, Dephosph Phagemid + Ligase 312 62 
7 Digested, Dephosph Phagemid - Ligase 316 61 
  
8 1:3 pG8SAET:pJMK30_EcoRV_Fr + Ligase 301 31 
9 1:3 pG8SAET:pJMK30_EcoRV_Fr - Ligase 580 42 
Table 2. 3 | Colony counts following electrotransformation of different vector 
preparations and re-ligation and test-ligation with pJMK30_EcoRV_Fr. The highest 
percentage of insert obtained in this experiment was 15%. 
Due to the low efficiency and high background colonies, vector 
preparation using SnaBI restriction digest, followed by dephosphorylation 
and/or gel purification was abandoned, and a new method that employed 
PCR adopted, as described earlier.  
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Figure 2. 9 | Linearization and purification of pG8SAET. The circular vector was digested with 1U, 5U and 10U of SnaBI enzyme/µg of vector DNA and half of the preparation dephosphorylated. 
The resulting DNA was either gel purified (Gel+) or used directly in a re-ligation experiment (L). These ligations were purified and transformed into E. coli TG1 cells, and assessed for background 
colonies (+ve/-ve). Complementary un-ligated DNA preparations (UL) were also transformed for comparison. 
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ii. PCR of Digested Vector to Produce Blunt ends [pG8SAET_V3] 
A blunt-ended linear vector was obtained (Figure 2.10) by PCR 
amplification using an aliquot of a SnaBI-digested pG8SAET as a 
template, alongside the ExpandTM HiFi PCR System and the primers 
pG8SAET_F1 and pG8SAET_R1, as described. The forward and reverse 
primers are highlighted as red and blue respectively in the vector sequence 
below (Figure 2.10). 
 
Figure 2. 10 | PCR Amplification of Vector using Primers pG8SAET_F1/R1. Primer 
sequences are highlighted in red and blue. 
The resulting PCR product was test-ligated and used to electro-transform 
E. coli TG1 cells. These were assessed for background colonies of 
undigested vector by plating a 100-µl of serially diluted cells on LB-Amp 
agar plates and incubating overnight. As shown in Table 2.4, it was 
observed that amplification of the vector by PCR greatly reduced the 
number of background colonies resulting from uncut vector. The results 
further proved that the smallest amounts of uncut vector DNA have the 
potential to be propagated in electrotransformation, given that PCR that 
used an uncut vector as a template simply produced enormous number of 
colonies as shown below. 
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Sample Description No. of 
Colonies  
Controls  
1 Undigested pG8SAET [+ve Control] Confluent 
2 No DNA                      [-ve Control] 0 
  
3 pG8SAET [PCR with uncut template] 428 
4 pG8SAET [PCR with cut template] 6 
5 pJMK30_EcoRV_Fr 0 
Ligations  
6 pG8SAET [PCR with uncut template] + Ligase 212 
7 pG8SAET [PCR with uncut template] -  Ligase 201 
  
8 pG8SAET [PCR with cut template] + Ligase 7 
9 pG8SAET [PCR with cut template] -  Ligase 4 
  
10 pG8SAET [PCR with uncut template]+pJMK30_SmaI_Fr +Ligase 221 
11 pG8SAET [PCR with uncut template]+pJMK30_EcoRV_Fr +Ligase 198 
12 pG8SAET [PCR with cut template] + pJMK30_SmaI_Fr + Ligase 9 
13 pG8SAET [PCR with cut template] + pJMK30_EcoRV_Fr + Ligase 9 
 Table 2. 4 | Colony counts following Electrotransformation of different Vector 
Preparations using PCR and Re-ligation and Test-ligation with pJMK30_EcoRV_Fr. 
Despite the reduction in the number of background colonies following 
vector preparation by PCR, colony analysis revealed that only 20-30% of 
colonies had inserts (data not shown). The highest percentage of colonies 
with insert obtained after further optimization was 44% [see Table 2.5 
below]. 
2.7.2.2 Creation of A-Tailed Linear Vector [pG8SAET_V4] 
SnaBI-digested linear vector and PCR-amplified, dephosphorylated vector 
DNA preparations were A-tailed [pG8SAET_V4a] by incubating with 
dATP and Taq polymerase as described above. Alternatively, using a Taq 
Polymerase (Roche) and primers pG8SAET_F1 and pG8SAET_R1, the 
SnaBI-digested vector was A-tailed through PCR [pG8SAET_V4b]. This 
PCR took advantage of the property of Taq polymerase to add an 
additional non-template-SDLUHGQXFOHRWLGH WR WKH¶HQGRI3&5SURGXFWV
and this nucleotide is normally A. 
Test ligations with complementary T-tailed inserts of pJMK30_EcoRV_Fr 
gave similar results to those obtained with the blunt-ended vector. Colony 
analysis indicated that only 20-30% of clones contained an insert (data not 
shown). 
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2.7.2.3 Linear Vector with Cohesive End-termini [pG8SAET_V5] 
i. Primers were designed to amplify a linear form of the vector 
incorporating a BfuCI/BglII recognition site from an aliquot of the SnaBI-
digested vector as described (Figure 2.11). 
 
 
Figure 2. 11 | Modification of SnaBI Recognition Site of pG8SAET to BfuCI/BglII Site. 
A SnaBI-digested vector was PCR amplified with primers containing BglII restriction 
sites, which after digestion with BglII and dephosphorylation yielded a linear vector with 
BfuCI site. 
A linear vector with BfuCI/BglII recognition site was obtained (Figure 
2.13) by PCR amplification using an aliquot of a SnaBI-digested 
pG8SAET as a template, alongside the ExpandTM HiFi PCR System and 
the primers pG8SAET_F2 and pG8SAET_R2, as described. The forward 
and reverse primers are highlighted as red and blue respectively in the 
vector sequences (Figures 2.11 and 2.12). 
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Figure 2. 12 | PCR Amplification of Vector using Primers pG8SAET_F2/R2. Primer 
sequences are highlighted in red and blue. A SnaBI-digested vector was PCR amplified 
with these primers containing BglII restriction sites, which after digestion with BglII and 
dephosphorylation yielded a linear vector with BfuCI site. 
 
ii. Following PCR amplification of the vector the primer ends were 
digested using BglII restriction enzyme to yield BfuCI-compatible ends, to 
enable insertion of BfuCI-digested chromosomal DNA fragments.  
The different vector preparations were analysed by agarose gel 
electrophoresis and are shown in Figure 2.14. 
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Figure 2. 13 | Linear vector with BfuCI-end termini. Following PCR amplification of vector 
using primers pG8SAET_F2 and pG8SAET_R2, the PCR product was subjected to BglII 
digestion yielding a linear vector with BfuCI end-termini. Primer sequences are highlighted in 
red and blue. 
 
 
Figure 2. 14 | Agarose gel electrophoresis photo of DNA preparations of pG8SAET vector; 
following (a) Extraction from E. coli cells (ca. 3.5 kb), (b) after SnaBI digestion (c) after blunt-
ended PCR using SnaBI-digested phagemid as template, (d) after PCR using an undigested 
phagemid as template, (e) after BfuCI/BglII-ended PCR using SnaBI-digested phagemid as 
template and (f) nested PCR using a blunt-ended PCR product as template. The same marker 
was used in the different experiments. 
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2.7.3 Preparation of Chromosomal DNA Inserts 
2.7.3.1 Creation of Blunt-ended Chromosomal DNA Fragments 
i. Sonication of Chromosomal DNA and Polishing 
C. jejuni NCTC11168 chromosomal DNA (cDNA) was fragmented by 
sonication as described above to obtain average insert sizes of 50 to 4,000 
bp and the fragments resolved using agarose gel electrophoresis to 
determine the DNA fragment size range (Figure 2.15). Samples with 
fragments considered too large were sonicated again, while those 
containing fragments that were too small were discarded. 
 
 
Figure 2. 15 | Agarose gel electrophoresis photo of sonicated cDNA of C. jejuni 
NCTC11168. Though the initial fragment sizes obtained ranged from 50 to 3,000 bp, 
much of it was between 500 and 3000 bp. 
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The sonicated chromosomal DNA was divided into two and a portion 
blunted immediately whilst the other portion was purified using QIAquick 
gel extraction kit as described above before blunting. The chromosomal 
DNA fragments were blunted by the Klenow fragment, followed by 
further polishing with T4 DNA polymerase as described above. 
2.7.3.2 Creation of Chromosomal DNA Fragments with Cohesive 
End-termini 
i. Creation of T-tailed Chromosomal DNA Fragments 
The blunt-ended or polished fragments of C. jejuni NCTC11168 
chromosomal DNA were T-tailed to improve ligation efficiency. 
ii. BfuCI Digestion of Chromosomal DNA 
As described above, BfuCI, an isoschizomer of Sau3AI, was used to digest 
chromosomal DNA of C. jejuni NCTC11168 to give DNA fragments with 
cohesive BfuCI end-termini, as depicted in Figure 2.16. An enzyme-DNA 
concentration of 0.1 U/µg yielded the best usable fragments with sizes 
ranging between 50 and 6,000 bp (Figure 2.17). The digested 
chromosomal DNA was divided into two and a portion purified 
immediately using QIAquick PCR purification kit whilst the other portion 
was purified using QIAquick gel extraction kit as described above. 
 
 
Figure 2. 16 | BfuCI digestion of cDNA to yield fragments with BfuCI compatible end-
termini. 
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Figure 2. 17 | Agarose gel electrophoresis photo of cDNA digestion using serial dilutions of 
BfuCI. Each 20-µl reaction volume contained ca. 1 µg of cDNA. 1: 0.4U, 2: 0.2U, 3: 0.1U, 4: 
0.05U, 5: 0.025U, 6: 0.25U. An enzyme-DNA concentration of 0.1 U/µg was used in all 
subsequent reactions. Though the fragment sizes obtained ranged from 50 to 6,000 bp, gel 
purification was employed to select for sizes between 500 and 3000 bp. 
2.7.4 Preparation of Chromosomal DNA Insert Models 
The plasmid, pJMK30, containing a kanamycin resistance cassette, aphA-3, 
was selected for use to create a model to mimic chromosomal DNA fragments 
in the experimental stages of the study. 
2.7.4.1 Creation of Blunt-ended Insert Models 
i. Blunt-ended insert models were obtained through restriction 
digestion of pJMK30 with EcoRV and SmaI. EcoRV digestion yielded two 
blunt-ended fragments with approximate sizes of 3160 and 1025 bp, whilst 
SmaI digestion yielded two blunt-ended fragments with approximate sizes 
2834 and 1359 bp [see Figure 2.6 and Figure 2.18]. The fragments of 
interest were the 1025-bp and the 1359-bp fragments from EcoRV and 
SmaI digestions [pJMK30_EcoRV_Fr and pJMK30_SmaI_Fr], the latter 
containing the kanamycin resistance cassette. Although the 
pJMK30_EcoRV_Fr did not contain a kanamycin resistance cassette, it 
was used as in sert model due to its smaller size. 
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ii. Polishing of EcoRV or SmaI Fragment of pJMK30 
In order to prevent self-ligation of the EcoRV and SmaI digested 
fragments [pJMK30_EcoRV_Fr and pJMK30_SmaI_Fr], they were 
polished as previously described to produce blunt-ended fragments. 
2.7.4.2 Creation of Insert Model with Cohesive End-termini 
i. Creation of T-tailed Insert Model 
The blunt-ended or polished pJMK30 fragments from the EcoRV and the 
SmaI digestion [pJMK30_EcoRV_Fr and pJMK30_SmaI_Fr] were T-
tailed to improve ligation efficiency. 
ii. BamHI Digestion of pJMK30 
Using BamHI, pJMK30 was digested to yield two fragments with 
approximate sizes of 2834 and 1359 bp [see Figure 2.6 and Figure 2.18] 
with cohesive BfuCI compatible end-termini as depicted in Figure 2.16. 
The smaller 1359-bp fragment containing the Kanr cassette was used 
(Figure 2.18, 1). 
 
Figure 2. 18 | Agarose gel photo of pJMK30 and fragments. Purified fragments were (1) 
pJMK_BamHI_Fr, (2) pJMK_SmaI_Fr and (3) pJMK_EcoRV_Fr, following restriction 
digest with BamHI, SmaI and EcoRV respectively. 
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2.7.5 Test Ligations 
Various combinations of vector and insert preparations as previously 
described, are given below. 
i. pG8SAET_V2 + Blunt-ended inserts 
ii. pG8SAET_V3 + Blunt-ended inserts 
iii. pG8SAET_V4a + T-tailed inserts 
iv. pG8SAET_V4b + T-tailed inserts 
v. pG8SAET_V5 + BfuCI-ended inserts 
Ligation reactions were set up with amounts of vector and insert DNA based 
on the calculation given in box 1. Following several test ligations, a vector-
insert ratio of 1:3 was found to give best results and was subsequently used in 
setting up ligation reactions. 
As described earlier, each single ligation reaction was re-suspended in 10 µl of 
nuclease-free deionised water after purification and 5 µl of the resulting DNA 
transformed into 50 µl of E. coli TG1 cells$IWHUDQKRXU¶VUHFRYHU\LQ62&
medium, a 100-µl aliquot of the serially diluted transformed E. coli TG1 cells 
was plated on LB agar containing 200 µg/ml of ampicillin (LB-Amp agar) or 
200 µg/ml of ampicillin and 50 µg/ml of kanamycin (LB-Amp/Kan agar) as 
appropriate, and incubated at 37°C overnight. Viable colonies were counted 
manually to estimate the number of E. coli transformants and the percentage 
of recombinant clones. 
Following several ligation experiments, the highest obtainable percentage 
insert rate, using blunt-ended vector and blunt-ended inserts, was 16% (Table 
2.5). Ligations using blunt-ended vector obtained from SnaBI digest 
[pG8SAET_V2] produced as low as 10% insert rate. T-tailing of inserts and 
A-tailing of the vector led to an improvement in ligation efficiency; the 
highest percentage insert rate obtained was 44%. 
Using BfuCI-ended vector and BfuCI-ended inserts led to a significant 
increase in the ligation efficiency, yielding as high as 100% insert rate in 
several instances, with the least being 90% [see Table 2.6]. The ligation 
efficiency following this methodology of DNA preparation was also readily 
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visible on agarose gels when the reaction mixtures were resolved by 
electrophoresis (Figure 2.19). This method was therefore chosen for the 
construction of the C. jejuni NCTC11168 phage display libraries. 
 
 
Figure 2. 19 | Agarose gel electrophoresis photo of test ligations using BfuCI-compatible 
vector and inserts. 1: pG8SAET PCR product, before treatment with BglII does not self-ligate. 
2: But self-ligates following treatment with BglII. 3: Dephosphorylation after treatment with 
BglII prevents the PCR of the vector from self-ligating. 4&5: Although some ligation is 
observed following BglII treatment of PCR-generated vector in the presence of 
pJMK30_BamHI fragments or BfuCI-digested cDNA fragments, the ligation is even better 
following dephosphorylation (6&7). 8: BfuCI-digested cDNA. 
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Table 2. 5 | Colony counts following electrotransformation E. coli TG1 cells with test-ligations 
using different vector and insert preparations. Apart from the original SnaBI-digested vector, 
pG8SAET_V2, all vector preparations used in the above test-ligations were PCR-generated to 
reduce background colonies resulting from uncut vector as previously discussed. The presence of 
an insert was determined using PCR or the number of colonies on an Amp/Kan agar plate in the 
case of SmaI_Fr. 
  
 
Sample 
 
Description 
No. of 
Colonies  
Amp Plates 
No. of Col  
Amp/Kan 
Plates 
Percentage 
(%) 
 Insert 
Controls 
 
1 No DNA         [-ve Control] 0 0 
 
2 pG8SAET_V1 [+ve Control of undigested pG8SAET] Confluent 0 
 
 
 
3 pG8SAET_V2 [SnaBI-digested, Blunt-ended vector] 122 0 
 
4 pG8SAET_V3 [PCR-generated, Blunt-ended vector] 8 0 
 
5 pG8SAET_V4a [A-tailed  pG8SAET_V3] 4 0 
 
6 pG8SAET_V4b [PCR-generated, A-tailed vector] 2 0 
 
7 pG8SAET_V5 [PCR-generated, BglII-digested vector] 4 0 
 
 
 
8 pJMK30_SmaI_Fr 2 2 
 
9 Blunt-ended cDNA Fragments 0 0 
 
10 pJMK30_BamHI_Fr 2 1 
 
11 BfuCI-ended cDNA Fragments 0 0 
 
Ligations 
12 pG8SAET_V2 + pJMK30_SmaI_Fr 132 13 10 
13 pG8SAET_V2 + Blunt-ended cDNA Fragments 137 0 14 
14 pG8SAET_V3 + pJMK30_SmaI_Fr 111 15 15 
15 pG8SAET_V3 + Blunt-ended cDNA Fragments 109 0 16 
  
16 pG8SAET_V4a + T-tailed pJMK30_SmaI_Fr 122 29 24 
17 pG8SAET_V4a + T-tailed pJMK30_EcoRV_Fr 108 2 18 
18 pG8SAET_V4a + T-tailed cDNA Fragments 126 0 20 
19 pG8SAET_V4b + T-tailed pJMK30_SmaI_Fr 138 61 44 
21 pG8SAET_V4b + T-tailed pJMK30_EcoRV_Fr 117 1 22 
22 pG8SAET_V4b + T-tailed cDNA Fragments 134 0 32 
  
23 pG8SAET_V5 + pJMK30_BamHI_Fr 194 195 100 
24 pG8SAET_V5 +  BfuCI-ended cDNA Fragments 188 0 95 
CHAPTER TWO 
 
 
Harry H Abruquah | Identification of host-pathogen interacting molecules of Campylobacter jejuni  
PhD Thesis | Microbiology | March 2009 
121 
 
2.7.6 Parallel Libraries 
To ascertain that the use of BfuCI-ended vector and BfuCI-ended inserts would 
yield libraries of sufficient complexities, parallel libraries were constructed 
using chromosomal DNA of Neisseria meningitidis MC58, Helicobacter 
pylori J99, as well as chromosomal DNA of C. jejuni NCTC11168, and their 
indices determined. As can be seen in Table 2.6, the transformation rates were 
almost the same for size-selected DNA preparations and column purified 
DNA preparations that included very small fragments of DNA as well as 
larger ones. However, the percentage insert rates or ligation efficiencies were 
higher for the former DNA preparations than for the latter. The resulting 
libraries from both forms of DNA preparations had very high titres of 1011 
comparable to published data (Mullen et al., 2007a; Zhu et al., 2008). 
 
Libraries No. of E. coli Transforman
ts (cfu/ml) 
Percentage 
Insert  
% 
Complexity 
(cfu/ml x 
%Ins) 
Titre  
(pfu/ml) 
1 : N. Meningitidis MC58     
(Column Purified DNA) 5.0 x 106 90 4.5 x 106 -- 
(Gel Purified DNA) 2.0 x 106 98 2.0 x 106 -- 
  
2: H. pylori J99     
(Column Purified DNA) 5.4 x 107 90 4.9 x 107 -- 
(Gel Purified DNA) 5.5 x 106 100 5.5 x 106 -- 
 
3: C. jejuni NCTC11168     
(Column Purified DNA) 2.7 x 107 96 2.6 x 107 2.0 x 1012 
(Gel Purified DNA) 4.4 x 106 100 4.4 x 106 2.6 x 1011 
 
4: C. jejuni NCTC11168     
(Column Purified DNA) 3.22 x 107 90 2.9 x 107 2.6 x 1011 
(Gel Purified DNA) 2.30 x 107 100 2.3 x 107 2.1 x 1011 
Table 2. 6 | Indices of Parallel Libraries using BfuCI-ended vector and BfuCI-digested 
chromosomal DNAs of N. meningitidis MC58, H. pylori J99, and C. jejuni NCTC1168. 
2.7.7 Construction of C. jejuni NCTC11168 Phage Display Libraries 
Two libraries, Cj11168 Library I and Cj11168 Library II, were constructed 
from BfuCI-digested chromosomal DNA of C. jejuni NCTC11168. Whereas 
the DNA used in Cj11168 Library I was simply column-purified with 
QIAquick PCR purification kit without size-selection, the DNA used in 
Cj11168 Library II was gel-purified selecting for fragment sizes of 300-3000 
bp. Each covered the whole genome of C. jejuni NCTC11168 several times 
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over. To determine the adequate number of ligations needed in such an 
experiment the following calculations were used: 
i. Estimated number of Clones needed in this library 
From the preliminary experiments, each 20 µl of ligation reaction contained 
200 ng of phage vector and 264 ng of chromosomal DNA. Following clean up 
and re-suspension in a final volume of 10 µl, 5µl of this was used to transform 
50 µl of E. coli TG1 cells and 950 µl of SOC medium was added to enable 
cells to recover. It was determined that 100 µl of this culture yielded 
approximately 18,000 colonies, which implied that 1,000 µl of culture would 
give 10 × 18,000 colonies i.e. 180,000. It could therefore be inferred that one 
ligation mixture of 10 µl would give twice as many colonies i.e. 2 × 180,000 
[360,000] colonies or clones. To obtain 1,000,000 or 1,600,000 clones based 
on the calculations in box 2 above, 3 - 4 ligations were needed to give 3 × 
360, 000 [1,080,000] and 4 × 360, 000 [1,800,000] colonies.  
Six ligation reactions were however set up for each library to ensure that each 
covered the entire genome of C. jejuni NCTC11168. 
2.7.8 Determination of Library Indices 
i. Estimation of Number of E. coli Transformants/Transformation 
Efficiency 
A 10-fold serial dilution of the electrotransformed E. coli TG1 cells was plated 
on LB-Amp agar plates and incubated at 37°C overnight. Colonies were 
counted manually and the number of E. coli transformants determined. 
The transformation efficiency for Cj11168 Library I was 3.42× 106, whilst that 
of Cj11168 Library II was 2.13 × 106. These conformed to published data. 
ii. Colony Analysis/Complexity of Libraries 
The DNAs of 24 and 23 randomly selected clones from each of libraries I and 
II respectively were analysed for the presence or otherwise of an insert, the 
size of the insert, and whether or not the inserts were of C. jejuni NCTC11168. 
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Whilst the percentage insert rate for Cj11168 Library I was 95.8%, with an 
average insert size of ca. 600 (Figure 2.20), that of Cj11168 Library II was 
100% with average insert size of ca. 1250 (Figure 2.21). The complexities of 
the libraries were calculated as the products of the percentage insert and the 
number of E. coli transformants i.e. the ratio of E. coli transformants carrying 
inserts. These are given in Table 2.7 below. 
By sequencing 10 randomly selected clones from each of Cj11168 Library I 
and Cj11168 Library II, all the inserts were confirmed to have 100% identity 
with C. jejuni NCTC11168 by BLAST searching the bacterial genome 
database. All 20 clones matched different genes, indicating the insert diversity 
of the libraries. 
iii. Titration of Libraries 
Following infection of 90-µl aliquot of E. coli TG1 with 10 µl of rescued 
phage, a 10-fold serial dilution of this was carried out and 90 µl of each 
dilution plated on LB-Amp agar plates incubated at 37°C overnight. Colonies 
were counted for each dilution and the titres of each library determined. 
The titre for Cj11168 Library I was 3.0 × 1011, whilst that of Cj11168 Library 
II was 3.3 × 1011. These conformed to published data (Mullen et al., 2007a; 
Zhu et al., 2008). 
Table 2. 7 | Summary of Library Indices of Cj11168 Library I and Cj11168 Library II. Library I 
was constructed from chromosomal DNA fragments that were not size-selected and hence 
contained small as well as large fragments, whilst library II was constructed from chromosomal 
DNA fragments that were size-selected using agarose gel extraction.  
 
Phage Display Libraries of 
C. jejuni NCTC11168 
No. of E. coli 
Transformants 
(cfu/ml) 
Percentage 
Insert  
(%) 
Complexity 
(cfu/ml × 
%Ins) 
Titre of 
Libraries 
(pfu/ml) 
Average 
Insert Size 
(bp) 
Library I (Col Purified DNA) 3.42 × 107 95.8 3.28 × 107 3.0 × 1011 611 
Library II (Gel Purified DNA) 2.13 × 107 100 2.13 × 107 3.3 × 1011 1247 
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Figure 2. 20 | Agarose gel photo of PCR of 24 randomly selected clones of Cj11168 Library I. Chromosomal DNA used in the construction of this library was not size-purified and therefore 
contained some very small inserts. The analysis also shows that only one clone had no insert i.e. 95.8% insert rate. There were two clones with inserts as large as 2,500 bp. 
 
 
 
Figure 2. 21 | Agarose gel photo of PCR of 23 randomly selected clones of Cj11168 Library II. Chromosomal DNA used in the construction of this library was size-purified and therefore 
contained very large inserts of 500 to 2,500 bp. The analysis also shows that all the clones had inserts i.e. 100% insert rate. 
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2.8 Discussion 
The phage display libraries, Cj11168 Library I and Cj11168 Library II, were 
constructed in the phagemid pG8SAET vector (Jacobsson et al., 2003). The 
construction of phage display libraries involves meticulous manipulation of 
DNA, cloning and transformation of E. coli cells, the latter also involving the 
use of appropriately purified DNA. It was therefore imperative that DNA 
extraction and purification methods were employed to maximize DNA yield, 
eliminate salt and silica contaminants following enzymatic reactions to ensure 
efficient cloning and transformations. 
The columns of the QIAquick PCR purification kit (Qiagen) can hold up to 10 
JRI'1$DFFRUGLQJWRWKHPDQXIDFWXUHU¶VPDQXDO7KXVXVLQJDVWDUWLQJ'1$
amount of ca. 10 µg, 91% of this was recoverable. The same amounts of DNA 
were employed in the other purification methods, facilitating comparison of the 
several methods employed in the construction of the libraries. The amount of 
recoverable DNA following the use of ethanol alone or iso-propanol alone was 
minimal necessitating the use of phenol-chloroform-isoamyl alcohol, which 
provided an aqueous inter-phase into which DNA aggregated for onward 
precipitation. The use of phenol-chloroform-isoamyl alcohol with yeast tRNA 
therefore proved superior to the other precipitation methods. 
In order to insert a foreign DNA the circular vector, pG8SAET, needed to be 
linearized and processed such that self-ligation was minimised. This proved to 
be more difficult than anticipated. Several methods were assessed to arrive at a 
methodology that eliminated background colonies resulting from uncut 
phagemid to an acceptable level. Based on the appearance of the digested 
product on agarose gel, 5 U of SnaBI enzyme/µg of vector DNA incubated at 
37°C overnight resulted in an optimal digest, whilst longer incubation periods or 
increased amount of enzyme resulted in star activity confirming that any 
restriction endonuclease can be made to cleave non-canonical sites under certain 
extreme conditions (Nasri & Thomas, 1986).  
The resulting product was not devoid of background colonies from uncut 
phagemid, making this method unfit for the required purposes. Although 
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purification of the digested vector using QIAquick gel extraction kit led to a 
reduction in the level of background colonies, it also reduced the ligation 
efficiency of the vector [see Table 2.3 and Figure 2.9]. This led us to resort to 
the use of PCR in amplifying the linear vector. As depicted in Table 2.4, PCR 
amplification of the vector using SnaBI-digested DNA led to the reduction of 
background colonies, whilst using uncut vector DNA still gave a large number 
of background colonies. 
Following elimination of the background colonies from uncut phagemid, blunt-
ended ligation with chromosomal DNA fragments resulted in a very low ligation 
efficiency. This therefore warranted the manipulation of the linear vector and 
the chromosomal DNA inserts to maximize ligation efficiency. Whereas A-
tailing of the linearized vector improved the ligation efficiency to 20-44% over 
the blunt-ended vector (Table 2.5), this was still significantly lower than ligation 
efficiencies reported by others (Jacobsson et al., 2003; Mullen et al., 2007b). 
Forthwith, the SnaBI restriction site within the original vector sequence was 
manipulated by PCR to produce a BfuCI restriction site. Ligations using such a 
BfuCI-ended vector with chromosomal DNA fragments with compatible end-
termini resulted in efficiencies of between 90 and 100% [see Figure 2.19 and 
Table 2.5]. This high ligation efficiency using BfuCI compatible vector and 
insert was further proven in the construction of other libraries that used 
chromosomal DNA from N. meningitidis MC58, H. pylori J99 and C. jejuni 
NCTC11168 (see Table 2.6). However, given that restriction endonucleases can 
only cut where enzyme sites exist, employing restriction digested DNA 
fragments in this kind of library would mean that some genes within the genome 
may never be represented as expressed proteins in the library.  
In panning experiments, true affinity selection is manifested by the isolation of 
clones with different inserts but emanating from the same gene i.e. overlapping 
sequences (Jacobsson et al., 2003; Mullen et al., 2007b). Isolation of 
overlapping sequences could be analysed to localise the binding domain of a 
gene to a specific ligand (Bjerketorp et al., 2004; Zhang et al., 2007b). 
However, with the use of restriction digested DNA fragments in this kind of 
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library, it may be theoretically impossible to obtain overlapping sequences in 
panning experiments.  
To overcome these disadvantages, two libraries were constructed; Cj11168 
Library I, which used column-purified DNA fragments made up of a wide range 
of different sizes from 50 to 4000 bp and Cj11168 Library II, which used gel-
purified DNA fragments made up of sizes ranging between 300 and 3000 bp, 
with each covering the genome of C. jejuni NCTC11168 several times over. 
The high insert rates in these phage display libraries of C. jejuni NCTC11168, 
together with the high complexities and high titres, are indicative of good 
genomic libraries (Jacobsson et al., 2003; Mullen et al., 2007b). Given that no 
such library has been described for C. jejuni, these will serve as rich resources 
for further host-pathogen protein interaction studies of C. jejuni for years to 
come. 
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CHAPTER THREE 
3.0 Panning of Phage Library of C. jejuni NCTC11168 
3.1 Introduction 
Screening of phage display libraries is done through a technique called 
³SDQQLQJ´ LQ ZKLFK SKDJH displaying different peptides or proteins are 
incubated with a ligand of interest and then bound phage eluted, amplified and 
analysed (Azzazy & Highsmith, 2002; Mullen et al., 2007a; Newton & 
Deutscher, 2008). As depicted in Figure 3.1, panning is conceptually simple but 
can be fraught with technical difficulties that can render it cumbersome (Kehoe 
& Kay, 2005). 
In theory, only one cycle of panning is ideal to select for phage particles that 
bind to the ligand of interest, but in practice the binding of non-specific phage 
particles places limitations on the use of single cycle enrichment (Azzazy & 
Highsmith, 2002; Kehoe & Kay, 2005). Thus, two or three rounds of panning 
may be necessary in selecting for true ligand-specific phage particles. 
This chapter describes the panning of the phage display library of C. jejuni 
NCTC11168. Various modifications that have been applied to the basic 
principle of panning for screening phage display-libraries have also been 
discussed. 
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Figure 3. 1 | A Schematic representation of panning of phage-display library. Phage 
displaying different peptides or proteins are incubated with a ligand of interest, and then 
washed to remove any unbound phage particles. The bound phage particles are then eluted 
and amplified in an appropriate E. coli host. The process is repeated as needed to enrich 
clones that specifically bind to the ligand of interest [Drawing based on principle from Azzazy 
& Highsmith, 2002; Mullen et al, 2007]. 
3.1.1 Panning against Immobilized Ligands 
Many researchers have performed panning of phage display libraries by 
immobilizing the ligands of interest, dissolved in appropriate buffer, on a 
plastic surface such as immunotubes (Maxisorb tubes, Nunc) or ELISA plates 
(Jacobsson & Frykberg, 2001a; Mullen et al., 2007a). Phage particles are then 
added and allowed to interact with the immobilized ligand over time. The 
immunotubes or ELISA plates are then washed to discard non-binding clones, 
whilst specific binders are eluted by lowering the starting pH and then 
amplified in E. coli cells. Using affinity columns charged with an appropriate 
ligand, phage display libraries can be screened by passing the phage particles 
through these columns (Azzazy & Highsmith, 2002). The columns are then 
washed to discard non-binding clones, whilst specific binders are eluted and 
amplified in E. coli cells. 
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Despite its widespread use, immobilization of ligands on solid surfaces may 
affect the conformational integrity of the ligand. Thus, phage-displayed 
peptides or proteins that may bind to the ligand in this form may subsequently 
not bind the protein in its native form (Azzazy & Highsmith, 2002). 
3.1.2 Panning against Ligands in Solution 
To overcome the conformational changes associated with immobilization of 
ligands on solid surfaces, panning of phage display libraries can also be 
carried out in solution (Azzazy & Highsmith, 2002). The ligand can be 
biotinylated and incubated with the phage particles. The phage particles bound 
to the biotinylated-ligand are then recovered using streptavidin-coated 
paramagnetic beads and subsequently dissociated from the ligand.  
Although this method eliminates the need for several rounds of panning, it can 
be limited by the presence or isolation of other peptides that may specifically 
bind to streptavidin. 
3.1.3 Panning against Cells 
Otherwise known as bio-panning, ligands present on cells can be employed in 
panning a library for peptides or proteins that bind to such molecules. This can 
be useful in selecting for antibodies or adhesion molecules to specific markers 
on cell surfaces from phage display libraries (Azzazy & Highsmith, 2002). 
Typically, the phage library is incubated on monolayers of cells adherent to 
tissue culture flasks or in suspension with cells. The unbound phage particles 
are washed away by rinsing the tissue culture flask or by centrifugation of cell 
suspension, and then specifically binding phage isolated for subsequent 
infection of the appropriate E. coli strains. 
To increase the sensitivity of this methodology, a competitive binding 
technique may be used, in which a small number of ligand-positive cells is 
diluted with an excess of ligand-QHJDWLYH ³DEVRUEHU´ FHOOV EHIRUH WKH SKDJH
particles are added. The absorber cells serve as a sink for non-specific binders, 
thereby increasing the specificity of the panning for highly specific binders of 
the ligand-positive cells. 
CHAPTER THREE 
 
 
Harry H Abruquah | Identification of host-pathogen interacting molecules of Campylobacter jejuni  
PhD Thesis | Microbiology | March 2009 
132 
 
3.1.4 In vivo Panning 
Injecting phage-displayed particles directly into live animals and examining 
tissues of the slaughtered animals for bound phage is another methodology 
used in panning libraries (Trepel et al., 2008). This is best applied in natural 
peptide libraries, especially antibody libraries (Pasqualini & Ruoslahti, 1996a; 
Pasqualini & Ruoslahti, 1996b; Yao et al., 2005). One advantage of this 
approach is that there is an inherent blocking step where phage-displayed 
peptides that recognise ubiquitous plasma and cell surface proteins are 
eliminated before reaching the targets of interest, thus, these targets are not 
missed (Trepel et al., 2002). Furthermore, the binding-peptides may provide 
useful information on host-pathogen interactions and may lead to the 
identification of new drugs and drug receptors (Christianson et al., 2007). 
In summary, the principles of panning of phage display libraries may seem 
simple, but they cannot be said to have no practical difficulties since different 
laboratories have experienced and reported numerous problems (Azzazy & 
Highsmith, 2002). In many instances, pannings have failed to enrich for highly 
specific binders, resulting in recovery of only low-affinity peptides (Mullen et 
al., 2007a). In many cases, comparison of insert sizes between different cycles 
of panning has shown that the fraction of phage with full-size inserts 
decreased following amplification since phage with smaller inserts tend to 
outgrow the former in mixed cultures (de Bruin et al., 1999). 
The panning of phage display library of C. jejuni NCTC11168 described here 
was done against immobilized ligands. 
3.2 Selection of Ligands 
3.2.1 Iron acquisition in C. jejuni 
Iron is essential in several metabolic pathways of bacteria, including C. jejuni, 
but much of it is available in the human host as Fe3+ complex with host iron-
binding and transport proteins such as haemoglobin (Hb), transferrin (Tf), and 
lactoferrin (Lf) (Payne & Finkelstein, 1978; Perez-Perez & Israel, 2000). In 
fact, excess free iron results in cellular damage through the formation of 
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harmful free radicals through the Haber-Weiss and Fenton reactions (Ratledge 
& Dover, 2000; Wally & Buchanan, 2007).  
Bacterial pathogens can sequester iron through: (i) release of low-molecular-
weight siderophores; (ii) active haem uptake; and (iii) host iron-binding and 
transport proteins (Parkkinen et al., 2002). Thus, with iron mostly in complex 
with host iron-binding and transport proteins it is mostly accessed by bacteria 
through specialised iron uptake systems  (Andrews et al., 2003).  
The importance of iron to Campylobacter has long been well-emphasised. 
Campylobacter cells grown in low-iron medium have been documented to 
exhibit slower growth rates and altered cellular morphology, as well as 
reduced toxin production (Field et al., 1986; McCardell et al., 1986). This 
importance is further emphasised by the presence of genes encoding multiple 
iron acquisition systems as well as detoxification systems indicating the 
central role that iron plays in Campylobacter gene regulation and virulence 
(Holmes et al., 2005; van Vliet et al., 2002). 
As stated earlier, the three well-known uptake systems in the C. jejuni genome 
are: (i) a haem/haemoglobulin uptake system called chuABCD; (ii) a 
periplasmic binding-protein-dependent transport (PBT) system for the uptake 
of a ferric enterochelin (cfrA and ceuBCDE); and (iii) a ferric siderophore 
uptake system, fhuABD (Galindo et al., 2001; Palyada et al., 2004; Richardson 
& Park, 1995; Ridley et al., 2006). The two predicted but yet to be 
characterized iron uptake systems are Cj1658-Cj1663 and Cj0173c-Cj0178 
(Parkhill et al., 2000). There has been some interest in the C. jejuni iron 
transporter operon akin to the E. coli feoAB operon for some time. The recent 
demonstration by Naikare et al. that FeoB is actually involved in ferrous iron 
acquisition in C. jejuni, contributing significantly to colonization of the 
gastrointestinal tract during both commensal and infectious relationships has 
rekindle our interest in this operon although these findings contradicts a 
previous assertion by Raphael and Jones that this operon played no role in iron 
acquisition (Naikare et al., 2006; Raphael & Joens, 2003).  
The response of the organism to environmental changes in iron concentrations 
is believed to be regulated by two paralogous genes, the ferric uptake regulator 
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(fur) gene and the peroxide repressor (perR) gene (Holmes et al., 2005; van 
Vliet et al., 1999; Wooldridge et al., 1994).  
Furthermore, the lipoprotein component of the ceuBCDE operon, encoded by 
ceuE, is thought to confer a haemolytic phenotype thus complicating our 
understanding of iron acquisition in C. jejuni (Park & Richardson, 1995).  
It is therefore imperative that Campylobacter researchers sought further 
clarification on the mechanism of iron acquisition in the organism.  
Although several pathogenic organisms including H. pylori and N. 
meningitidis have been reported to utilise iron bound to lactoferrin it has 
previously been thought that this iron source cannot be used by C. jejuni 
(Husson et al., 1993; Pickett et al., 1992). However, Miller and co-workers 
have recently shown that there is bacterial growth following supplementation 
of iron-deficient medium MEM with Lf-bound and Tf-bound iron, which is 
comparable to supplementation with FeSO4 (Miller et al., 2008). Mutation of 
an 84.1-kDa outer membrane protein gene, Cj0178, previously thought to be a 
probable siderophore, led to a significant reduction in growth in the presence 
of Lf-bound and Tf-bound iron, suggesting that the product of this gene may 
be involved in Lf or Tf binding for iron uptake, and possibly contributing to C. 
jejuni pathogenesis (Miller et al., 2008; Palyada et al., 2004).  
Since the growth promoting effect of Lf is not completely abolished in Cj0178 
mutants, it is likely that other, as yet unidentified, proteins may also be 
involved in the acquisition of iron from Lf in C. jejuni (Miller et al., 2008). 
Cogan et al., showed that exposure of Campylobacter to the mammalian 
neuroendocrine hormone norepinephrine causes an increase in the virulence-
associated properties of the organism (Cogan et al., 2007). Since 
norepinephrine is known to be capable of supplying iron for bacterial growth 
in the presence of Tf or Lf, it can be hypothesised that Campylobacter made 
XVHRI/ILQ&RJDQ¶VH[SHULPHQWV(Anderson & Armstrong, 2008; Cogan et al., 
2007; Freestone et al., 2000).  Indeed, as C. jejuni is a mucosal pathogen, it is 
likely to rely on Lf for iron acquisition.  
For these reasons, therefore, Lf was chosen as a ligand to pan the C. jejuni 
NCTC11168 phage display library.  Lf represented an ideal ligand because the 
CHAPTER THREE 
 
 
Harry H Abruquah | Identification of host-pathogen interacting molecules of Campylobacter jejuni  
PhD Thesis | Microbiology | March 2009 
135 
 
C. jejuni gene, Cj0178, is a likely candidate protein that would provide a 
target for potential validation of the panning against Lf, in an attempt to 
identify other uncharacterised Campylobacter proteins that may be involved in 
binding to Lf, and hence in C. jejuni iron acquisition. 
Tf, Fn and BSA were also used as control ligands in validation of the library 
and optimisation of the panning protocol. 
3.2.2 Lactoferrin 
Lactoferrin (Lf), belonging to the transferrin family of proteins, is a non-haem 
iron-binding protein that shares the same properties with serum Tf, 
ovotransferrin and melanotransferrin (Gonzalez-Chavez et al., 2008; Gray-
Owen & Schryvers, 1996; Singh et al., 2002). It is an 80-kDa glycosylated 
protein of approximately 700 amino acids, with a simple folding structure of 
two symmetrical lobes, N and C, connected by a hinge (Legrand et al., 2008). 
(DFK OREH LV PDGH XS RI Į-KHOL[ DQG ȕ-pleated sheets, with each capable of 
binding to an Fe2+ or Fe3+, but also to Cu2+, Zn2+ and Mn2+ (Gonzalez-Chavez 
et al., 2008). It has a homology of 33-41% among different species, with the 
asparagine residues in both the N- and C-terminal lobes providing sites for N-
glycosylation of the protein (Baker & Baker, 2009; Tomita et al., 2009). 
Due to its ability to bind reversibly to Fe3+, Lf can exist free of the metal (apo-
Lf) or in complex with it (holo-Lf) changing the three-dimensional 
conformation in so doing (Pierce & Legrand, 2009). Whereas apo-Lf has an 
open conformation, holo-Lf is closed and hence resistant to proteolysis 
(Legrand et al., 2008). 
Ubiquitous in most mammalian secretions, Lf is a glycoprotein produced by 
mucosal epithelial cells and is abundant in milk and gastrointestinal fluids 
including bile and saliva (Pierce & Legrand, 2009). Lf is also found in 
significant amounts in secondary neutrophils, tear, semen, vaginal fluid, urine, 
amniotic fluid, plasma and is most abundant in milk and colostrum, playing 
various physiological roles such as regulation of iron absorption in the bowel, 
immune response and anti-microbial activity (Gonzalez-Chavez et al., 2008; 
Ochoa & Cleary, 2009; Puddu et al., 2009; Wong et al., 2009). 
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Aside its main function of transporting iron, Lf is also known for its anti-
microbial, anti-carcinogenic, and enzymatic activities both in vitro and in vivo, 
as well as for its immunomodulatory  and anti-inflammatory roles (Iigo et al., 
2009; Jenssen & Hancock, 2009; Leon-Sicairos et al., 2009; Li et al., 2009; 
Mohan & Abrams, 2009; Ochoa & Cleary, 2009; Paesano et al., 2009; Puddu 
et al., 2009; Wong et al., 2009; Yen et al., 2009). It is believed that the anti-
microbial effect of Lf is achieved through two main mechanisms, namely, 
sequestration of iron at sites of infection, depriving micro-organisms of this 
QXWULHQW ZKLFK VXEVHTXHQWO\ OHDGV WR D ³EDFWHULRVWDWLF-OLNH´ HIIHFW DQG
interaction of the positive amino acids in Lf with anionic molecules on some 
bacterial, fungal, and parasite surfaces causing cell lysis (Gonzalez-Chavez et 
al., 2008; Jenssen & Hancock, 2009; Leon-Sicairos et al., 2009; Mohan & 
Abrams, 2009; Ochoa & Cleary, 2009; Onishi et al., 2008). However, the 
interaction of the highly cationic lactoferricin moiety of Lf with the anionic 
surface structures of some organisms are known to inhibit the anti-microbial 
effect of Lf, enabling them to utilise Lf-bound iron (Senkovich et al., 2007). 
It is therefore not surprising that despite its wide range of anti-microbial 
activity, several micro-organisms including Helicobacter pylori, Prevotella 
nigrescens, Clostridium species have long been known to utilise Lf as an iron 
source (de Lillo & Fierro, 1997; Dhaenens et al., 1999; Husson et al., 1993; 
Jarosik & Land, 2000; Tomita et al., 1998). It is also purported that Lf has a 
positive influence on the growth of L. acidophilus and Bifidobacterium species 
(Kim et al., 2004). Other pathogens known to utilise Lf iron include Neisseria 
meningitidis, Streptococcus pneumoniae, Haemophilus influenzae, 
Staphylococcus species, Bordetella species, Treponema species, Gardnerella 
vaginalis, and Tritrichomonas foetus (Fang & Oliver, 1999; Grab et al., 2001; 
Hammerschmidt et al., 1999; Jarosik & Land, 2000; Menozzi et al., 1991; 
Naidu et al., 1992; Park et al., 2002a; Schryvers & Morris, 1988; Schryvers, 
1989; Staggs et al., 1994). Other organisms also known to utilise Lf iron 
include Enterobacter sakazakii and Entamoeba histolytica (Kim et al., 2002; 
Leon-Sicairos et al., 2005; Wakabayashi et al., 2008). Recently, two 
membrane proteins of the parasite, Toxoplasma gondii, have been described as 
being involved in Lf-binding and acquisition of iron (Dziadek et al., 2007). 
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3.2.3 Transferrin 
Transferrin (Tf), like Lf, is also a non-haem iron-binding protein of the 
transferrin protein family with a molecular weight of ca. 79 kDa (Gomme et 
al., 2005). In the mammalian body, Tf functions as an iron transporter from 
sites of iron absorption and sites of iron recycling to all tissues involved in 
erythropoiesis or active cell division (Macedo & de Sousa, 2008). Again, Tf 
can exist free of Fe3+ (apo-Tf) or in complex with it (holo-Tf) changing the 
three-dimensional conformation in so doing (Hirayama et al., 1990). 
By binding to holo-Tf via bacterial Tf-like receptors, microbial pathogens can 
sequester iron through Tf (Parkkinen et al., 2002). Although the utilisation of 
Lf- and Tf-bound iron has been described in several pathogenic organisms, 
this was not the case for C. jejuni until Miller et al. recently reported their 
observation in support of this (Miller et al., 2008). 
By virtue of the close similarity of Tf to Lf in its structure and function, it was 
also chosen as a target ligand for screening the library. 
3.2.4 Fibronectin 
Fibronectin (Fn) is a larger glycoprotein with a molecular weight of ca. 440 
kDa that serves as a general cell adhesion molecule to anchor cells to collagen 
or proteoglycan substrates (Pankov & Yamada, 2002). A component of the 
extracellular matrix (ECM), Fn can mediate cellular interaction with the ECM 
through its binding to membrane-bound Fn receptors on the surfaces of 
numerous pathogens including Campylobacter (Graham et al., 2008). 
C. jejuni was shown to bind to Fn through a 37-kDa outer-membrane protein, 
CadF (Campylobacter adhesion to Fn) in the late 1990s (Konkel et al., 1997). 
CadF has since been shown to mediate the binding of Campylobacter species 
to Fn, and has also been utilised in the identification of both C. jejuni and C. 
coli (Konkel et al., 1999a; Ziprin et al., 1999). 
Prior to the identification of CadF, several studies had shown that C. jejuni 
was capable of binding to ECM and Fn (Kuusela et al., 1989; Moser & 
Schroder, 1995; Moser et al., 1997). Following its identification, CadF has 
CHAPTER THREE 
 
 
Harry H Abruquah | Identification of host-pathogen interacting molecules of Campylobacter jejuni  
PhD Thesis | Microbiology | March 2009 
138 
 
been shown to be not only necessary for adherence of Campylobacter to 
enterocytes, but also required for internalization of the organism (Graham et 
al., 2008; Krause-Gruszczynska et al., 2007; Monteville et al., 2003). In fact, 
the native form, as well as truncated form, of this Fn-binding protein of 
Campylobacter has been expressed and the Fn-binding domain identified 
(Konkel et al., 2005; Mamelli et al., 2006). 
Based on the above evidence, Fn was selected as one of the ligands for the 
panning experiments described in this chapter, purely to serve as a positive 
control, since it was expected to pick up all or parts of the cadF gene. 
3.2.5 Bovine Serum Albumin 
Bovine serum albumin (BSA), which is used in numerous biochemical and 
molecular biology applications including ELISAs and which has a molecular 
weight of ca. 66.4 kDa (Walcher et al., 2003), was used as a blocking agent to 
block uncoated portions of the immuno-wells after coating with ligands. It was 
therefore also added to the phage library before incubation with the ligand to 
prevent non-specific binding. Initial panning against this protein also provided 
invaluable information in the optimisation of the panning procedure. 
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3.3 Materials and Methods 
3.3.1 General Materials 
3.3.1.1 Phage Library 
Construction of the C. jejuni NCTC11168 phage display libraries used for 
the panning experiments described in this chapter is described in chapter 
two. 
3.3.1.2 Bacterial Strains and Culture conditions 
[See Section 2.6.1 above] 
3.3.1.3 R408 Helper Phage 
[See Section 2.6.2 above] 
3.3.1.4 Antibiotic Supplements 
[See Section 2.6.3 above] 
3.3.1.5 Culture Media 
[See Section 2.6.4 above] 
3.3.1.6 Miscellaneous Buffers and Solutions 
[See Section 2.6.5 above] 
3.3.1.7 Polymerase Chain Reaction 
[See Section 2.6.8 above] 
3.3.2 Ligands 
For the purposes of this study, all ligands used were of human source or 
origin. Lactoferrin (apo- and holo-Lf), holo transferrin (holo-Tf) and 
fibronectin (Fn) were obtained from Sigma, and were dissolved in sodium 
carbonate buffer. 
3.3.3 ELISA Wells and Tubes 
MaxiSorp ImmunoTubes® and MaxiSorp ImmunoWells® (Nunc) were both 
used as solid surfaces for immobilsing the ligands.  
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3.3.4 Growth stage of E. coli TG1 cells and Infectivity of Phage 
particles 
To ensure reproducibility of amplification and titration of eluted and amplified 
phage, the growth stage of E. coli TG1 cells at which maximal phage infection 
can be obtained was determined. E. coli TG1 cells were grown to an optical 
density at 600 nm (OD600) of 1.0. This was serially diluted with LB broth and 
grown for a further 4 h at 37°C with shaking until OD600 of between 0.3 and 
1.0 were obtained. A 90-µl aliquot of each was infected with 10 µl of the 
phage library. Infection was allowed to proceed at room temperature for 30 
min. A 10-fold serial dilution of this was prepared and 90 µl of each dilution 
plated on LB-Amp agar plates and incubated at 37°C overnight. The following 
day, the numbers of colonies of E. coli transformants were counted and the 
phage titres calculated. 
3.3.5 Effect of Lf on in vitro infectivity of Phage particles 
As discussed above, Lf is also known for its antiviral activity and to ensure 
that this did not affect the results of the panning of the phage library against Lf 
its effect on in vitro infectivity of phage particles was tested (Jenssen & 
Hancock, 2009; Leon-Sicairos et al., 2009). A 180-µl aliquot of the phage 
library was incubated at room temperature for 2 h with 100 µl of apo- or holo-
Lf dissolved in 50 mM sodium carbonate, pH 9.7, to a final concentration of 1, 
10, and 100 µg/ml. This was further incubated for 1 h with 100 µl of 20 × 
blocking solution [i.e. 1% BSA in PBS-0.05% Tween 20 (PBS-T)] to yield a 
mixture containing 1% BSA. 
A 10-µl aliquot of this mixture was used to infect 90 µl of freshly grown E. 
coli TG1 cells. As control, 9 µl of the phage library was used to infect 90 µl of 
freshly grown E. coli TG1 cells with optical density at 600 nm (OD600) of 0.5-
0.6. Infection was allowed to proceed at room temperature for 30 min. A 10-
fold serial dilution of each infection was carried out and 90 µl of each dilution 
plated on LB-Amp agar plates and then incubated at 37°C overnight. The next 
day, colonies were counted for each dilution and the titres estimated. 
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3.3.6 Effect of Lf on in vitro growth of E. coli TG1 cells 
As discussed above, Lf is also known for its bactericidal activity and to ensure 
that this did not affect the results of the panning of the phage library against Lf 
its effect on in vitro growth of E. coli TG1 cells was tested (Leon-Sicairos et 
al., 2009). A 90-µl aliquot of freshly grown E. coli TG1 cells (OD600 of 0.5-
0.6) was incubated at room temperature for 2 h with apo- or holo-Lf dissolved 
in 50 mM sodium carbonate, pH 9.7, to a final concentration of 1, 10, and 100 
µg/ml. This culture was mixed with 20 × blocking solution to yield a mixture 
containing 1% BSA and further incubated for 1 h. 
The resulting mixture containing E. coli TG1 cells was infected with 9 µl of 
the phage library. As control, 9 µl of the phage library was used to infect 90 µl 
of freshly grown E. coli TG1 cells. Infection was allowed to proceed at room 
temperature for 30 min. A 10-fold serial dilution of each infection was carried 
out and 90 µl of each dilution plated on LB-Amp agar plates and then 
incubated at 37°C overnight. The next day, colonies were counted for each 
dilution and the number of transformed E. coli TG1 cells estimated. 
3.3.7 Panning 
3.3.7.1 Preparation of Target Ligands and Phage 
A solution of the protein ligand [apo-Lf, holo-Lf, apo-Tf, Fn or BSA] was 
made up in 50 mM sodium carbonate, pH 9.7 to a final concentration of 10-
100 µg/ml and stored at 4°C until used. 
200 µl of 10 × blocking solution was added to 1,800 µl of the phage library 
to give a mixture containing 1% BSA. This was incubated at room 
temperature for 1 h before being added to the ligand-coated wells. 
3.3.7.2 The Panning Procedure 
100-µl aliquots of the appropriate ligand (100 µg/ml of ligand dissolved in 
50 mM sodium carbonate, pH 9.7) were immobilised in wells of ELISA-
ready 96-well plates (NuncTM, Denmark) as described earlier and incubated 
at 4°C overnight. 
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The following day, wells were washed once with PBS and then blocked 
using 200 µl of blocking solution. Wells were incubated at room 
temperature for 1 h. 
A 100-µl aliquot of phage library in blocking solution was then added to the 
wells and incubated at 4°C overnight. Unbound phage particles were 
removed by washing the wells three times with PBS±T, followed by two 
additional washes with PBS. 
Bound phage particles were eluted by adding 100 µl of freshly grown E. coli 
TG1 cells [OD600 of 0.5-0.6], and incubating at 37°C for 1 h. E. coli TG1 
cells were serially diluted and 10-µl aliquots plated on LB agar containing 
200 µg/ml ampicillin (LB-Amp plates) for determining the titre of the eluted 
phage. The remaining phage-infected E. coli TG1 cells was also plated on 
LB agar containing 200 µg/ml ampicillin and 2% glucose as a catabolite 
suppressor (LB-Glu-Amp plate) for harvesting. Plates were incubated at 
30°C overnight to minimize growth. 
In the preliminary stages of the study, bound phage were eluted by adding 
100 µl of 50 mM Na3C3H5O(COO)3/140 mM NaCl (pH 2.0) to each well 
and incubating at room temperature for 15 min. The solution was then 
neutralised by transferring eluted phage to a new well containing 50 µL 
neutralization solution (1M Tris-HCl, pH 8.0). The resulting solution was 
then used to infect freshly grown E. coli TG1 cells. 
3.3.7.3 Amplification of Recovered Binding Phage 
Cells were harvested from the LB-Glu-Amp plate into 1.5 ml LB-Glu-Amp 
broth and 16% glycerol added for storage. Aliquots of 100 µl of harvested 
cells were added to 5 × 5 ml of LB-Glu-Amp broth [start OD600 of 0.05-0.1].  
These were incubated at 37°C until an OD600 of 0.5-0.6 was reached.  
These cultures were infected with R408 helper phage at a multiplicity of 
infection of 20-50 (i.e. 100 µl of 1.3 × 1013 pfu/ml stock) and infection 
allowed to proceed at 37°C for a further 1 h with shaking (150 RPM). The 
R408-infected cultures were pooled together, and the cells pelletted by 
centrifugation at 4,500 ×  g for 5 min. Pelletted cells were re-suspended in 5 
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ml of fresh LB-Amp broth and 20 ml of molten soft agar, pre-cooled to 
45°C and containing 200 µg/ml of ampicillin, added. The mixture was 
poured unto five LB-Amp agar plates, i.e. 5 ml of soft agar per plate and 
incubated at 30°C overnight. 
The following day, the soft agar overlays were transferred into a 250-ml 
flask containing 25 ml of LB-Amp broth, i.e. 5 ml of broth per plate, to a 
final volume of approximately 50 ml. This was incubated at 37°C for 4 h 
with vigorous shaking. The resulting culture was centrifuged at 9,000 ×  g 
for 45 min, and the supernatant transferred into a fresh tube. This was then 
filter-sterilised (0.45 µm pore sterile Millex®) to remove any remaining 
bacterial cells. This filtered fraction constituted the final ³ENRICHED 
PHAGE LIBRARY´ fraction. This was stored in 1-ml aliquots at -80°C 
until required. 
3.3.7.4 Preparation of Enriched Library for Repeat Panning 
The enriched phage library following the first round panning was titrated. 
An aliquot of this was then mixed with 10 × blocking solution as described 
before. The same procedures, [sections 3.3.6.2 and 3.3.6.3], were carried out 
two more times to produce the second and third round enriched phage 
fractions. 
3.3.8 Determination of Phage Titres after Amplification 
At the end of each round, the number of phage particles was determined 
indirectly as the number of plaque- (colony-) forming units per milliliter 
(pfu/ml) of E. coli following infection with the phage. 
A laboratory stock of E. coli TG1 was grown in fresh LB broth at 37°C until 
the optical density at 600 nm (OD600) was between 0.5 and 0.6. A 90-µl 
aliquot of this culture was infected with 10 µl of rescued phage in a 1.5-ml 
Eppendorf tube. Infection was allowed to proceed at room temperature for 30 
min. A 10-fold serial dilution of this was prepared and 90 µl of each dilution 
plated on LB-Amp agar plates and incubated at 37°C overnight. The following 
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day, the numbers of colonies of E. coli transformants were counted and the 
phage titres calculated. 
3.3.9 Isolation of Plasmid for PCR and Sequencing 
After determination of phage titres, twenty four colonies were randomly 
selected for PCR and sequencing. Clones were cultured in 1.5 ml of LB broth 
containing appropriate antibiotics at 37°C overnight. Cells were harvested by 
centrifugation at 16,000 × g for 5 min and the pellet resuspended in the 
appropriate buffer for plasmid extraction using QIAprep Spin Miniprep kit 
(Qiagen). The chromosomal DNA inserts were amplified by PCR with the 
primers pG8SAET_F and pG8SAET_R_Long to confirm the presence or 
otherwise and the size of the insert for each clone [see sections 2.6.8 and 
2.6.18ii]. 
3.3.10 Nucleotide Sequencing of Chromosomal DNA Inserts 
Sequencing of the chromosomal DNA inserts was performed with Taq 
polymerase-catalyzed cycle sequencing using fluorescent-labelled BigDye 
terminator kit, accordiQJ WR PDQXIDFWXUHU¶V LQVWUXFWLRQV LQ DQ $%, 0 
Genetic Analyser (ABI Perkin-Elmer) at the Biopolymer Synthesis and 
Analysis Unit, School of Biomedical Sciences, University of Nottingham. 
Primers pG8SAET_F and/or pG8SAET_R_Short were used to sequence the 
inserts in both the forward and reverse directions [section 2.6.8]. 
3.3.11 Bio-informatic Analysis of Chromosomal DNA Inserts 
The Basic Local Alignment Search Tool (BLAST) of the Wellcome Trust 
Sanger Institute C. jejuni gene database 
(http://www.genedb.org/genedb/cjejuni/blast.jsp) was used to analyse the 
sequences obtained for similarity. The results were compared with similar 
BLAST searches at the National Center for Biotechnology Information 
(NCBI) website (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
Translation initiation sequences within each insert were searched for using the 
DNAMAN software (Lynnon Corporation), and then analysed for their 
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orientation with respect to the Campylobacter gene itself and with respect to 
gene 8 or protein VIII of the pG8SAET vector.  
Clones were considered candidates if their inserts were in the right orientation 
and in frame with gene 8 of the vector and had a unique predicted function of 
possible interest. Where an insert was not in frame with gene 8 but was in the 
right orientation in the Campylobacter genome and of a unique predicted 
function, it was also considered as candidate gene. This is because it is 
believed that ribosomal slippage corrected the frameshifts during translation 
(Chen et al., 2009; Jacobsson et al., 2003). 
Selected genes were analysed for the presence of signal sequences using the 
SignalP 3.0 Server for Gram-negative bacteria 
(http://www.cbs.dtu.dk/services/SignalP/).  
Using the TMHMM 2.0 programme 
(http://www.cbs.dtu.dk/services/TMHMM-2.0/) an attempt was made to also 
identify transmembrane domains in the selected genes. 
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3.4 Results 
3.4.1 Growth stage of E. coli TG1 cells and Infectivity of Phage 
particles 
In order to ensure reproducibility of results generated from the use of E. coli 
TG1 cells, the optical density at 600 nm at which best infectivity with phage 
would be obtained was determined with a simple experiment as described [see 
section 3.3.4]. Following infection of E. coli TG1 cells at various stages of 
growth with an aliquot of phage library, the resulting ampicillin-resistant 
colonies were counted and the titres determined. It was observed the growth 
stage at which maximal infectivity of phage was obtained was OD600 of 0.4-
0.6 (Figure 3.2). All subsequent titrations were therefore made using freshly 
grown E. coli TG1 cells with OD600 of 0.5-0.6. 
 
 
Figure 3. 2 | Effect of the growth stage of E. coli on phage titres. E. coli TG1 cells were 
grown to an OD600 of 1.0 and then serially diluted and grown for a further 4 h at 37°C to 
obtain OD600 of between 0.3 and 1.0. A 90-µl aliquot of each was infected with 10 µl of the 
phage library. The E. coli cells were then plated on LB-Amp agar and incubated at 37°C 
overnight and the number of ampicillin-resistant colonies counted to determine the titres. 
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3.4.2 Effect of Lactoferrin on in vitro infectivity of Phage particles 
To ensure that Lf had no inhibitory effect on phage and phage infectivity in 
this study, phage particles were incubated with Lf and used to infect E. coli 
TG1 cells [see section 3.3.5]. Following incubation of the phage library with 
increasing amounts of apo- and holo-Lf, and the solvent Na2CO3 as a control, 
freshly grown E. coli TG1 cells were infected as described above. After 
spreading the cells on LB-Amp agar plates and incubating overnight at 37°C, 
the numbers of transformed cells were counted on each plate and the phage 
titres estimated. 
As depicted in Figure 3.3 below, there were no significant differences between 
the titres of the apo-Lf treated phage and the holo-Lf treated phage or between 
the Lf-treated phage and the Na2CO3-treated phage. Compared with the titres 
of the starting phage no inhibitory effect on the abilities of the phage particles 
to infect the E. coli cells was observed following treatment with apo- or holo-
Lf and Na2CO3. 
 
 
Figure 3. 3 | Effect of Lf on in vitro infectivity of phage particles. 180-µl aliquots of phage 
library were incubated with varying amounts of apo-Lf, holo-Lf or Na2CO3 as a control. Aliquots 
if these were used to infect 90 µl of freshly grown E. coli TG1 cells at room temperature over 30 
min. A 10-fold serial dilution of each infection was carried out and 90 µl of each dilution plated 
on LB-Amp agar plates and then incubated at 37°C overnight. Ampicillin-resistant colonies were 
counted and titres estimated.  
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3.4.3 Effect of Lf on in vitro growth of E. coli TG1 cells 
To ensure that Lf had no inhibitory effect on E. coli TG1 cells and infectivity 
with phage in this study, E. coli TG1 cells were incubated with Lf and then 
infected with phage [see section 3.3.6]. Following incubation of the E. coli 
TG1 cells with increasing amounts of apo- and holo-Lf, and the solvent 
Na2CO3 as a control, cells were infected with fresh phage particles as 
described above. After spreading the cells on LB-Amp agar plates and 
incubating overnight at 37°C, the numbers of transformed cells were counted 
on each plate and the phage titres estimated. 
As depicted in Figure 3.4 below, there was no significant difference between 
the titres of the apo-Lf treated E. coli TG1 cells and the holo-Lf treated E. coli 
TG1 cells or between the Lf-treated E. coli TG1 cells and the Na2CO3-treated 
E. coli TG1 cells. Again, compared with the titres of untreated phage versus 
untreated E. coli no inhibitory effect on the E. coli cells was observed 
following treatment with apo- or holo-Lf and Na2CO3. 
 
 
 
Figure 3. 4 | Effect of Lf on in vitro growth of E. coli TG1 cells. 90-µl aliquots of freshly grown 
E. coli TG1 cells were incubated with varying amounts of apo-Lf, holo-Lf or Na2CO3 as a 
control. Aliquots if these were then infected with 9 µl of phage library at room temperature over 
30 min. A 10-fold serial dilution of each infection was carried out and 90 µl of each dilution 
plated on LB-Amp agar plates and then incubated at 37°C overnight. Ampicillin-resistant 
colonies were counted and titres estimated. 
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However, it must be stated that the titres obtained following treatment of E. 
coli with Lf were 5-10-fold lower compared with the titres following treatment 
of the phage particles with Lf. This can be attributed to the disruption of the 
optimal growth conditions for the E. coli cells during incubation with Lf at 
room temperature, rather than the effect of Lf. 
3.4.4 Panning 
Since BfuCI was used in the fragmentation of the chromosomal DNA of C. 
jejuni NCTC11168, it would be expected that panning of both libraries I and II 
against any ligand would result in the enrichment of same peptides, plus 
additional smaller peptides in the case of library I. 
Initial panning of library I yielded smaller single inserts, whilst initial panning 
of library II yielded larger inserts, including some multiple inserts. Library I 
was therefore used in all subsequent panning experiments to ensure the 
enrichment of single smaller inserts. Besides, gene 8 is supposed to display 
smaller inserts better than larger ones. 
3.4.4.1 Panning against BSA and Fibronectin 
To determine the superiority of one over the other for use in panning, 
MaxiSorp ImmunoWells® (wells) and MaxiSorp ImmunoTubes® (tubes) 
were coated with Fn and BSA as described in section 3.3.7. The phage 
library was panned against these ligands and the phage titres at the end of 
each round of panning determined as described. BSA was used in this 
instance as a control without any blocking step. 
Firstly, phage eluted from both the wells and the tubes had similar titres in 
the range of 104 plaque-forming units (pfu) for BSA and 106 plaque-
forming units (pfu) for Fn (Figure 3.5) indicating that neither the wells nor 
the tubes had demonstrable superiority in this respect. MaxiSorp 
ImmunoWells® (wells) were therefore used in all subsequent panning 
experiments for its convenience. 
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Secondly, panning against Fn generated titres of 105 compared with the 
titres of 104 generated after panning against the BSA control, indicating 
the ability of Fn to bind more phage than does BSA. 
Thirdly, the titres of the eluted phage showed no consistent increases in the 
numbers of bound phage with successive pannings, indicating that the 
panning process did not result in significant enrichment of specific clones 
at the end of the third round of panning. 
 
 
 
Figure 3. 5 | Titres of eluted-phage after panning of phage library in wells and tubes.  The 
titres of bound phage after three successive rounds of panning (Rd1, Rd2 and Rd3) were 
determined by infecting E. coli TG1 cells with the eluted phage solution as described. The 
E. coli cells were then plated on LB-Amp agar and incubated at 37°C overnight and the 
number of ampicillin-resistant colonies counted. Phage titres obtained for the wells 
compared favourably with that obtained for the tubes, in both Fn and BSA although more 
phage were eluted from the Fn-coated wells/tubes than from BSA-coated wells/tubes.  
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The eluted-phage from the rounds 1 and 3 pannings against Fn and BSA in 
both wells and tubes were amplified in 0.2% soft agar as described. The 
eluted-phage particles from the round 2 pannings were amplified directly in 
LB-Amp broth overnight following infection with helper phage. The 
resulting phage for each panning was then titrated and compared (Figure 
3.6).  
Amplification in 0.2% soft agar produced phage titres 100-fold higher (Rd1 
and Rd3) than direct amplification in LB-Amp broth (Rd2) as shown below. 
Again, the titres obtained for each round of panning for each experiment 
were consistent indicating the consistency of the amplification procedures, 
although amplification in 0.2% soft agar was preferred. 
Amplification of a fourth round panning (data not shown) produced phage 
titres of 108 that were consistent with that obtained for Rd2. These data 
informed our decision on the use of soft agar in all subsequent amplification 
experiments.  
 
 
Figure 3. 6 | Titres of phage after amplification of eluted phage in LB broth or soft agar. 
After three successive rounds of panning (Rd1, Rd2 and Rd3), Rd1 and Rd3 phage were 
amplified in soft agar, whilst Rd2 was amplified directly in LB broth. TG1 E. coli cells 
were infected with the resulting amplified phage and plated on LB-Amp agar and incubated 
at 37°C overnight. The number of ampicillin-resistant colonies was counted and the titres 
calculated. 
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3.4.4.2 Panning against Several Ligands Concurrently 
A repeat panning of the phage display library of C. jejuni NCTC11168 
against Fn and BSA was done, alongside panning against apo-Lf and apo-Tf 
concurrently [see Figure 3.7]. Titration of the eluted phage at the end of 
each successive round consistently gave titres of between 104 and 105, with 
Fn producing the highest numbers of bound phage, reflecting the 
³VWLFNLQHVV´RI )QDQGKHQFH WKHSURSHUW\ WRELQGPRUHSKDJH WKDQZRXOG
the other ligands.  
The titres of the eluted phage for each ligand showed no consistent increases 
in the numbers of bound phage with successive pannings, indicating that the 
pannings did not produce enrichment of specific clones at the end of the 
third round of panning. 
 
 
 
Figure 3. 7 | Titres of eluted phage after concurrent panning against BSA, Fn, apo-Tf and 
apo-Lf. After three successive rounds of panning, E. coli TG1 cells were infected with the 
eluted phage solution as described and plated on LB-Amp agar. These were incubated at 
37°C overnight and the number of ampicillin-resistant colonies counted to determine the 
titres. 
3.4.4.3 Elution of Bound Phage using E. coli TG1 cells or Acid 
Solution 
As part of the initial panning experiments, bound phage were eluted with 50 
mM Na-Citrate/140 mM NaCl, pH 2.0 and neutralised with 1M Tris-HCl, 
1.00E+00
1.00E+01
1.00E+02
1.00E+03
1.00E+04
1.00E+05
1.00E+06
BSA Fn apo-Tf apo-Lf
Ligands
Lo
g
 o
f 
P
h
a
g
e
 T
it
re
s 
(p
fu
/m
l)
Concurrent Panning of Phage Library against 4 Different 
Ligands
Rd1
Rd2
Rd3
CHAPTER THREE 
 
 
Harry H Abruquah | Identification of host-pathogen interacting molecules of Campylobacter jejuni  
PhD Thesis | Microbiology | March 2009 
153 
 
pH 8.0 as described. The resulting solution was then used to infect freshly 
grown E. coli TG1 cells.  
Compared with elution of bound phage by directly adding E. coli TG1 cells 
to the wells, the results from the former methodology resulted in low colony 
counts (data not shown). Bound phage was therefore eluted by direct 
addition of E. coli TG1 cells to the wells in all subsequent experiments. 
3.4.4.4 Panning against Fibronectin, apo-Transferrin and apo-
Lactoferrin 
Following successful optimization of the panning, elution, amplification and 
titration conditions, the phage display library of C. jejuni NCTC11168 was 
panned in separate experiments against Fn, apo-Tf, and apo-Lf [see Figure 
3.8]. These yielded exponential increments in the number of bound phage 
after each successive panning, suggesting enrichment of specific clones. 
Furthermore, the amplification of eluted phage after each round also 
produced consistent titres. This ensured reproducibility of the panning 
experiments since it ensured that the number of phage particles applied to 
each well was the same at the beginning of each round for each panning 
experiment. 
 
Figure 3. 8 | Phage titres showing exponential increases after each successive panning. 
After three successive rounds of panning E. coli TG1 cells were infected with the eluted 
phage solution as described. The E. coli cells were then plated on LB-Amp agar and 
incubated at 37°C overnight. The number of ampicillin-resistant colonies was then counted 
to determine the titres. 
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3.4.4.5 Repeat Panning against apo-Lactoferrin and holo-
Lactoferrin 
The panning of the phage display library of C. jejuni NCTC11168 against 
apo-Lf was repeated twice and then once against holo-Lf in separate 
experiments [see Figure 3.9]. Again, these pannings yielded exponential 
increments in the number of bound phage after each successive panning, 
indicating enrichment of specific clones. Furthermore, the amplification of 
eluted phage after each round also produced consistent titres, which were 
consistent with previous experiments. 
 
Figure 3. 9 | Phage titres showing exponential increases after each successive panning. The 
phage titres resulting from the pannings against apo-Lf and holo-Lf were consistent with 
previous experiments. Both the first and the second repeat panning against apo-Lf (1-apo-
Lf and 2-apo-Lf respectively) compared very well with the panning against holo-Lf (1-
holo-Lf). 
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3.4.5 Bio-informatic Analysis of Selected Clones 
For each panning, 24 clones were randomly selected and the inserts 
sequenced. Usable sequences were analysed. A summary of the genes isolated 
from the pannings against the various ligands is provided in Table 3.1 below.  
After analyses of the DNA inserts, clones were considered candidate genes if 
they were in the right orientation and in frame with gene 8 of the vector and 
had a unique predicted function of possible interest, with or without the 
presence of signal peptide and transmembrane domain (TMD). 
 
Table 3. 1 | Summary of unique ligand-specific genes after three rounds of panning. All 
clones that produced readable sequences were analysed, and the inserts in the right 
orientation within the vector positively identified. Based on the probable function and 
location within C. jejuni, three clones were selected for each ligand and the presence of 
signal peptide or transmembrane domain determined. Y/N mean yes/no. 
  
Ligand Isolated 
C. .jejuni 
Gene(s) 
The Insert Predicted Function (s) SignalP 
(Y/N) 
TMD 
(Y/N) Size  
(bp) 
Fre-
quency 
 
 
  
   
 
   Non-enriched Pannings   
BSA i.Cj1564 
ii. Cj1283  
iii.  Cj1075 
827 
1159 
1096 
2/20 
2/20 
2/20 
Putative methyl-accepting chemotaxis protein  
Probable K+ uptake protein 
Conserved hypothetical protein 
Y 
Y 
N 
Y 
Y 
N 
 
      
apo-Tf i. None 
ii. None 
iii. None 
 0/20 
0/20 
0/20 
Almost all of the isolated genes were in reverse 
orientation/combination of smaller inserts. The 
only inserts that were in the correct orientation 
encoded for ribosomal RNA. 
  
 
      
Fn i.Cj1127c 
ii.Cj0530 
iii.Cj1235 
992 
152 
895 
2/40 
2/40 
2/40 
Probable oligosaccharyl transferase 
Probable periplasmic protein 
Probable periplasmic protein 
N 
N 
N 
N 
Y 
N 
 
      
 
   Enriched Pannings   
apo-Lf i. Cj0609c 
ii.Cj1618c 
 
iii.Cj0599 
457 
586 
 
129 
26/42 
4/42 
 
2/42 
Probable periplasmic protein 
Probable haemin uptake system/periplasmic 
haemin-binding protein 
Putative OmpA family protein 
Y 
N 
 
Y 
N 
N 
 
Y 
 
      
holo-Lf i. Cj0609c 
ii. Cj0525c 
iii.Cj0697 
457 
95 
65 
14/24 
2/24 
2/24 
Probable periplasmic protein 
Putative penicillin-binding protein 
Flagellar basal-body rod protein 
Y 
Y 
N 
N 
Y 
N 
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3.4.5.1 Enrichment versus non-Enrichment after Successive 
Pannings 
Analyses of the DNA sequences of randomly selected clones from the non-
enriched pannings (pannings that did not produce sequential increase in 
phage titres) revealed the isolation of unrelated Campylobacter genes (see 
Figures 3.5 ± 3.7). Panning of library I led to the isolation of inserts whose 
sequences were concatamers of several BfuCI-target sequences and hence 
did not match any genes in the Campylobacter genome database. 
By contrast, analyses of the DNA sequences of selected clones from the 
enriched pannings (pannings that produced sequential increase in phage 
titres) revealed the isolation of identical Campylobacter genes in ca. >50% 
of clones (see Figures 3.8 ± 3.9). Again, analyses of randomly selected 
clones from their second round pannings further revealed the isolation of 
genes that were related to those from the third round panning, with 30-40% 
of clones being identical. 
3.4.5.2 Panning against Several Ligands Concurrently 
Following panning of the CjNCTC11168 phage display library concurrently 
against BSA, apo-Tf, Fn and apo-Lf, analyses of randomly selected clones 
from each panning revealed the isolation of identical clones. Obviously, 
these clones were not considered to be uniquely binding to any specific 
OLJDQG 7KLV FRQILUPHG -DFREVVRQ¶V DVVHUWLRQV WKDW SKDJH SDUWLFOHV ZRXOG
easily cross-contaminate experiments and therefore warranted that panning 
against different ligands was done in separate experiments at different times. 
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3.5 Discussion 
Phage display is a powerful technique with major applications in protein-protein 
interactions, and has been successfully used in the identification of novel 
interacting proteins of several pathogens with host proteins (Chen et al., 2009; 
Jacobsson et al., 2003; Segvich et al., 2009; Wu et al., 2008; Zhu et al., 2008). 
By extension, this technique can be used to screen the genomes of pathogenic 
organisms for genes encoding proteins that interact with specific host proteins. 
To date, phage display has only been used in the identification of potential 
adhesins in only a few Gram-positive pathogens (Bjerketorp et al., 2004; 
Jacobsson et al., 2003; Karlstrom et al., 2004; Mullen et al., 2006; Mullen et al., 
2008; Wall et al., 2003; Zhang et al., 1999). This therefore represents the first 
report of a phage display natural peptide library in, not only Campylobacter, but 
also in a Gram-negative organism. 
To identify unique Campylobacter genes encoding specific ligand-binding 
proteins in such a library, several factors needed to be considered in the design 
and optimization of panning protocols. Firstly, in order to obtain consistent 
results from titration of the enriched libraries, the stage of bacterial growth at 
which optimal infectivity of the phage particles can be attained had to be 
identified. Following repeated experiments of infecting E. coli TG1 cells grown 
to different levels at optical density of 600 nm (OD600) with same amount of 
phage particles, it was observed that maximal infectivity of phage was obtained 
at OD600 of 0.5-0.6. This was not surprising since this point of growth fell well 
within the log phase of growth of the E. coli TG1 cells. This obviously 
represents the growth phase at which the bacterial cells are actively dividing and 
are therefore likely to replicate effectively at the same rate following 
transformation with phage genes (Skarstad et al., 1983). In fact, whilst obtaining 
OD600 of 0.4-0.6 as the optimal growth stage for maximal phage infectivity in 
most of their experiments, Jacobsson and co-workers recommended that this 
value was determined for each individual study (Jacobsson & Frykberg, 2001a; 
Jacobsson et al., 2003). 
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The choice of Lf as the main ligand for panning in this study was informed by 
the recent study by Miller and co-workers that showed that supplementation of 
iron-deficient medium MEM with Lf-bound and Tf-bound iron was comparable 
to supplementation with FeSO4 in C. jejuni growth (Miller et al., 2008). Huynh 
et al. have also recently contended that Lf, which has been considered a 
potential addendum to the treatment regime of H. pylori, is ineffective against 
the organism and can rather enhance growth and gastric inflammation (Huynh et 
al., 2009). 
Having selected Lf as the main ligand for panning in this library, it was 
important to ascertain the effect of Lf on E. coli TG1 cells and phage particles 
used in this library. This is due to the contradicting reports of the anti-bacterial 
and anti-viral, as well as growth promoting effects of lactoferrin (Huynh et al., 
2009; Kim et al., 2004; Leon-Sicairos et al., 2009). In fact, it was not surprising 
that Lf had no effect on the phage particles or the E. coli TG1 cells in this study. 
An additional factor that needed to be clarified was the use of immuno-tubes 
and immuno-wells. Whereas both wells and tubes have been extensively used in 
various experiments, wells seemed more convenient than did tubes (Jacobsson 
& Frykberg, 2001a; Mullen et al., 2007a). Although the initial panning 
experiments with Fn and BSA were all non-enriched pannings, they provided 
good indices that informed the decision to choose the well format in all 
subsequent experiments. The use of MaxiSorp Immunotubes was abandoned 
due simply to its cumbersome nature and all subsequent experiments were 
carried out in MaxiSorp Immunowells. 
Generally, pannings are carried out in two or three successive experiments, and 
specific binding is manifested by exponential increases in the titres of the 
eluted-phage from the successive pannings (Jacobsson & Frykberg, 2001a; 
Jacobsson et al., 2003). With a starting phage titre of 1011 in every single 
panning experiment, the elution of ca. 103 or 107 is an indication of enrichment 
of 104 or 108 in each round, which should in theory result in enrichment of 
binding sequences after only 2 or 3 rounds given that the library contains only 
1,000,000 ± 1,600,000 clones. Colonies can then be randomly selected from the 
second or the third round pannings and their inserts analysed, which should 
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result in the isolation of identical clones. Further rounds of panning will result 
only in selection of phage that have a growth advantage over the library phage 
(McCafferty, 1996). The absence of this exponential increase in the titres in the 
successive pannings (see Figures 3.5 and 3.7) was therefore an obvious 
indication of non-enrichment and hence warranted further optimisation of the 
panning protocol.  
As indicated earlier, it was thought that bound phage can be eluted with an 
acidic solution and then neutralised before the solution was used to infect E. coli 
TG1 cells. However, this was abandoned and bound phage particles were eluted 
by directly adding E. coli TG1 cells to the wells. This methodology was 
considered superior since the phage particle binds ligands through the major 
coat protein, pVIII, whilst infecting through the minor coat protein, pIII (Azzazy 
& Highsmith, 2002). Thus, whilst elution with acidic solution can leave some 
phage particles un-dissociated from the ligand, elution with E. coli TG1 cells 
would result in the infection of the bacterial cells by all bound phage particles. 
After elution of the bound phage in each panning cycle, the former was 
amplified to multiply the phage titres for use in subsequent experiments. The 
phage particles are obtained by super-infection of the E. coli TG1 cells with 
helper phage and further incubation overnight. The E. coli cells can be grown 
either in LB broth with the appropriate antibiotics or in 2.0% soft agar as 
previously described. Growth in soft agar yielded the highest level of phage 
titres comparable to published data (Jacobsson & Frykberg, 2001a; Jacobsson et 
al., 2003), and also yielded consistent values. However, an explanation cannot 
be offered for this observation (Figure 3.6). The expected titres can still be 
achieved through amplification in LB broth providing small volumes of cells are 
cultured in larger containers, with aeration and proper shaking (Schofield et al., 
2007). 
Following optimisation of the panning protocol, panning experiments were done 
against BSA, Fn, apo-Tf and apo-Lf concurrently, the results of which indicated 
not just non-enrichment, but also the isolation of genes identical for all four 
ligands. This can be attributed to the high sensitivity of the phage particles, and 
their ability to easily contaminate adjacent experiments. This observation can be 
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likened to JaFREVVRQ¶VREVHUYDWLRQWKDWZRUNLQJZLWKVHYHUDOGLIIHUHQWOLEUDULHV
in the same laboratory led to a high enrichment after panning against a ligand 
but isolation of peptides that emanated from another library (Jacobsson et al., 
2003). Again, Jacobsson et al. reported that experiments with libraries made in 
different vectors resulted in isolation of inserts that were out of frame with the 
vector sequence. 
An enrichment panning was manifested as exponential increases in the titres of 
the successive pannings, as depicted in Figure 3.8 by the panning against Fn, 
apo-Tf and apo-Lf. This exponential increase is the result of the fact that 
amplification of eluted phage results in the application of more of the same 
clones to the ligand in the subsequent panning resulting in an increase in the 
number of bound phage in that panning. These data were observed in the repeat 
experiment with apo-Lf as well as the panning against holo-Lf. Furthermore, 
sequence analyses of clones from these enriched pannings also revealed the 
isolation of identical Campylobacter genes in ca. >50% of the clones (see Table 
3.1). Again, analyses of randomly selected clones from their second round 
pannings further revealed the isolation of genes that were identical to those from 
the third round panning, ca. 30-40% of clones. These sequences were 
considered as potentially encoding for peptides that can bind to Lf. The repeated 
isolation of Cj0609c in the enriched pannings against apo-Lf (ca. 62%) and 
holo-Lf (ca. 58%) is an interesting finding worth further investigating. 
Whilst the isolation of Cj0609c in these panning can be reliable, the absence of 
the cadF gene in all of the pannings against Fn can be attributed to the fact that 
those pannings did not lead to enrichment. However, this may also be the result 
of the different conformations that Fn can assume in solution and after 
application to the wells. Again, the absence of the necessary glycosylation in the 
proteins expressed by the phage particles may also affect their ability to bind to 
the right target ligand. Further work is therefore needed to confirm or otherwise 
of the authenticity of the isolated genes.  
Non-enriched pannings, on the contrary, manifested as the absence of 
exponential increases in the titres of the successive pannings, with sequence 
analyses of clones from these pannings also revealing the isolation of sequences 
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from non-identical Campylobacter genes (see Table 3.1). Thus, the pannings 
against BSA, apo-Tf, and Fn did not result in the isolation of any unique gene as 
depicted in Table 3.1. 
Generally, if a gene appeared more than once (2-5×) in the sequenced clones, it 
was analysed in more detail. However, the most isolated gene for both apo- and 
holo-Lf remained Cj0609c. 
Finally, it must be emphasised that the there is significant difficulty in preparing 
and panning phage display libraries as well as the utility of this approach but, 
conversely, this represents an approach that can be applied to the study of C. 
jejuni and other pathogens, and in particular, to the identification of previously 
unidentified protein-protein interactions that may be involved in host-pathogen 
interactions. 
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CHAPTER FOUR 
4.0 Analysis of Enriched Phage Library 
4.1 Introduction 
Following enrichment of a phage library, it is important to confirm that the 
phage particles present in the enriched library after the third round panning do 
really bind to the selected ligand(s). This was achieved by comparing the 
binding of the first and second round enrichments with the third round 
enrichment. 
Furthermore, after isolation of a number of clones encoding putative binding 
proteins specific for a specific ligand from the third round enrichment, it is 
important that the binding specificities of the encoded proteins are also 
confirmed.  
This could be achieved through enzyme-linked immunosorbent assay or through 
comparative binding of the encoding phage to the initial target ligand and to 
other unrelated ligands (Jacobsson et al., 2003). In the case of the latter, the 
resulting titres of the bound phage on the original target ligand are 1,000-10,000 
folds higher than that obtained for the unrelated ligands (Jacobsson et al., 2003). 
Binding specificity could also be confirmed through a viral competitive 
inhibition assay, in which binding of phage stocks of single clones from the 
third round panning could be inhibited by antibodies to the ligand (Nilsson et 
al., 2004b). 
Phage stocks of single clones from the third round panning could also be used in 
phage ELISA experiments to ascertain which clone binds more specifically. 
This approach has been used in many recent phage display studies (McCafferty 
& Johnson, 1996; Schofield et al., 2007). 
This chapter therefore discusses the use of ELISA to analyse the enriched-
pannings resulting from the panning of phage display library CjNCTC11168 
against apo-Lf and holo-Lf. 
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4.2 Materials and Methods 
4.2.1 General Materials 
4.2.1.1 Phage Library 
[See Section 3.3.1.1 above] 
4.2.1.2 Bacterial Strains and Culture conditions 
[See Section 2.6.1 above] 
4.2.1.3 R408 Helper Phage 
[See Section 2.6.2 above] 
4.2.1.4 Antibiotic Supplements 
[See Section 2.6.3 above] 
4.2.1.5 Culture Media 
[See Section 2.6.4 above] 
4.2.1.6 Miscellaneous Buffers and Solutions 
[See Section 2.6.5 above] 
4.2.1.7 Polymerase Chain Reaction 
[See Section 2.6.8 above] 
4.2.1.8 Ligands 
[See Section 3.3.2 above] 
4.2.1.9 ELISA Wells 
[See Section 3.3.3 above] 
4.2.2 Enriched Phage Library 
Enriched phage libraries following three rounds of panning against each of 
apo-Lf (×2) and holo-Lf were used in the experiments described in this 
chapter. 
4.2.3 HRP Anti-M13 Antibodies 
Horseradish peroxidase (HRP) anti-M13 monoclonal conjugate (GE 
Healthcare) consists of horseradish peroxidase conjugated to mouse anti-M13 
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monoclonal antibody. The antibody purified from BALB/c mouse ascites 
fluid, reacts specifically with the bacteriophage M13 major coat protein 
product of gene 8. 
4.2.4 Substrate Detection 
ABTS® peroxidase substrate solution was obtained from KPL, Gaithersburg 
(USA). This two-component liquid substrate system develops a blue-green 
hue when reacted with peroxidase labelled conjugates in Microwell plates. 
4.2.5 ELISA Confirmation of Binding Activity of Enriched Phage 
Library 
100-µl aliquots (ca. 10-100 µg/ml) of the dissolved ligands, apo-Lf and holo-
Lf, were immobilised in a row of 8 microtiter wells of ELISA-ready plates and 
incubated at 4°C overnight. The next day, the wells were washed once with 
PBS and then blocked with 200 µl of blocking solution [i.e. 1% BSA in PBS-
0.05% Tween 20 (PBS-T)].  Plates were incubated at room temperature (RT) 
for 1 h. 
Using rescued phage from the first, second and third round pannings, and 1 in 
2 dilution of third round phage, alongside appropriate negative controls, 100 
µl each of the above samples were applied to the wells as before [see Figure 
4.1]. The wells were incubated at room temperature for 1 h and then at 4°C 
overnight. The next day, unbound phage particles were removed by washing 
the wells 3× with PBS±T, followed by two additional washes with PBS. 
A 4-µl aliquot of HRP/anti-M13 monoclonal conjugate (GE Healthcare) was 
diluted in 21 ml of 1 × blocking solution to give a dilution of 1:5000 [adequate 
for 96-well plate], and 100 µl of this added to each well where appropriate. 
This was then incubated at RT for 3 h. The wells were washed twice with 
PBS±T, followed by two additional washes with PBS, and then 100 µl of 
ready-ABTS substrate solution added to each appropriate well. This was 
incubated at room temperature for 45 min before the absorbance was read in a 
microplate reader at 405 and 595 nm. The reading was repeated at 60 min. All 
samples were tested in triplicate, giving twelve readings in all for each sample. 
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Figure 4. 1 | ELISA of enriched phage. Wells were coated with Lf and incubated at 4°C 
overnight (O/N). After washing and blocking for 1 h, phage was added and incubated again 
O/N. Wells were then washed to remove unbound phage and HRP/anti-M13 monoclonal 
conjugate added. This was incubated for 3 h at room temperature (RT), washed and then 
ready-ABTS substrate solution added to detect bound phage. After incubation at RT for 45 
min, the absorbance was read in a microplate reader at 405 and 595 nm. The absorbance 
reading was repeated after 60 min incubation. To confirm binding of enriched panning, 
rescued phage from the first, second and third round pannings, and 1 in 2 dilution of third 
round phage; appropriate negative controls were used. Rd 3 phage was used in samples 1-4, 
whilst sample 5 used phage without insert (null phage). ¥DGGHG;QRWDGGHG 
4.2.6 ELISA Screening of Candidate Phage Clones 
Following the initial ELISA assays of the third round rescued phage, 24 
colonies were selected from the LB plate of the third round elute and cultured 
in LB-Glu-Amp broth at 37°C overnight. A 10-µl aliquot of each culture was 
then grown in fresh LB-Amp broth for 1 h and R408 helper phage added at a 
multiplicity of infection of 1011 and incubated for a further 8 h. Phage from 
each colony was rescued by centrifugation at 9,000 × g for 45 minutes and the 
supernatant used in an ELISA as described above. The absorbance for each 
clone was measured at a wavelength of 405 nm and a reference wavelength of 
595 nm after incubation for 45 min and then again at 60 min. All samples 
were tested in triplicate, giving twelve readings in all for each sample. 
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4.2.7 Validation of the ELISA 
Since there is no commercial/ready-to-go kit available for phage ELISA, it 
was important that the ELISA results were validated in order to produce 
consistency in different phage ELISA experiments. A phage library was 
therefore constructed with a pG8SAET vector that had no insert, and then used 
in an ELISA alongside four other negative controls, each of which had one 
missing reagent. These data were then compared with three additional ELISAs 
that could potentially produce false positive results in determining the 
sensitivity of the assay (Figure 4.2). 
 
Figure 4. 2 | Validation of phage ELISA. Wells were coated with Lf and incubated at 4°C 
overnight (O/N). After washing and blocking for 1 h, appropriate substrate or phage was 
added and incubated again O/N. Wells were then washed to remove unbound phage/substrate 
and HRP/anti-M13 monoclonal conjugate added. This was incubated for 3 h at room 
temperature (RT), washed and then ready-ABTS substrate solution added for detection. After 
incubation at RT for 45 min, the absorbance was read in a microplate reader at 405 and 595 
nm. The absorbance reading was repeated after 60 min incubation. Negative controls were 
obtained by omitting one of the substrates in the process. Scenarios that could lead to false 
positive results were also used as controls. Rd 3 phage was used in samples 1-4, whilst sample 
5 used phage without insert (null phage). ¥DGGHG;QRWDGGHG 
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4.2.8 Statistics 
Data were analyzed using the Minitab 15 software program (Minitab). The 
Chi squared test was performed to study the difference in positivity rate 
between individual clones and the mean of the negative controls. Differences 
were considered statistically significant at a p-value of less than 0.05.  
4.2.9 Isolation of Plasmid from Positive Clones for PCR and 
Sequencing 
Following confirmation of the binding affinity of the round three enriched 
phage and that of the individual clones, the twenty four colonies were 
prepared for PCR and sequencing. Aliquots of phage clones that yielded 
positive results were used to infect E. coli TG1 cells as described. Clones were 
cultured in 1.5 ml of LB broth containing appropriate antibiotics at 37°C 
overnight. Cells were harvested by centrifugation at 16,000 × g for 5 min and 
the pellet resuspended in the appropriate buffer for plasmid extraction using 
QIAprep Spin Miniprep kit (Qiagen). The chromosomal DNA inserts were 
amplified by PCR with the primers pG8SAET_F and pG8SAET_R_Long to 
confirm the presence or otherwise and the size of the insert for each clone [see 
Sections 2.6.8 and 2.6.18ii]. 
4.2.10 Nucleotide Sequencing of Chromosomal DNA Inserts 
Sequencing of the chromosomal DNA inserts was performed with Taq 
polymerase-catalyzed cycle sequencing using fluorescent-labelled BigDye 
terminator kit, DFFRUGLQJ WR PDQXIDFWXUHU¶V LQVWUXFWLRQV LQ DQ $%, 0 
Genetic Analyser (ABI Perkin-Elmer) at the Biopolymer Synthesis and 
Analysis Unit, School of Biomedical Sciences, University of Nottingham. 
Primers pG8SAET_F and/or pG8SAET_R_Short were used to sequence the 
inserts in both the forward and reverse directions [see Section 2.6.8]. 
4.2.11 Bio-informatic Analysis of Chromosomal DNA Inserts 
The Basic Local Alignment Search Tool (BLAST) of the Wellcome Trust 
Sanger Institute C. jejuni gene database 
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(http://www.genedb.org/genedb/cjejuni/blast.jsp) was used to analyse the 
sequences obtained for similarity. The results were also compared with similar 
BLAST searches at the National Center for Biotechnology Information 
(NCBI) website (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
Nucleotide sequence data were analyzed using the DNAMAN software 
(Lynnon Corporation) and their orientation with respect to the Campylobacter 
gene itself and with respect to gene 8 or protein VIII of the pG8SAET vector 
determined.  
Clones were considered candidates if their inserts were in the right orientation 
and in frame with gene 8 of the vector and had a unique predicted function of 
possible interest. Where an insert was not in frame with gene 8 but was in the 
right orientation in the Campylobacter genome and of a unique predicted 
function, it was also considered as candidate gene. This is because it is 
believed that ribosomal slippage can result in correction of frameshifts during 
translation (Chen et al., 2009; Jacobsson et al., 2003). 
Selected genes were analysed for signal peptide-triggered and non-classical 
protein secretion using the signalP 3.0 and SecretomeP 2.0 servers for Gram-
negative bacteria respectively (http://www.cbs.dtu.dk/services/).  
Protein sequences of the selected genes were also used to perform BLASTP 
searches of the non-redundant protein database (nrdb95) and the Omniome 
pep database using the WU-BLAST2 servers at http://dove.embl-
heidelberg.de/Blast2/ and http://tigrblast.tigr.org/cmr-blast/, respectively. 
Using the TMHMM 2.0 programme 
(http://www.cbs.dtu.dk/services/TMHMM-2.0/) an attempt was made to also 
identify transmembrane domains in the selected genes. 
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4.3 Results 
4.3.1 Validation of Phage ELISA 
Currently, there is no commercial ELISA kit available for evaluation of phage 
display libraries and the ELISA assays described by various researchers have 
been designed to suit their individual needs. Since the use of ELISA was 
necessary to confirm whether or not enriched phage or clones have the 
potential to bind to a specific ligand, it was important that reliable ELISA data 
were obtained. Several experiments were therefore carried out that made use 
of a phage display library made from pG8SAET vector without insert (Null 
phage) and a combination of the reagents added to the ELISA wells at 
different times (Figures 4.1 and 4.2). This approach provided information on 
the level of sensitivity and the specificity of target binding. 
In contrast to the addition of whole proteins in conventional ELISA, phage 
ELISA involves the addition of phage particles. In the characterization of 
phage clones by ELISA, it is difficult to add more than 1012 virions per 100 µl 
well, which corresponds to a phage concentration of only 16 nM (Adey et al., 
1995). At this concentration, an unambiguously positive ELISA signal can 
only be observed if the binding affinity is in the micromolar range or better 
(McCafferty & Johnson, 1996). Signals obtained are therefore low, but 
significant. 
The cut-off score for positivity was determined by calculating the mean 
absorbance of five sets of negative controls and three sets of false positive 
controls (0.048), plus three standard deviations (3×0.017). Any colour signal 
with an absorbance above this value (0.065) was regarded as positive (Figure 
4.3). The three false positive controls were used as a way of increasing the 
sensitivity of the assay. 
All samples in the ELISA assays were tested in triplicate, and read twice at 
different times, yielding 12 readings. The mean absorbance was then 
determined. 
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Figure 4. 3 | Validation of phage ELISA. The cut-off score of 0.065 for positivity was 
determined by calculating the mean absorbance of five sets of negative controls and three sets 
false positive controls, plus three standard deviations. 
4.3.2 ELISA Confirmation of Binding Activity of Third Round Phage 
Using enriched phage from the first, second and third round pannings, and 1 in 
2 dilutions of third round enriched phage, alongside appropriate negative 
controls, ELISA was carried out to ascertain the binding of the final enriched 
phage to apo-Lf. All four samples yielded positive results. With the exception 
of the first round enriched phage which gave a mean absorbance of 0.068, the 
mean absorbance of the second and third round enriched phage, as well as the 
1:2 dilution of the third round phage, were above 0.07 (Figure 4.4). 
When the same populations were screened against holo-Lf, the first and 
second round enriched phage gave mean absorbance of 0.065 and 0.066 
respectively, whereas the third round and its 1:2 dilution gave mean 
absorbance of 0.076 and 0.072 respectively (Figure 4.5). 
There were no significant differences between the absorbance of the enriched 
libraries from the pannings against apo- or holo-Lf. 
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Figure 4. 4 | ELISA of enriched phage-1. ELISA was done using 5 sets of negative controls 
and aliquots from the first, second and third round enriched phage after three successive 
pannings against apo-Lf. A final sample of 1:2 dilutions of third round enriched phage was also 
used. All samples were positive in the ELISA although the first round phage gave a weakly 
positive result. 
 
 
 
Figure 4. 5 | ELISA of enriched phage-2. ELISA was done using 5 sets of negative controls 
and aliquots from the first, second and third round enriched phage after three successive 
pannings against holo-Lf. A final sample of 1:2 dilutions of third round enriched phage was 
also used. All samples were positive in the ELISA although the first and second round phage 
gave weakly positive results. 
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4.3.3 ELISA Screening of Candidate Phage Clones 
After confirmation of binding of the enriched library following two separate 
pannings against apo-Lf and one panning against holo-Lf, 24 colonies were 
randomly selected from each panning experiment and cultured further to 
generate individual phage clones, as described previously, and tested 
individually in ELISA assays. Of the twenty four clones selected from the 
enriched library from the first apo-Lf panning, twenty of them generated 
usable cultures. The lids of the other four cultures came off so they were 
presumed contaminated. All twenty clones (100%) gave positive ELISA 
results (Figure 4.6), with an average absorbance of 0.074, significantly greater 
than the cut-off point (p<0.005). All twenty four clones (100%) from the 
second apo-Lf panning also gave positive ELISA results (Figure 4.7), with an 
average absorbance of 0.084, significantly greater than the cut-off point 
(p<0.005). Twenty one of the twenty four clones (87.5%) from the holo-Lf 
panning gave positive ELISA results (p<0.005) (Figure 4.8), with an average 
absorbance of 0.085. the three clones, 14, 15 and 22, that yielded the negative 
results had mean absorbance each of 0.052, 0.063 and 0.054 respectively. 
 
 
Figure 4. 6 | ELISA screening of candidate clones-1. 24 colonies were randomly selected from 
the enriched library following three successive pannings against apo-Lf and cultured to 
generate individual phage clones which were used in an ELISA assay. Of the twenty four 
clones, twenty yielded usable cultures, all yielding positive ELISA results. The negative 
controls (-ve Ctrls) and the false positive controls (+ve Ctrls) are given on the right hand side 
of the graph as samples 26-30, and 32-34 respectively. 
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Figure 4. 7 | ELISA screening of candidate clones-2. 24 colonies were randomly selected from 
the enriched library following three successive pannings against apo-Lf and cultured to 
generate individual phage clones which were used in an ELISA assay. All twenty four clones 
yielded positive ELISA results, although clone 22 was weakly positive with a mean absorbance 
of 0.066. The negative controls (-ve Ctrls) and the false positive controls (+ve Ctrls) are given 
on the right hand side of the graph as samples 26-30, and 32-34 respectively. 
 
 
 
Figure 4. 8 | ELISA screening of candidate clones-3. 24 colonies were randomly selected from 
the enriched library following three successive pannings against apo-Lf and cultured to 
generate individual phage clones which were used in an ELISA assay. Twenty one clones 
yielded positive ELISA results, with clones 14, 15 and 22 yielding weakly positive results with 
a mean absorbance below 0.065. The negative controls (-ve Ctrls) and the false positive 
controls (+ve Ctrls) are given on the right hand side of the graph as samples 26-30, and 32-34 
respectively. 
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4.3.4 Sequencing of Plasmid from Positive Clones 
Following the ELISA assays, aliquots of the phage clones that yielded positive 
results were used to infect E. coli TG1 cells as described. These were cultured 
and plasmid DNA extracted for sequencing. Given that only three clones gave 
weakly positive results from the holo-Lf panning, the clones were also 
prepared for sequencing.  
Usable sequence results were obtained for 42 of the 44 clones from the two 
apo-Lf pannings and all 24 clones from the holo-Lf panning. 
4.3.5 Bio-informatic Analysis of Positive Clones 
A summary of the genes isolated from the pannings against the various ligands 
is provided in Table 4.1 below. After analyses of the DNA inserts, clones were 
considered candidate genes if they were in the right orientation and in frame 
with gene 8 of the vector and had a unique predicted function of possible 
interest, with or without the presence of signal peptide and transmembrane 
domain (also see Table 3.1). 
The gene, Cj0609c, was repeatedly isolated from the sequence results of both 
apo- and holo-Lf pannings. Whilst all clones that harboured sequence derived 
from Cj0609c yielded significantly positive ELISA results, the mean 
absorbance varied among the different clones. The sequence result of the 
insert of clone 4 from the holo-Lf panning, which had the highest mean 
absorbance of 0.15, revealed the isolation of Cj0609c. 
The sequence results of clones 15 and 22 from the holo-Lf panning, which 
gave negative ELISA results, indicated that they had no inserts. However, 
clone 14, also from the holo-Lf panning, which also gave negative ELISA 
result, encoded for the gene Cj0697. This gene was also isolated in clone 8, 
which gave a positive ELISA result with mean absorbance of 0.089. 
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Table 4. 1 | Summary of unique ligand-specific genes after three rounds of panning. All 
clones that produced readable sequences were analysed, and the inserts in the right orientation 
within the vector positively identified. Based on the probable function and location within C. 
jejuni, three clones were selected for each ligand and the presence of signal peptide or 
transmembrane domain determined. All clones were ELISA-positive except one of Cj0697. 
Y/N mean yes/no. 
4.3.6 The Gene, Cj0609c 
The most frequently isolated gene in the panning against Lf, Cj0609c, encodes 
a ca. 45-kDa periplasmic protein predicted to be basic, with pI of 10.3. In 
silico analysis of Cj0609c was carried out using the SignalP 3.0, LipoP 1.0 
and SecretomeP 2.0 servers (http://www.cbs.dtu.dk/services/).  This revealed 
the presence of a signal peptidase I cleavage site at TSSYAĻ22QNLNT with a 
probability of 0.997 but a low signal anchor probability of 0.002. This is an 
indication that once this protein is exported out of the cytoplasm, it had no 
association with the inner membrane. This was confirmed with the TMHMM 
server which showed that the protein has no transmembrane helices. However, 
the SecretomeP 2.0 server predicted the possibility of Cj0609c being a non-
classically secreted protein. 
Whereas Cj0609c is identical to some conserved domain proteins in other 
Campylobacter strains such as C. jejuni subsp. doylei 269.97, C. jejuni 
RM1221, C. jejuni 81-176, C. coli and C. upsaliensis, it is also homologous to 
a number of uncharacterized periplasmic proteins in several Gram-negative 
bacteria notably Helicobacter hepaticus, Helicobacter cinaedi, Neisseria 
meningitidis, Neisseria gonorrhoeae, Fusobacterium nucleatum, and some 
Gram-positive bacteria such as Bacillus cereus, Lactobacillus acidophilus, 
Clostridium botulinum, and Clostridium perfringens.  Cj0609c is also 
homologous to putative lipoproteins of Proteus mirabilis, Pseudomonas 
Ligand Isolated 
C. .jejuni 
Gene(s) 
The Insert Predicted Function (s) SignalP 
(Y/N) 
TMD 
(Y/N) Size 
(bp) 
Fre-
quency 
 
   Enriched Pannings   
apo-Lf i. Cj0609c 
ii.Cj1618c 
 
iii.Cj0599 
457 
586 
 
129 
26/42 
4/42 
 
2/42 
Probable periplasmic protein 
Probable haemin uptake 
system/periplasmic haemin-binding protein 
Putative OmpA family protein 
Y 
N 
 
Y 
N 
N 
 
Y 
 
      
holo-Lf i. Cj0609c 
ii. Cj0525c 
iii.Cj0697 
457 
95 
65 
14/24 
2/24 
2/24 
Probable periplasmic protein 
Putative penicillin-binding protein 
Flagellar basal-body rod protein 
Y 
Y 
N 
N 
Y 
N 
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fluorescens, and the virulence factor mviN of Clostridium tetani. However, 
Cj0609c had no homology with the Lf-binding proteins of N. meningitidis or 
N. gonorrheae. 
Further analysis of conserved domains within this gene revealed that Cj0609c 
is a putative periplasmic member of the SGNH-family of hydrolases, a diverse 
family of lipases and esterases, which are composed of an active site, a 
catalytic triad and an oxyanion hole (Wei et al., 1995); all these features are 
predicted in Cj0609c with high confidence [see Figure 4.9].  
 
 
Figure 4. 9 | BLAST search of Cj0609c depicting SGNH hydrolase superfamily. All 
three features of the SGNH-family of hydrolases are present in Cj0609c, suggesting a role 
in hydrolysis of a protein(s).  
Furthermore, Cj0609c is the first of four adjacent operon-like genes, Cj0609c-
Cj0612c, with the first two encoding probable periplasmic proteins and the 
last two encoding a probable transmembrane transport protein and a probable 
ferritin respectively. The last of these four genes, Cj0612c, has been described 
in the past as Campylobacter ferritin (cft) gene but has not been extensively 
studied in conjunction with the other three, including Cj0609c (Wai et al., 
1996; Wai et al., 1997). 
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4.4 Discussion 
Since the use of ELISA was necessary to confirm whether or not enriched phage 
or clones in this study have the potential to bind to a specific ligand, it was 
important that reliable ELISA data were obtained, which necessitated initial 
validation to provide information on the level of sensitivity and the specificity 
of the response. 
Usually, the cut-off score for positivity is determined by calculating the mean 
absorbance of a set of negative controls, plus three standard deviations 
(Robinson et al., 1997). However, due to the low signals produced in phage 
ELISA it was important that signals that could present as positive results were 
eliminated and hence the use of the three false positive controls in addition to 
the conventional negative controls (Figure 4.2). In this regard, any absorbance 
above the determined value of 0.065 would have eliminated the background 
effect of the negative controls as well as that from the false positive controls, 
and could be regarded as true positive. This made the interpretation of ELISA 
results easier. 
As stated earlier, it is difficult to add more than 1012 virions per 100 µl well 
during characterization of phage clones by ELISA (Adey et al., 1995). At this 
concentration of ca. 16 nM, an unambiguously positive ELISA signal can only 
be observed if the binding affinity is in the micromolar range or better 
(McCafferty & Johnson, 1996). The iterative nature of phage selection permits 
identification of peptides with a broad range of affinities to a specific ligand, 
from sub-nanomolar to 1 millimolar, so lower affinity clones may even not 
show a positive ELISA signal (Adey et al., 1995). However, it is worthwhile 
doing it since it could also provide invaluable information for further studies. 
In the ELISA experiments described in this chapter, it was only possible to add 
approximately 107 virions per 100 µl well based on the starting phage titres and 
the dilution factor of the blocking solution. This meant that if the binding 
affinity of any of the clones was low, then only minimal signal would be 
produced. Signals obtained in the optimization experiments were generally 
lower (data not shown) than the signals obtained in the substantive experiments. 
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This can be attributed to the fact that in the optimization experiments, 
incubation was carried out for only two hours following addition of the phage 
clones to Lf-coated wells, whilst in the substantive experiments incubation was 
done overnight as in the panning experiment. 
Confirmation of the binding activity of the enriched libraries after three 
successive pannings was the starting point in clone isolation for further analysis. 
Thus, if a purportedly enriched library did not give a positive ELISA result, 
there would be no need to proceed to isolate single clones for further analysis. 
Obviously, all three pannings against apo-Lf and holo-Lf led to the enrichment 
of the phage display library CjNCTC11168 for the respective ligands. Although 
the first and the second holo-Lf pannings yielded weak ELISA results, the third 
one produced a slightly higher absorbance of 0.076. However, there were no 
significant differences between the mean absorbance of the enriched libraries 
from the two pannings. 
Majority of the selected individual clones (65/68 or 95.6%) gave positive 
ELISA results. Nevertheless, the mean absorbance for each individual clone 
varied among the clones, which could be a normal variation in binding affinity. 
Although clone 4 from the holo-Lf panning seemed like an outlier with a very 
high mean absorbance, it was interesting to know that its insert encoded for the 
most commonly isolated gene i.e. Cj0609c. Generally, if a gene appeared more 
than once (2-5×) in the sequenced clones, it was analysed in more detail. 
C. jejuni contains both N- and O-linked glycosylation systems, which is an 
important determinant of the functions of its proteins (Szymanski et al., 2003). 
The absence of the necessary glycosylation in the proteins expressed by the 
phage particles may therefore affect their ability to bind to the right target 
ligand. Further work is therefore needed to confirm or otherwise the authenticity 
of the isolated genes. 
However, the repeated isolation of Cj0609c cannot be overlooked. The presence 
RIDVLJQDOSHSWLGDVH,FOHDYDJHVLWHDW766<$Ļ22QNLNT in Cj0609c, without 
any association with the inner membrane indicates a sec-dependent transport 
(Kim & Kendall, 2000). Furthermore, the possibility of Cj0609c being a non-
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classically secreted protein may also suggest a further transport beyond the 
periplasm. 
Cj0609c is identical to some conserved domain proteins in other Campylobacter 
strains, and some Gram-positive bacteria.  Although the functions of these 
proteins are unknown, it is likely that they play a vital role in the survival or 
pathogenesis of these organisms. It is therefore not surprising that Cj0609c is 
also homologous to putative lipoproteins of Proteus mirabilis, Pseudomonas 
fluorescens, and the virulence factor MviN of Clostridium tetani (Ling et al., 
2006; Rudnick et al., 2001). 
The presence of active sites, a catalytic triad and an oxyanion hole in Cj0609c in 
consonance with SGNH-family of hydrolases is an indication of a probable role 
as a hydrolase (Upton & Buckley, 1995; Wei et al., 1995). Characterization of a 
SGNH hydrolase variant from the cyanobacterium, Anabaena species, has 
demonstrated its crucial role in substrate binding and catalytic activity (Bakshy 
et al., 2009). Hydrolases are found in essentially all domains of life both as 
intracellular and extracellular enzymes and are largely involved in nutrient 
acquisition (Bakshy et al., 2009). A recent characterization of a homologue of 
Cj0609c in a Bacillus species revealed the presence of a substrate binding 
region at the N-terminus of the protein (Navarro-Fernandez et al., 2008). 
The well-characterized C. jejuni adhesin, PEB1, is a periplasmic protein that has 
a signal peptidase II cleave site and has been demonstrated in culture 
supernatants (Young et al., 2007). It is therefore possible that the protein 
encoded by Cj0609c, although predominant in the periplasm, is transported to 
the cell surface where it binds to Lf, hydrolyzing it in the process to aid iron 
transport into the bacterium. Further work is needed to confirm or otherwise that 
this gene encodes a Lf-binding protein in C. jejuni and possibly contributing to 
the utilization of Lf-bound iron in the organism. 
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CHAPTER FIVE 
5.0 Identification and Expression of a  Campylobacter 
Autotransporter 
5.1 Introduction 
5.1.1 Protein Secretion Mechanisms in Gram-negative Bacteria 
Bacterial proteins, manufactured within the cytoplasm, are usually subjected 
to compartmentalization, with as much as 50% transported to membrane 
compartments, the periplasm in Gram-negative bacteria or entirely out of the 
cell (Cao & Saier, 2003; Desvaux et al., 2004b; Kim & Kendall, 2000). 
Transport across the inner membrane is aided by a ubiquitous mechanism, the 
sec-dependent pathway consisting of the Sec proteins, well-characterized in E. 
coli or through the sec-independent or twin-arginine translocation (Tat) and 
signal recognition particle (SRP) pathways (Binet et al., 1997; Henderson et 
al., 2004; Kim & Kendall, 2000). Bacterial pathogenesis is almost invariably 
defined by these proteinaceous factors that are secreted into the external 
milieu or to the cell surface (Finlay & Falkow, 1997; Henderson & Nataro, 
2001a). These proteins are usually manufactured as precursors with N-
terminal amino sequences, termed signal sequences that are important for 
efficient export (Omori & Idei, 2003). Whereas in Gram-positive bacteria the 
Sec pathway alone is capable of secreting proteins to the extracellular milieu, 
with cleavage of the signal peptide releasing the mature polypeptide, in Gram-
negative bacteria another barrier in the form of the outer membrane has to be 
overcome (Binet et al., 1997; Desvaux et al., 2004b).  
Gram-negative bacteria have, therefore, developed a number of specialised 
pathways or secretion systems by which proteins of diverse functions are 
transported across their double membrane system (Henderson et al., 2000a; 
Henderson et al., 2004). Recently, Desvaux, Hebraud, Talon and Henderson 
have proposed that these transport pathways are numbered from I to VIII for 
Gram-negative baFWHULDRQO\ZKLOVWWKHWHUPV³6HF´VHFUHWLRQ³Tat´ (twin-
DUJLQLQH WUDQVORFDWLRQ ³)($´ (fODJHOOD H[SRUW DSSDUDWXV ³)3(´ (fimbrilin-
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SURWHLQ H[SRUWHU ³KROLQ´ KROH IRUPLQJ DQG ³:VV´ (WXG100 secretion 
system) be applied to translocation systems across the cytoplasmic membrane 
of both Gram-positive and Gram-negative bacteria (Desvaux et al., 2009). For 
the purposes of this study, I shall briefly discuss types I to V. 
The type I secretion system (T1SS) is energy-dependent but sec-independent 
bypassing the periplasm, and involves a multimeric ATP-binding cassette 
(ABC) protein and two accessory proteins that make up a channel spanning 
both the inner and outer membranes, and is exemplified by the pathway by 
which the Escherichia coli haemolysin A is secreted (Andersen, 2003; Fath & 
Kolter, 1993; Shimada et al., 1994). This specific ATP-driven protein 
translocon of the ABC superfamily consists of two membrane-embedded 
hydrophobic and two conserved hydrophilic ATP-binding domains, which can 
either be parts of a single polypeptide or separate polypeptides (Binet et al., 
1997). The two accessory proteins are an inner membrane protein and an outer 
membrane protein, with the latter consisting of a short N-terminal 
hydrophobic domain anchoring it in the inner membrane, a large hydrophilic 
domain located in the periplasmic space and a C-WHUPLQDO GRPDLQ ZLWK D ȕ-
sheet structure interacting with the outer membrane (Binet et al., 1997; 
Delepelaire, 2004). These proteins form a continuum represented in E. coli as 
HlyB, HlyD and TolC involved in the export of the HlyA toxin (Balakrishnan 
et al., 2001; Holland et al., 2005; Wandersman & Delepelaire, 1990; 
Wooldridge et al., 2005). 
Although the type II secretion system (T2SS) also spans both the inner and 
outer membranes, this requires as many as fourteen additional accessory 
proteins encoded on a single continuous operon as exemplified by the 
pullulanase (PulA) secretion system of Klebsiella oxytoca (Nunn, 1999; 
Possot & Pugsley, 1997; Pugsley et al., 1997). Unlike the T1SS, the T2SS is 
dependent on the inner membrane sec translocase, which is made up of SecA 
and SecYEG, whilst SecB prevents folding of the substrates within the cytosol 
prior to secretion (Chapon et al., 2001; Py et al., 1999). The sec system is 
necessary for translocation into the periplasmic space, and once in the 
periplasmic space the resultant proteins are exported into the extracellular 
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space through the T2SS which is composed of many gene products, twelve 
xcp genes in the case of P. aeruginosa (Mori & Ito, 2006a; Mori & Ito, 2006b; 
Omori & Idei, 2003). The type II transport system is employed in the secretion 
of several exoproteins including elastase, exotoxin, protease, and 
phospholipase C (Crosby & Kachlany, 2007; Mansson et al., 2007; Pradere et 
al., 2007). Thus, both the Sec and the Tat pathways are used in the 
translocation of protein across the inner membrane, whilst T2SS exports the 
protein to the extracellular milieu (Desvaux et al., 2004b). 
First described in 1990 by Michiels and co-workers, the type III secretion 
system (T3SS) is a virulence mechanism by which some pathogenic bacteria 
inject proteins directly into the cytosol of eukaryotic cells modulating 
signalling responses during infection (Cornelis, 2002; Michiels et al., 1990). It 
involves a complex apparatus of proteins which assemble into a tightly 
regulated oligomeric structure spanning both the inner and the outer 
membranes, and in some cases, the target host cell membrane (Henderson & 
Nataro, 2001a). The sec system is required for the translocation of some of the 
component proteins of the secretion apparatus across the inner membrane, but 
not in the secretion of the effector molecules (Galan & Collmer, 1999; Hueck, 
1998; Veenendaal et al., 2009). It is exemplified by the secretion or injection 
of the Yersinia outer proteins (Yops) into the cytosol of host cells that come 
into contact with the plague-causing agent, Yersinia pestis (Felek & Krukonis, 
2009; Michiels et al., 1990; Pan et al., 2009). The shigellosis-causing Gram-
negative bacterium, Shigella flexneri, also initiates infection by inducing a 
rapid burst of Ipa invasins secreted via this secretion system into colonic 
epithelial cells (Espina et al., 2006; Picking et al., 2005; Zurawski et al., 
2009). The T3SS and the Gram-negative flagellar export apparatus are thought 
to be homologous, leading researchers to classify the flagellar biosynthesis 
pathway as T3SS (Blocker et al., 2003; Macnab, 1999). 
The type IV secretion system (T4SS) comprises a diverse transporter family 
involved in competence and conjugative transfer of DNA and/or protein, 
enabling translocation of effector proteins from a Gram-negative bacterium to 
another or to a eukaryotic host cell (Burns, 2003; Craig & Li, 2008; Yen et al., 
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2002). This system is therefore employed in maintaining genome plasticity 
and contributing to the evolution of pathogens through dissemination of 
antibiotic resistance and virulence genes, whilst contributing to pathogenesis 
(Juhas et al., 2007; Juhas et al., 2008). Although this secretion system also 
involves similar numbers of proteins as the type II and type III systems, these 
proteins are variously associated with the inner and outer membranes and are 
located within the periplasm and the cytoplasm, as exemplified by secretion of 
the pertussis toxin of Bordetella pertussis and Bartonella species (Burns, 
1999; Dehio, 2008; Shrivastava & Miller, 2009).  
The type V secretion system (T5SS) was previously thought to be the simplest 
of all Gram-negative transport mechanisms involving the translocation of 
proteins across the outer membrane via a membrane pore formed by a self-
HQFRGHG ȕ-barrel structure, and hence the name autotransporter (Desvaux et 
al., 2004a; Yen et al., 2002). However, recent developments have revealed 
minor variations in export of these proteins leading experts to suggest 
subdivisions [see Figure 5.1] such as the type Va (T5aSS) or autotransporter, 
the two-partner secretion (TPS) system or type Vb (T5bSS) and the Oca 
family or type Vc (T5cSS), although the generic name autotransporter still 
holds (Dautin & Bernstein, 2007; Desvaux et al., 2004a; Desvaux et al., 2009; 
Renn & Clark, 2008).  
The T5aSS is the simplest described below, whilst the T5bSS or TPS involves 
the secretion of proteins such as adhesins and cytolysins whose translocator 
domains are transcribed and translated independently of the effector protein as 
TpsB and TpsA respectively (Jacob-Dubuisson et al., 2001). 
In 2004, Surana and co-workers described a novel subfamily of 
autotransporters in Haemophilus influenzae, characterised by a short trimeric 
C-terminal translocator domain and referred to these as trimeric 
autotransporters (Cotter et al., 2005; Surana et al., 2004). These trimeric 
autotransporters (T5cSS) have since been described in E. coli, N. meningitidis, 
Bartonella and Haemophilus influenzae (Leduc et al., 2009; Pina et al., 2009; 
Sjolinder et al., 2008; Szczesny et al., 2008; Szczesny & Lupas, 2008; Valle et 
al., 2008).  
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Figure 5. 1 | Schematic representation of the T5SSs. All three subdivisions of the system use 
the dedicated the inner membrane sec translocase, which is made up of SecA and SecYEG, 
with SecB serving as a chaperon to prevent cytosolic folding of substrate. Autotransporters 
$ DUH SURGXFHG DV VLQJOH SRO\SHSWLGH FKDLQV ZKLFK DUH WKHQ WUDQVORFDWHG YLD WKH ȕ-barrel 
domain at their C-terminus. The TPS effector proteins (B) and their translocator domains are 
produced as separate polypeptides, which associate within the periplasm prior to secretion of 
the effector protein. Proteins secreted via the T5cSS (C) essentially behave as autotransporter 
proteins but have a shortened C-terminal domain encompassing one third of a translocation 
XQLWSUHGLFWHGDVIRXUȕ-strands), which form a functional translocator as a trimer [Adopted 
with permission from Bacterial Secreted Proteins, edited by Karl Wooldridge, 2009]. 
The genome sequence of C. jejuni reveals the presence of both the sec-
dependent and the sec-independent (Tat) protein export pathways for secretion 
of proteins across the inner membrane and the periplasmic space, as well as 
the signal recognition particle pathway (Fouts et al., 2005; Parkhill et al., 
2000). Whilst there is no evidence of T1SS or T4SS in Campylobacter, the 
flagellar system of C. jejuni is known to function as both a flagellum and 
protein secretion system; this secretion system is known to be homologous to 
T3SS (Guerry, 2007). The transfer of genetic material is achieved through 
T2SS in C. jejuni (Konkel et al., 2004a; Wang & Taylor, 1990; Wiesner et al., 
2003). The initial part of this study which involves a protein secreted by the 
T5SS (autotransporter) was recently also reported in C. jejuni (Ashgar et al., 
2007). 
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5.1.2 Autotransporter Proteins 
This secretion pathway (T5aSS) was first described as being responsible for 
the secretion of IgA1 protease of Neisseria gonorrheae, the components of 
which consist of an N-terminal leader peptide required for sec-dependent 
secretion across the inner membrane, a functional secreted mature protein 
known as the passenger domain, and a C-terminal domain, which forms a ȕ-
barrel or pore in the outer membrane through which the passenger domain 
passes to the exterior [see Figures 5.1, 5.2 and 5.3] (Henderson et al., 2000b; 
Henderson et al., 2004; Meyer et al., 1987; Pohlner et al., 1987a).  
 
Figure 5. 2 | Schematic representation of the structure of autotransporter proteins. Proteins 
exported through the type V secretion system comprise of an N-terminal leader peptide, a 
functional secreted passenger domain, and a C-WHUPLQDO ȕ-barrel/domain through whose 
aperture the passenger domain passes to the exterior. 
These auto-transported proteins or autotransporters have become a rapidly 
growing family of proteins among Gram-negative bacteria due to their diverse 
passenger domains and different functions (Henderson et al., 2004; Jose & 
Meyer, 2007). Secretion via this pathway requires the sec system for transport 
across the inner membrane but further secretion beyond the outer membrane is 
thought to be determined by features that are contained within the secreted 
molecule (Henderson & Nataro, 2001a). It has been suggested that the size of 
ȕ-barrel may define the structural properties of the secreted proteins 
(Henderson et al., 1998; Henderson et al., 2004; Oomen et al., 2004). Again, it 
is believed that the physiological functions of the protein may determine or be 
determined by what happens once it is at the cell surface (Henderson et al., 
1998).  
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Figure 5. 3 | The Crystal structure of the autotransporter NalP
 
of N. meningitidis. Side view of 
NalPȕ in space group P6122 shows a 12-VWUDQGHGȕ-barrel (blue ribbon representation). The 
hydrophobic membrane-embedded region is flanked by aromatic residues (yellow ball-and-
stick). The periplasmic side is characterised by short turns (T0±T5) and the extracellular side 
by longer loops (L1±/FRQQHFWLQJWKHDOWHUQDWLQJȕ-VWUDQGV$QĮ-KHOLFDOµSOXJ
UHGULEERQ
representation) is connected to the barrel via T0 and positions the N-terminus of the 
translocator domain (Ala 786) at the extracellular side [Adopted from Oomen et al., 2004]. 
The passenger domain may (LUHPDLQDWWDFKHGWRWKHȕ-domain and protrude 
from the bacterial surface as a large polyprotein; (LLEHFOHDYHG IURP WKHȕ-
domain, but remain loosely associated with it via non-covalent interactions; or 
(LLL EH FOHDYHG DQG WRWDOO\ GHWDFKHG IURP WKH ȕ-domain to perform its 
functions in the external environment (Henderson et al., 1998). A further level 
of variation exists ± some proteins, such as the IgA proteases catalyse their 
own cleavage, while others, such as the IcsA of Shigella flexneri, require an 
accessory protease for cleavage (Shere et al., 1997; Steinhauer et al., 1999; 
Veiga et al., 1999). A significant number of auto-transporter proteins have 
been characterized for several Gram-negative pathogens with most of these 
organisms secreting more than one protein and some proteins having multiple 
functions (Henderson et al., 2004). In summary, characterized autotransporter 
proteins have been known to function as adhesins, proteases, mucinases, and 
toxins or to mediate serum resistance (Henderson & Nataro, 2001b; Lawrenz 
et al., 2009; Reidl et al., 2009; Swanson et al., 2009; Van Gerven et al., 2009; 
Wagner et al., 2009).  
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5.1.3 Aim of the Study in This Chapter 
In spite of the identification of several autotransporter proteins with virulence 
functions in several pathogenic organisms including Neisseria species, 
Haemophilus species, Bordetella species, Shigella species, E. coli and H. 
pylori, only one has so far been described for Campylobacter (Ashgar et al., 
2007).  
Several of the autotransporter proteins which were discovered several years 
ago such as the MisL of Salmonella enterica serovar Typhimurium have only 
recently been characterized (Blanc-Potard et al., 1999; Dorsey et al., 2005; 
Tukel et al., 2007), whilst others, such as the Ssa1 of Mannheima 
(Pasteurella) haemolytica A1, which were not considered members of this 
family, have recently been shown to possess autotransporter properties (Gioia 
et al., 2006; Lo et al., 1991).  
The autotransporter mechanism of protein secretion has therefore become an 
area of intense research with ongoing studies leading to the identification and 
characterization of several complex arrays of proteins secreted in this way, 
and adding to our understanding of the fundamental features of these proteins 
and their roles in bacterial pathogenesis (Leduc et al., 2009; Serruto et al., 
2009; van der Woude & Henderson, 2008).  
Thus, given the varied pathogenic functions of autotransporters, an in silico 
analysis of the C. jejuni NCTC11168 genome was carried out to identify 
putative autotransporter proteins and further express one of them for 
characterization.  
The main aim of this study was to express the full-length CapA protein to 
enable structural and further functional characterization of the protein. 
A full-length CapA protein could be used in further studies including: 
x identification of host cell ligands 
x whole cell inhibition assay 
x raising antibodies for western-blotting and immuno-
precipitation 
x cross-linking experiments 
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5.2 Materials & Methods 
5.2.1 Bio-Informatic Searches and Sequence Analysis 
In order to identify novel autotransporter proteins of C. jejuni, the amino acid 
sequences of previously described autotransporters IgA1 protease (Pohlner et 
al., 1987b), AIDA-I (Benz & Schmidt, 1989), Hia (Barenkamp & St Geme, 
1996), Hap (Hendrixson & St Geme, 1998), Pet (Eslava et al., 1998), Pic 
(Henderson et al., 1999), and AspA (Turner et al., 2002) were employed to 
search the predicted coding sequences of C. jejuni NCTC11168 genome 
through the Basic Local Alignment Search Tool (BLAST) of the Wellcome 
Trust Sanger Institute C. jejuni gene database 
(http://www.genedb.org/genedb/cjejuni/blast.jsp).  
The resulting protein sequences were examined for the typical characteristics 
of autotransporter proteins as given by Henderson (Henderson et al., 2004). 
Protein sequences of the predicted passenger domains were used to perform 
BLASTP searches of the non-redundant protein database (nrdb95) and the 
Omniome pep database using the WU-BLAST2 servers at http://dove.embl-
heidelberg.de/Blast2/ and http://tigrblast.tigr.org/cmr-blast/, respectively.  
Using the Neural Network Promoter Prediction program 
(www.fruitfly.org/seq_tools/promoter.html) DNA segments were examined 
for potential promoter sequences. Ribosome-binding sites were also predicted 
using the Gene Locator and Interpolated Markov ModelER server (Glimmer 
3.02) (http://www.ncbi.nlm.nih.gov/genomes/MICROBES/glimmer_3.cgi). 
Identified proteins were analysed for signal peptide-triggered and non-
classical protein secretion using the signalP 3.0 and SecretomeP 2.0 servers 
for Gram-negative bacteria respectively (http://www.cbs.dtu.dk/services/). 
Using the TMHMM 2.0 programme 
(http://www.cbs.dtu.dk/services/TMHMM-2.0/) an attempt was made to also 
identify transmembrane domains in the selected genes. Nucleotide sequence 
data were analyzed using the DNAMAN software (Lynnon Corporation). 
Two genes were identified to encode autotransporter proteins in the available 
genome sequences of C. jejuni, which based on their initial functional 
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characterization, were later designated Campylobacter adhesion protein A, 
capA [Cj0628/Cj0629] and Campylobacter adhesion protein B, capB 
[Cj1677/Cj1678] (Section 5.3.1). The focus of this chapter was on the 
expression of capA. 
5.2.2 General Materials 
5.2.2.1 Antibiotic Supplements 
[See Section 2.6.3 above] 
5.2.2.2 Culture Media 
[See Section 2.6.4 above] 
5.2.2.3 Miscellaneous Buffers and Solutions 
 [See Section 2.6.5 above] 
5.2.2.4 DNA Extraction, Purification and Quantification 
[See Section 2.6.9, 2.6.10, and 2.6.11 above] 
5.2.2.5 DNA Sequencing 
[See Section 3.6.11 above] 
5.2.2.6 Polymerase Chain Reaction 
PCR was carried out using a Techne 96-well thermocycler. Primers used in 
this study (Table 5.1) were synthesized by Eurofins GmbH (Germany). 
Table 5. 1 | PCR Primers used in the amplification of truncations of the capA gene. The 
capA gene comprises of two open reading frames (ORFs), Cj0628 and Cj0629 when out 
of frame, made up of nucleotides 1-541 and 721-3421 respectively. Deletion of a T or G 
between nucleotides 497 and 511 puts the two ORFs in frame, and can be translated as 
one protein. PCR was done to amplify fragments of the gene as well as the full-length 
capA after deletion of a G. 
Primer Sequence Amplification of 
 
  
capA_F1 
capA_R1  
5´ - ATTTCTTTTTTGGCAAGTTGTAC - 3´  
5´ - ATAGACATTGACCACCATTTAA - 3´ 
Truncated capA ORF 
Cj0628, nt 114-1115 
 
  
capA_F2 
capA_R2 
5´ - GGATCCATGGGTGTAAATGTTCGTTC -3´ 
5´ - GTCGACTTACCAAAGATAATTAAACTGAGC - 3´ 
Truncated capA ORF 
Cj0629 , nt 751-3413 
 
  
capA_F3 
capA_R3 
¶- ATGAATAAAACTGCATTAACTAAAACATAC - ¶ 
¶- TACCCATACAGGATTTGCTCAGT - ¶ 
Full-length capA ORFs 
Cj0628/Cj0629, nt 1-3421 
 
  
capA_F4 
capA_R4 
5´ - TAACGGTGTTAGCATAGAAACC - 3´ 
5´ - CAGTATTAGAGTGAATAGTTCCAC - 3´  
Across poly-T/poly-G tract 
of  Cj0628, nt 444-555 
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5.2.3 Bacterial Strains and Culture conditions 
Wild type Campylobacter jejuni NCTC11168 was obtained from laboratory 
stock maintained in a 50:50 mixture of glycerol and Mueller-Hinton (MH) 
broth and stored at -80°C. C. jejuni NCTC11168 was grown at 42°C on 
charcoal-cefoperazone-desoxycholate agar (CCDA) or in MH broth (Oxoid) 
with shaking, in a MACS VA500 Microaerophilic workstation (Don Whitley 
Scientific) in atmospheric conditions of 6% O2, 5% CO2, 3% H2 and 86% N2. 
Commercial E. coli strains, JM83 (Promega), Tuner (DE3) pLacI (Novagen) 
and BL21-CodonPlusTM (Stratagene) were used to express various forms of 
CapA protein. E. coli cells were cultured in LB broth or agar, containing the 
appropriate antibiotics, at 37°C overnight, with shaking where appropriate. 
5.2.4 Cloning and Mutagenesis 
The capA gene comprises of two ORFs, Cj0628 and Cj0629 when out of 
frame, made up of nucleotides (nt) 1-541 and 721-3421 respectively. Deletion 
of a G or T between nucleotide 497 and 511 puts the two ORFs in frame, and 
can be translated as one protein. PCR was done to amplify fragments of the 
gene as well as the full length capA. 
5.2.4.1 Cloning of Full-length capA 
Primers capA_F3 and capA_R3 were used to amplify either the capA gene 
from chromosomal DNA of wild type C. jejuni NCTC11168 or capA mutant 
harbouring a repaired-capA gene [see section 5.2.7], each approximately 3.5 
kb in size. The sequences spanning the poly-T/poly-G tracts of capA in the 
two constructs were confirmed by PCR and sequencing using primers 
capA_F4 and capA_R4. 
A 25-µl PCR reaction mixture contained 1 µl of DNA, 0.5 µM each of the 
respective forward and reverse primers, 10 mM dNTPs, 2.5 µl of 10 × PCR 
buffer, and 2 U of Taq Polymerase. Reactions were subjected to an initial 
denaturation at 95°C for 3 min, followed by 30 cycles of denaturation at 
94°C for 45 s, an annealing temperature of 50°C for 45 s, an extension at 
68°C for 4 min, an annealing step at 50°C for 45 s and a final extension at 
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68°C for 3 min. PCR products were then analyzed by gel electrophoresis 
using ethidium bromide staining.  
The resulting PCR products were labelled as original capA and repaired 
capA, capAori/capArep respectively. The PCR products were ligated into 
pETBlue- $FFHS7RU YHFWRU 1RYDJHQ DFFRUGLQJ WR PDQXIDFWXUHU¶V
instructions, generating two recombinant genes pET-capAori and pET-
capArep respectively. 
5.2.5 Generation of CapA Proteins 
As stated earlier, the capA gene comprises of two ORFs, Cj0628 and Cj0629, 
when out of frame, encoded by nucleotides (nt) 1-541 and 721-3421 
respectively. Deletion of a T or a G, or four nucleotides, between nucleotide 
497 and 511 puts the two ORFs in frame to translate as one protein with a 
molecular mass of ca. 120 kDa. 
5.2.5.1 Expression and Purification of Full-length CapA Protein 
The resulting full-length capA gene products, pET-capAori and pET-
capArep, encoded proteins pET-capAori [possibly one or two fragments] 
and pET-capArep respectively. The expected molecular mass of pET-
capArep was calculated to be 116 kDa. 
The two gene products were each used to transform two separate E. coli 
strains, Tuner (DE3) PLacI competent cells (Novagen) and BL21-
CodonPlus competent cells 6WUDWDJHQH DFFRUGLQJ WR PDQXIDFWXUHUV¶
instructions. The transformed E. coli strains were cultured in LB broth to 
mid-log phase, and then induced using IPTG. Cells were grown for a further 
4 h and then harvested by centrifugation at 4000 × g. These were analyzed 
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
and immunoblotting using Rabbit anti-VHUXPUDLVHGDJDLQVW&DS$5Į&DS$
[see Section 5.2.6]. 
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5.2.6 Repair of capA 
To ensure that expression of a full-length CapA protein was fixed and no 
phase variation could occur, the capA gene was engineered using PCR so that 
the poly-T and adjacent poly-G tracts, which interrupt the full capA coding 
sequence, were replaced with a DNA sequence 4-bp shorter (to put capA in-
frame) and encoding the same amino acids, but containing no homopolymeric 
sequences. A novel complementation strategy was developed to insert a single 
copy of capA into the genome of a capA mutant. This approach involved 
inserting capA and its upstream promoter sequence into the intergenic space 
between the Cj0652 and Cj0653c genes. Once this gene and a resistance 
marker had been introduced into the chromosome by double homologous 
recombination from a suicide vector, the genotype of the resulting strain was 
confirmed by PCR and sequencing. Immunoblotting experiments on 
equivalent amounts of whole cell protein were then carried out to confirm that 
CapA was being expressed in the complemented strain. 
5.2.7 SDS-PAGE, Coomassie-staining, Western- & Immuno- Blotting 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
carried out using standard procedures. Western blotting was carried out using 
D7UDQV%ORW6'%LR5DGDFFRUGLQJWRPDQXIDFWXUHU¶VLQVtructions. Gels were 
run in duplicate for Coomassie staining and immunoblotting. 
Gels were stained using SimplyBlueTM SafeStain for a minimum of 1 h, and 
de-stained with distilled water for a minimum of 2 h. Gels were photographed 
using the AlphaDigiDoc software via an Olympus digital camera. Duplicate 
gels were transferred in an appropriate buffer for Semi-dry Western transfer 
and immunoblotting analysis.  
After western transfer, nitrocellulose membranes were blocked for 2 h with 20 
ml of blocking solution [either in 5% non-fat milk solution or 2% BSA 
(Bovine Serum Albumin, Sigma) in phosphate buffered saline (PBS, Oxoid) 
and 0.05% Tween20]. Pre-adsorbed RDCapA, which had been diluted 1:500 
in blocking solution, was added to each membrane covering it completely. 
This was incubated at room temperature overnight with shaking. 
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Blotting membranes were washed twice with PBS-Tween for 20 min in each 
case with shaking. A secondary antibody of Goat anti-rabbit HRP conjugate 
diluted 1:2000 in 20 ml of blocking solution was added to each membrane and 
incubated at room temperature for 2 h with shaking. Membranes were washed 
twice with PBS-Tween for 20 min with shaking, and radiographed. 
5.2.8 Detection of Proteins on Blotting Membranes 
Membranes were developed using Enhanced ChemiLuminescent (ECL) 
reagents *(+HDOWKFDUHDFFRUGLQJWRPDQXIDFWXUHU¶VLQVWUXFWLRQV.  
ECL is known to be more sensitive. However, in some instances where 
membranes did not produce satisfactory images with ECL, they were washed 
with PBS-Tween and re-developed using the conventional 4-Chloro-1-
naphthol (4-CN). Approximately 3 mg of 4-CN was added to 1 ml of ethanol 
in a separate tube. Another mixture containing 1 ml of 0.5M Tris-HCl (pH 
6.8), 9 ml of dH2O and 50 µl of H2O2 was prepared separately, and then the 
content of the two tubes added up, and placed on the membranes for about 10 
min. 
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5.3 Results 
5.3.1 In Silico Sequence Analysis of two Campylobacter 
Autotransporters 
Using the amino acid sequences of known adhesion-associated and other well-
characterized autotransporters to search the predicted coding sequences of C. 
jejuni NCTC11168, two genes, Cj0628 and Cj1677 [see Figure 5.4], were 
identified as coding for proteins that bear all of the typical characteristics of 
autotransporter proteins (Henderson et al., 2004).  
The C-terminal two-thirds of the protein sequences of the two genes 
(extending from 375F in Cj0628 and 349F in Cj1677) bear 100% identity 
(Figure 5.3), with portions (residues 862S to 1144W in Cj0628 and 839S to 1121W 
in Cj1677) encoding the predLFWHGDXWRWUDQVSRUWHUȕ-barrel domain terminating 
LQ WKH ³</:´ PRWLI ZKLFK FRQIRUPV WR WKH W\SLFDO DXWRWUDQVSRUWHU PRWLI
(Y/V/I/F/W)-X- (F/W) (Henderson et al., 2004).   
 
Figure 5. 4 | Schematic diagram of the predicted protein sequences of CapA (Cj0628/Cj0629) 
and CapB (Cj1677/Cj1678). Green shading, signal peptidase II-dependent signal peptides 
(SPII); Red shading, pasVHQJHUGRPDLQVEOXHVKDGLQJȕ-domains. Predicted signal peptidase 
II cleavage sites are indicated. Both the Cj0629 and Cj1678 predicted protein sequences end 
ZLWKWKHPRWLI³</:´ZKLFKFRQIRUPVWRWKHW\SLFDODXWRWUDQVSRUWHr motif (Y/V/I/F/W)-X-
(F/W). Red vertical stripes indicate regions of identity between CapA and CapB. White solid 
arrows represent the ORFs encoding each protein; homopolymeric tracts resulting in 
frameshifts are also indicated. Unless otherwise indicated, numbers refer to amino acids [see 
Ashgar et al. 2007, J Bacteriol 189, 1856-1865]. 
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They were later designated Campylobacter adhesion protein A, capA [Cj0628] 
and Campylobacter adhesion protein B, capB [Cj1677] respectively based on 
their adhesion properties (described later). 
By contrast, the N-terminal regions are highly divergent except for 20 amino 
acids immediately preceding the likely signal peptidase II cleavage site. The 
only two cysteines found in the protein are contained in the predicted signal 
peptide, which also conforms to the low cysteine content of known 
autotransporter proteins (Henderson et al., 2004). 
The annotated sequence released by the Sanger Institute reveals, in the 
unspliced DNA of each gene, the presence of two separate ORFs, previously 
assigned Cj0628/Cj0629 and Cj1677/Cj1678 respectively, due to the presence 
of premature stop codons downstream of homopolymeric tracts. There is a 5-
bp poly-T tract immediately followed by a 10-bp poly-G tract between 
nucleotides (nt) 497 and 511 in the case of capA, deletion of a single residue 
from either tract of which places the two adjacent coding sequences, Cj0628 
and Cj0629, within a single ORF. In the case of capB, there is a 7-bp poly-T 
tract between nucleotides 578 and 584, deletion of a single residue thereof 
similarly places the adjacent coding sequences, Cj1677 and Cj1678, within a 
single putative gene.  
The two pairs of ORFs were hypothesised to constitute a single gene each due 
to the presence of promoter sequences and ribosome-binding sites upstream of 
Cj0628 and Cj1677, but not Cj0629 or Cj1678. Again, using the SignalP 
algorithm, both Cj0628 and Cj1677 are predicted to encode proteins with 
signal peptidase II domains whose cleavage sites are predicted to be 
33)/$Ļ36SCTHA41TL43T and 33FLA36SCANAĻ41KL43N respectively. 
However, given that the sequences at both cleavage sites contain a putative 
lipid attachment motif and lipoprotein modification/processing site it would 
appear that the actXDOFOHDYDJHVLWHPD\EHDW)/$6Ļ37C in conformity with 
other lipoproteins (Hayashi & Wu, 1990; Juncker et al., 2003).  
It is also noteworthy that 37C is the last of a stretch of 20 residues that are 
conserved between CapA and CapB. Cleavage at the predicted sites would 
result in the residues at +2 being cysteine and leucine respectively.  
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In E. coli, retention of lipoproteins within the inner membrane is dependent on 
the presence of aspartate at this position, in combination with aspartate, 
glutamate, glutamine, or asparagine at position 3 (Hara et al., 2003). The 
absence of aspartate at position +2 would, therefore, suggest an outer 
membrane location for both CapA and CapB (Hara et al., 2003).  
Similarity searches of available gene databases with the passenger domains of 
capA and capB demonstrated the presence of both genes in a number of C. 
jejuni strains (Table 5.2). 
 
Genome sequence CapA CapB 
C. jejuni NCTC 11168  + + 
C. jejuni RM1221  - - 
C. jejuni 84-25  + + 
C. jejuni 81-176  - - 
C. jejuni CF93-6  + + 
C. jejuni 81116 - - 
C. jejuni CG8486 + + 
C. jejuni 260.94  - - 
C. jejuni 269.97 + + 
C. jejuni HB93-13  - - 
Total 5/10 5/10 
Table 5. 2 | The presence of CapA and CapB in the available gene databases of other 
Campylobacter strains. In the case of C. jejuni subsp. doylei 269.97, the sequence is listed as 
autotransporter beta-domain-containing protein. 
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5.3.2 Campylobacter Adhesion Protein A, CapA 
As stated earlier, the capA gene comprises of two ORFs, Cj0628 and Cj0629, 
when out of frame, encoded by nucleotides 1-541 and 721-3421 respectively. 
Deletion of a T or a G, between nucleotide 497 and 511 puts the two ORFs in 
frame to translate as one protein of 1,144 amino acids and a calculated 
molecular mass of ca. 120 kDa, becoming 116 kDa after cleavage of the 
predicted signal sequences. It is predicted to be weakly acidic, with pI of 6.8.  
 
Protein % ID 
with 
CapA 
E-Value Autotransporter 
ȕ-Domain 
SignalP Organism 
AIDA-I 43 9.5 e-07 Yes Yes Escherichia coli  
 
     
TapA 43 2.5 e-14 Yes Yes Acidithiobacillus ferrooxidans 
 
     
Mycobacterial PPE 
membrane proteins 
41 2.5 e-14  Yes Mycobacterium tuberculosis 
 
     
Haemagglutinin-like 
autotransporter 
44 6.8 e-18 Yes Yes Ralstonia solanacearum 
 
     
Outer membrane 
protein/Haemolysin 
43 4.5 e-09  Yes Fusobacterium nucleatum 
 
     
Putative 
Autotransporter  
34 0.41 Yes Yes Rhodopseudomonas palustris 
TIE-1 
 
     
Putative lipoprotein 45 3.0 e-20  Yes Helicobacter pullorum MIT 
98-548 
 
     
rOMP B  9.1 e-07 Yes Yes Rickettsia Spp 
 
     
Blr6013 protein 42 5.4 e-08 Yes Yes Bradyrhizobium japonicum 
 
     
Outer membrane 
autotransporter 
42 0.007 Yes Yes Caulobacter sp. K31 
 
     
Outer membrane 
autotransporter 
43 1.0 e-04 Yes Yes Polynucleobacter necessarius 
Table 5. 3 | Similarity of CapA with other Gram-negative proteins. Whereas some of these 
closely identical proteins have been listed as autotransporters, others are listed simply as outer 
membrane proteins. 
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Further analysis revealed that the capA gene is flanked by an upstream gene 
encoding a probable hydrogenase isoenzyme (hypA) and a downstream gene 
encoding a 321-amino-acid conserved hypothetical protein. Whilst the hypA 
gene is in the same orientation as capA but separated from it by an 875-bp 
intergenic sequence containing a 14-bp inverted repeat, the downstream 
hypothetical gene is in the opposite orientation to capA, suggesting that capA 
is likely to be transcriptionally independent of its neighbouring genes.  
Similarity searches of available gene databases with the passenger domain of 
CapA demonstrated similarity with a number of known autotransporters 
and/or surface proteins as well as some uncharacterised proteins (Table 5.3). 
5.3.3 Complementary Experiments [By Ashgar & Oldfield, Ashgar et 
al. 2007] 
The initial characterization of CapA and CapB involved experiments which 
are detailed in this section to clarify subsequent data and/or information. To 
avoid possible problems with slipped-strand mispairing at the homopolymeric 
tracts due to the presence of shared, as well as gene specific, regions within 
the capA and capB, separate fragments of capA were constructed: the gene-
specific region of capA, which corresponds to aa 38 to 372 of the in silico-
reconstructed CapA sequence and the entire downstream ORF of CapA 
(Cj0629), which corresponds to aa 243 to 1144 of the in silico-reconstructed 
CapA sequence and contains sequences common to capA and capB. Each 
fragment was cloned into the pMAL-c2X vector to produce plasmids pMAL-
trCapA and pMAL-trCapAB respectively, in order to express maltose-binding 
protein (MBP) fusions of each truncated protein.  
After induction of E. coli cells harbouring pMALtrCapAB, a recombinant 
protein (MBP-trCapAB) with a molecular mass of ca. 140 kDa was strongly 
expressed. This was consistent with the predicted molecular weight of MBP 
fused to the CapAB common region. The MBP-trCapAB fusion protein was 
affinity purified using amylase-resin columns and further purified by 
electroelution from sodium dodecyl sulfate-polyacrylamide gels (SDS-PAG) 
before being used to raise rabbit antibodies against both CapA and CapB 
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5ĮCapAB). The antiserum recognized proteins with molecular masses of 140 
kDa and 115 kDa in lysates of E. coli expressing the recombinant protein; 
these were assumed to be the full-length recombinant fusion protein and a 
breakdown product of this protein. Recombinant proteins containing the gene-
specific region of CapA was expressed and purified in the same way from 
pMALtrCapA-containing E. coli cells, and used to generate the CapA-specific 
DQWLVHUXP5Į&DS$ZKLFK strongly recognized proteins of the expected size in 
lysates of E. coli expressing CapA. 
In order to obtain controls for expression studies and for phenotypic studies of 
CapA, single-knockout mutants of capA and capB (11168capA and 
11168capB, respectively), as well as a double mutant (11168capAcapB) in 
which both genes were disrupted, were constructed. Each gene was disrupted 
by insertion of either a kanamycin or a chloramphenicol resistance cassette 
toward the beginning of the structural gene. Successful insertion of the 
respective antibiotic genes at the intended locations was confirmed by PCR 
and sequencing (Ashgar et al., 2007). 
Using 5ĮCapAB to probe whole cell extracts of C. jejuni in immunoblotting 
experiments, Ashgar et al. observed that while CapA was consistently 
expressed in strain NCTC11168, there was no detectable expression of CapB 
under the culture conditions used (Ashgar et al., 2007). 
 
Figure 5. 5 | Expression of CapA in C. jejuni. 5ĮCapAB recognizes a protein of ca. 116 kDa 
in whole-cell preparations of strain NCTC11168 (lane 1) and in four heterologous clinical 
isolates (lanes 3 to 6) but not in 11168capA (lane 2). A protein of the same size was also 
detected in extracts from isolates obtained from chickens experimentally inoculated with 
strain NCTC11168 at 2 (lane 7), 3 (lane 8), and 4 (lane 9) weeks post-inoculation and in post-
mortem isolates (lane 10). No protein was detected in extracts of isolates from chickens 
inoculated with strain 11168capA at 1 week (lane 11) or 2 weeks post-inoculation (lane 12) 
[see Ashgar et al. 2007, J Bacteriol 189, 1856-1865]. 
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In a further southern-blotting experiment and immunoblotting, Ashgar et al. 
observed that only 2/8 of multilocus sequence-typed (MLST) human isolates 
contained the capA gene, whilst 8/11 recent clinical isolates had the gene 
(Ashgar et al., 2007). Of the 8 recent clinical isolates that had the gene, only 4 
of them expressed detectable CapA protein, whilst both capA-containing 
MLST isolates expressed CapA [see Figure 5.5]. 
Using sub-cellular fractions of CapA-producing C. jejuni strains grown in the 
presence or absence of globomycin, Ashgar et al. confirmed that CapA is 
indeed a lipoprotein that is localised in the outer membrane (Ashgar et al., 
2007). They further showed that CapA plays a role in association and invasion 
of Caco2 cells, and that it is required for efficient colonization of chicken guts 
(Ashgar et al., 2007). 
5.3.4 Repair of capA 
It was important that the CapA protein was expressed in its native form in 
order to further characterize the protein. Repair of capA was therefore carried 
out [courtesy, Dr Neil Oldfield and Dr Karl Wooldridge] to create a non-
phase-variable variant of the capA gene to ensure the expression of a full-
length CapA protein.  
The poly-T and adjacent poly-G tracts were replaced with a DNA sequence 4-
bp shorter (to put capA in-frame) and encoding the same amino acids, but 
containing no homopolymeric sequences (Figure 5.6).  
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Figure 5. 6 | Repair of capA gene and complementation. The capA gene used in the 
complementation was engineered using PCR so that the poly-T and adjacent poly-G tracts, 
which interrupt the full capA coding sequence, were replaced with a DNA sequence 1-bp 
shorter (to put capA in-frame) and encoding the same amino acids, but containing no 
homopolymeric sequences. Thus, expression of a full-length CapA protein was fixed and no 
phase variation could occur. 
The genotype of the resulting strain was confirmed by PCR and sequencing. 
By using immunoblotting experiments on equivalent amounts of whole cell 
protein were then carried out to confirm that CapA was being expressed in the 
complemented strain. These showed that CapA was being expressed, but at 
greatly reduced levels compared to the wild type [see Figure 5.7].  
The adherence properties of the complemented strain were then compared to 
the wild type and capA mutant strains in vitro. These experiments showed that 
the complemented strain was indistinguishable from that of the mutant. This 
was interpreted as being a consequence of the low level of CapA expression in 
the complemented strain. 
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Figure 5. 7 | Expression of Full-length CapA. Rabbit polyclonal anti-CapA serum recognizes 
a protein of c. 116 kDa in a whole-cell preparation of C. jejuni NCTC11168 (lane 1) but not in 
the CapA-deficient derivative (lane 2). Complementation by inserting a single copy of capA 
into the genome of the capA mutant restores CapA expression, but not to wild type levels 
(lane 3). 
5.3.5 Cloning of Full-length CapA 
Using PCR the capA gene was amplified from chromosomal DNA of wild 
type C. jejuni NCTC11168 or capA mutant harbouring a repaired-capA gene 
[see section 5.2.7], each approximately 3.5 kb in size (Figure 5.8). The 
resulting PCR products, capAori and capArep respectively, were ligated into 
pETBlue-1 AccepTor vector (Novagen) according WR PDQXIDFWXUHU¶V
instructions, generating two recombinant genes pET-capAori and pET-
capArep respectively. 
 
Figure 5. 8 | Agarose gel electrophoresis photo of PCR of capA gene. 1 and 2, repaired capA 
gene (capArep); lane 3, wild type capA (capAori) harbouring the homopolymeric tracts at nt 
497-511. The repaired capA gene is only 4 nucleotides shorter than the original capA gene. 
The presence of restriction sites within the recombinant plasmids (insert and 
vector) were used to ascertain the orientation of the insert before they were 
used in transformation of E. coli hosts [see Figures 5.9 and 5.10]. Insertion of 
capA in the same orientation as the T7 promoter of the vector creates an EcoRI 
site yielding three fragments of 420 bp, 3241bp and 3251 bp in a double digest 
with EcoRI and XbaI. In contrast, insertion of capA in a reverse orientation to 
the vector disrupts the EcoRI site yielding two fragments of 1236 bp and 5734 
bp in a double digest with EcoRI and XbaI. 
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Figure 5. 9 | Schematic representation of the recombinant plasmid, pET-capA. The DNA 
sequence of the capA gene has an XbaI restriction site at position 99, but no EcoRI site, whilst 
pETBlue-1 vector has an EcoRI site within the multiple cloning region of the vector. Insertion 
of capA DNA sequence in the correct orientation to the T7 promoter results in the availability 
of the EcoRI site for digestion with the enzyme, whilst insertion of capA in the reverse 
orientation disrupts the EcoRI site. A double digest with XbaI and EcoRI, therefore, 
differentiates between a capA insert in the correct or reverse orientation. 
 
 
 
Figure 5. 10 | Agarose gel photo of XbaI/EcoRI double digestion reactions of pET-capArep 
and pET-capAori. Insertion of capA in the correct orientation to the T7 promoter of the vector 
creates an EcoRI site upstream, a double digest with EcoRI and XbaI of which yields two 
fragments of 3241bp and 3251 bp detectable   as one fragment and a non detectable fragment 
of 420 bp, while a single digest with XbaI yields only one detectable fragment of 6.5 kb. In 
contrast, insertion of capA in a reverse orientation to the vector removes the EcoRI site 
yielding three detectable fragments of 1237 bp, 2434 bp and 3241 bp in a double digest with 
EcoRI and XbaI, while a single digest with XbaI yields two detectable fragments of 1237 bp 
and 5.6 kb. The above digest depict insertion of capA in the correct orientation to the T7 
promoter. 1, undigested plasmid; 2, single digest with XbaI; and 3, double digest with XbaI 
and EcoRI. 
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5.3.6 Expression of Full-length CapA 
Following initial cloning and verification of constructs in NovaBlue 6LQJOHV
competent cell host (Novagen) the recombinant plasmids were transformed 
into the Tuner (DE3) pLacI competent cells (Novagen) according to 
PDQXIDFWXUHU¶V LQVWUXFWLRQV for protein expression. As expected, no protein 
expression of CapAori was detected, whilst expression of CapArep was 
obtained. However, this was inconsistent in different experiments. Clones that 
expressed the protein in some experiments did not express it at other times.  
After several unsuccessful attempts to express CapArep in Tuner cells, the 
pET-capArep plasmid was used to transform BL21-CodonPlus competent 
cells 6WUDWDJHQH DFFRUGLQJ WR PDQXIDFWXUHU¶V LQVWUXFWLRQV for protein 
expression. These cells contain some rare tRNAs that allow high level 
expression of many heterologous recombinant genes. 
Using lysates from wild type C. jejuni strain NCTC11168 expressing CapA as 
a positive control and its mutant as a negative control, protein expression from 
clones containing the repaired capA construct (CapArep-1 and CapArep-2) 
produced a characteristic band at the expected size of CapA [see Figures 5.11 
and 5.12]. However, this protein pattern was observed in clones that contained 
the pETBlue-1 vector without insert. Very strong protein bands with 
molecular weights of ca. 83 kDa and 175 kDa were also observed in the 
lysates.  
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Figure 5. 11 | Immunoblotting analysis of CapA expression by two clones of the repaired 
capA gene, CapArep-1/2 in (A) BL21-CodonPlus cells and (B) Tuner Competent cells. WT C. 
jejuni strain NCTC11168 expressing CapA, its negative control in which the capA gene has 
been knocked out and pETBlue-1 vector without an insert (pET) were used as controls. Fresh 
overnight cultures of BL21-CodonPlusTM cells or Tuner (DE3) pLacI competent cells 
containing the capA clones and a pET-null were incubated in duplicate for two hours to mid-
log phase growth. One of each duplicate culture was then induced with IPTG (+), the other 
un-induced (-) and incubated for further 3 h. Rabbit polyclonal anti-CapA serum recognizes a 
protein of ca. 116 kDa in a whole-cell preparation of the resultant cultures. Photo developed 
using 4-CN. 
 
 
Figure 5. 12 | Immunoblotting analysis of CapA expression by two clones of the repaired 
capA gene, CapArep-1/2 in BL21-CodonPlus cells. WT C. jejuni strain NCTC11168 
expressing CapA, and pETBlue-1 vector without an insert were used as controls. Fresh 
overnight cultures of BL21-CodonPlusTM cells the capA clones or a pET-null (pET) were 
incubated in triplicate for two hours to mid-log phase growth. Two each of the capA clones 
were then induced with IPTG (+), the other un-induced (-) and incubated for further 3 h. 
Rabbit polyclonal anti-CapA serum recognizes a protein of ca. 116 kDa in a whole-cell 
preparation of the resultant cultures. Photo obtained using ECL. 
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5.4 Discussion 
The identification and initial characterization of Campylobacter adhesion 
protein A (CapA) has been reported in the Journal of Bacteriology, 189(5): 
1856-65 (Ashgar et al., 2007). This constituted the first report of a 
Campylobacter autotransporter.  
Although we have expressed truncated forms of the protein in E. coli for initial 
characterization, expression of the full-length CapA has only been consistently 
demonstrated in wild type C. jejuni strains.  
The non-expression of the full-length of the original CapA in an E. coli host was 
not surprising because of the presence of the poly-T and poly-G tracts within its 
sequence and the fact that the gene was out of frame. Obviously, transcriptional 
slippage or stutter occurring during transcription resulting in frameshifts and 
phase variation could have led to the expression of the CapA protein, but this 
was not the case (van der Woude & Baumler, 2004).  
Phase variation is a well-known phenomenon that has been observed in many 
aspects of C. jejuni biology (Bacon et al., 2001; Coward et al., 2006; Guerry et 
al., 2002; Prendergast et al., 2004). The sequenced genome of the C. jejuni 
NCTC11168 reveals the presence of short polymeric tracts of nucleotides within 
several genes making them highly phase variable (Gundogdu et al., 2007; 
Parkhill et al., 2000; Wassenaar et al., 2002). Several Campylobacter genes 
such as the wlaN gene which encodes a galactosyltransferase, the maf1, maf4 
and maf5 genes involved in flagellation are all known to contain homopolymeric 
tracts that render them phase variable (Karlyshev et al., 2002; Linton et al., 
2000a). Thus, WKHSUHVHQFHRIKRPRSRO\PHULF WUDFWV DW WKH¶ HQGRI capA, as 
depicted by the gene sequence, suggests that its expression could also be phase-
variable. Furthermore, whilst confirming that not all C. jejuni isolates had the 
capA gene, some clinical isolates that harboured the capA gene did not express 
detectable CapA protein (Ashgar et al., 2007). Using micro-array comparative 
studies, Dorrell et al. identified genes in several NCTC 11168 loci that are either 
absent or highly divergent in these isolates (Dorrell et al., 2001). 
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Based on the available data, it was difficult to interpret whether or not CapA 
was being expressed by the capArep constructs. The intensity of the protein 
detected in the null-vector-containing E. coli was identical to the intensity of the 
protein detected in the capArep constructs. The original capA gene was repaired 
using PCR so that the poly-T and adjacent poly-G tracts, which interrupt the full 
capA coding sequence, were replaced with a DNA sequence 4-bp and 1-amino 
acid shorter (to put capA in-frame) and encoding the same amino acids, but 
containing no homopolymeric sequences. Thus, expression of a full-length 
CapA protein was expected to be fixed and no phase variation could occur. This 
was, however, not the case, as the protein was expressed in some experiments 
but not in others. It is possible that CapA was being expressed but at a very low 
level. Although both capArep-1 and capArep-2 were identical, there were only a 
few instances where they gave identical protein expression profiles. 
Low level expression was also observed following complementation of the capA 
mutant of C. jejuni, which also showed adherence properties identical to those 
of the original mutant. It is not clear whether the site of insertion of the repaired 
capA during complementation played a role in this. This location was selected 
EHFDXVH WKH &M DQG &MF JHQHV DUH RULHQWDWHG LQ D µWDLO-to-WDLO¶
orientation, with a 123-bp gap in between, allowing for the insertion of DNA 
without polar effects. 
It was therefore decided that the repaired capA be cloned into a vector and the 
protein expressed in an E. coli host. The pETcapA plasmids were therefore 
transformed into Tuner competent cells since these cells contained the 
suppressor lacI gene. Since the pETBlue-1 vector does not contain a copy of the 
lacI gene, it requires an additional source of lac repressor to suppress basal 
expression of target genes in the absence of inducer. Thus, the presence of the 
pLacI plasmid in the Tuner cells provides this additional source of lac repressor 
after pETBlue recombinants have been transfected into the former. 
Following unsuccessful attempts to consistently express CapA in Tuner 
competent cells, it was thought that a more specialized commercial E. coli 
would be needed for consistent expression. BL21-CodonPlusTM cells were 
therefore employed because of their ability to enable efficient expression of 
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heterologous proteins in E. coli due to the presence of extra copies of genes 
encoding tRNAs that are rare in E. coli. However, these also failed to 
consistently express the CapA protein. These observations could be attributed to 
the AT rich nature of the gene which might probably have resulted in promoter-
like sequences and interfere with proper gene expression (Huerta et al., 2006). 
The expression of a full-length CapA may be dependent on other protein(s). 
Thus, in the complemented C. jejuni mutant strain or the E. coli hosts, where the 
other gene(s) may be showing phase variation or totally absent, the expression 
of CapA may also be hampered. Furthermore, the very low-level expression of 
the CapA protein in the complemented strain, which is likely to be the case in 
the E. coli hosts, could account for the absence of detectable levels of the 
protein in some experiments.  
A comparison of the adherence properties of wild type C. jejuni NCTC11168 
and its mutant deficient in capA, showed, in the initial characterization, that 
capA mutants lacked the ability to colonize chicken guts or adhere to Caco2 
cells (Ashgar et al., 2007). However, complementation of the capA mutant with 
repaired capA failed to confirm this, since the adherence properties of the two 
strains were indistinguishable. This could be attributed to the low level of CapA 
expression in the complemented strain.  
That CapA is absent in some strains of C. jejuni despite being pathogenic could 
also be attributed to the roles of other known adhesins such as PEB-1, JlpA, 
CadF and MOMP described thus far. This is also likely to account for the 
residual adherence observed in the capA mutant strain. Thus, the very low-level 
expression of the CapA protein in the complemented strain was unlikely to 
detectably enhance the ability of this strain to adhere. 
Through bio-informatic analysis, it has been demonstrated that CapA possesses 
all the features of autotransporter proteins (Henderson et al., 2004) and shares 
homology with several Gram-negative autotransporters and adhesins as shown 
in Table 5.3. In spite of close homology of CapA with another Campylobacter 
protein, CapB, the transcription or expression of the latter has not been 
demonstrated, whilst that of CapA has. 
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In conclusion, Cj0628 encodes a Campylobacter outer membrane 
autotransporter protein, CapA, which plays some role in colonisation of 
chickens and adhesion to human epithelial cells in vitro. It would be necessary 
to produce a full-length CapA protein for structural and further functional 
characterization of this protein. 
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General Discussion 
 
Identification of Host-pathogen Interacting Molecules of Campylobacter jejuni using 
Phage Display Technology and in silico Sequence Analysis 
 
CHAPTER SIX 
 
 
Harry H Abruquah | Identification of host-pathogen interacting molecules of Campylobacter jejuni  
PhD Thesis | Microbiology | March 2009 
213 
 
CHAPTER SIX 
6.0 Final Remarks 
6.1 General Discussion 
Campylobacter jejuni KDVHVWDEOLVKHGLWVHOIDVWKHZRUOG¶VOHDGLQJFDXVHRIIRRG- 
and water-borne human gastroenteritis which is sometimes followed by 
unprecedented complications, ranging from localized peritonitis, pericarditis and 
encephalopathy to debilitating neuropathy and bacteraemia (Alzand et al., 2009; 
Lang et al., 2009; Roan et al., 2009; Wesley et al., 2009; Young et al., 2009; 
Young et al., 2007; Zilbauer et al., 2008). Although much progress has been 
made in the past three decades in regards to its virulence determinants, our 
understanding of the molecular basis of C. jejuni pathogenesis, still lags behind 
that of other enteric pathogens (Poly & Guerry, 2008; Zilbauer et al., 2008). 
Bacterial pathogenesis is known to be dependent upon the panoply of 
proteinaceous virulence factors that are transported to the bacterial cell surface 
or released into the external environment to interact with host cellular 
molecules, including the extracellular matrix proteins (Casadevall & Pirofski, 
2001; Finlay & Falkow, 1997; Patti et al., 1994; Wilson et al., 2002). 
Understanding the molecular basis of interactions between these proteins and 
host cells is therefore necessary in understanding and controlling infections.  
The C. jejuni genome encodes as many as 1,643 proteins, of which 10-20% is 
predicted to be membrane, periplasmic or lipoproteins of unknown function 
(Gundogdu et al., 2007; Parkhill et al., 2000). Of these, 121 have been 
characterized and assigned as being involved in adhesion (10), motility (63), 
two-component systems (15), toxin production and drug resistance (19) (Fouts 
et al., 2005; Gundogdu et al., 2007; Parkhill et al., 2000). The sequencing of 
additional strains of C. jejuni has further revealed that the total number of 
uncharacterized membrane proteins ranges between 185 and 218 (Fouts et al., 
2005). Obviously, these individual proteins may well be involved in virulence 
processes, such as adhesion, colonization, iron acquisition, gut survivability and 
toxicity towards host cells. 
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To decipher all the genes encoding these proteins and their roles in pathogenesis 
calls for the use of different strategies in identifying these proteins and their 
respective functions. Several strategies have been described, including two-
dimensional gel electrophoresis (2-DE), mass spectrometry, yeast two-hybrid 
screens, antibody screens, and comparative genomics (Cordwell et al., 2008; 
LaGier & Threadgill, 2008; Parrish et al., 2007; Shoaf-Sweeney et al., 2008). 
Two approaches have been employed in this study, namely, phage display 
technology and in silico sequence search/analysis of available gene databases. 
Whereas in silico search of gene databases and analysis of individual genes may 
lead to the identification of novel proteins, based on previously characterized 
homologues in other pathogens, the method could potentially miss other 
proteins that may play the same functions but have no homology to other 
characterized proteins. A detailed analysis of lactoferrin-binding proteins of N. 
meningitidis revealed homology in the sequences of some Gram-negative 
organisms, but also a lack of similarity to other known Lf-binding proteins of 
other organisms. For instance, two different Lf-binding proteins have been 
described in N. meningitidis (Pettersson et al., 2006; Schryvers & Lee, 1989). 
This deficiency could be complemented by phage display technology which, not 
only screens libraries expressing many thousands of unique peptides and 
proteins by way of binding to specific ligands but also, has the capacity to 
maintain a molecular link between the displayed protein and the DNA sequence 
encoding it (Azzazy & Highsmith, 2002; Mullen et al., 2006). 
To my knowledge, this is the first description of a phage display library of C. 
jejuni, although other libraries have been described including a lambda gt11 
library, genomic microarray library and a novel cloning of C. jejuni ORFs 
(Burucoa et al., 1995; Parrish et al., 2004; Poly et al., 2004). This phage display 
library of C. jejuni NCTC11168 was constructed using the major coat protein of 
the M13 bacteriophage in a phagemid vector, pG8SAET (Jacobsson et al., 
2003). Based on the fact that minor coat proteins will display larger proteins 
more effectively than pVIII (Kehoe & Kay, 2005), two libraries were 
constructed; one that was made from size-selected DNA fragments for larger 
inserts and another that was not size-selected and hence contains smaller inserts. 
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Given that some short peptides cannot be displayed, whilst some proteins as 
large as penicillin G acylase, an 86-kDa heterodimer, have been displayed on 
both pIII and pVIII, this library should more than suffice for its intended 
purpose  (Verhaert et al., 1999).  
The high insert rates in these phage display libraries of C. jejuni NCTC11168, 
together with the high complexities and high titres, are also indicative of good 
genomic libraries (Jacobsson et al., 2003; Mullen et al., 2007b). Since no such 
library has been described for C. jejuni, these will serve as rich resources for 
further host-pathogen protein interaction studies of C. jejuni for years to come. 
Using these two approaches, therefore, we sought to identify host-pathogen 
interacting molecules of C. jejuni. On one hand, Lf has been implicated in a 
number of pathogenic processes including activation of macrophages via TLR4-
dependent and -independent signalling pathways (Curran et al., 2006), 
regulation of helper T cells, Th1 and Th2, responses (Fischer et al., 2006), and 
above all the role of Lf in iron metabolism and the ability of some organisms to 
utilise Lf-bound iron (Furano & Campagnari, 2004; Perkins-Balding et al., 
2004). Thus, with the recent finding that C. jejuni could utilise Lf-bound iron 
(Miller et al., 2008), which hitherto was not thought to be the case, Lf was 
considered a suitable ligand for the very first substantive panning of the phage 
display library. 
As stated earlier, autotransporters, on another hand, have become a rapidly 
growing family of proteins among Gram-negative bacteria due to their diverse 
passenger domains and their unique roles in host-pathogen interactions 
including adhesion, toxigenicity and intracellular spread  (Henderson et al., 
2004). Through in silico sequence analysis, Cj0628 was identified. Cj0628 
encodes a protein which has been characterized and designated Campylobacter 
adhesion protein A (CapA) (Ashgar et al., 2007).  
Through phage display technology the gene, Cj0609c, was also identified and 
shown to encode a periplasmic protein. This study has provided the first 
evidence that this protein may be involved in Lf-binding and/or iron acquisition. 
However, it is yet to be fully characterized.  
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There are a number of iron sources to pathogens in the blood, tissue fluids and 
(particularly important for Campylobacter) in the mucosa. Lf is one such 
potential source in the latter habitat, although only a handful of pathogenic 
organisms including H. pylori and N. meningitidis have been reported to utilise 
iron from Lf and Tf sources (Husson et al., 1993; Krewulak & Vogel, 2008; 
Pickett et al., 1992).  
Siderophores are low-molecular weight iron-chelating compound synthesised by 
Gram-negative and Gram-positive bacteria to scavenge iron from precipitates or 
host proteins LQWKHPLFURRUJDQLVP¶VH[WUDFHOOXODUHQYLURQPHQW(Faraldo-Gomez 
& Sansom, 2003). Iron is typically obtained from these sources by Gram-
negative bacteria through specialised uptake pathways made up of a TonB-
dependent outer membrane receptor, a periplasmic binding protein (PBP), and 
an inner membrane ABC transporter as depicted in Figure 6.1 (Faraldo-Gomez 
& Sansom, 2003; Krewulak & Vogel, 2008). Whereas iron-siderophore 
complexes may enter the periplasm, iron-Lf/Tf and iron-haem complexes are 
prevented from doing so due to their sizes. An addition to the features of the 
TonB-GHSHQGHQW VLGHURSKRUH UHFHSWRUV LQFOXGH D ȕ-barrel with an amino 
terminal segment that folds independently into a globular plug domain that 
RSHQV RU FORVHV WKH ȕ-barrel depending on the presence or absence of a 
siderophore (Faraldo-Gomez & Sansom, 2003; Krewulak & Vogel, 2008). 
Nevertheless, the processes involved in the removal of iron from Lf and Tf and 
its subsequent transport across the outer membrane are still not well-understood 
(Khan et al., 2007) and, until recently C. jejuni was not known to utilise Lf as a 
source of iron. 
Although a TonB dependent or ligand-gated outer membrane receptor for 
ferrienterochelin and colicins, Iha adhesin, has been predicted in C. jejuni, it is 
yet to be characterised (Gundogdu et al., 2007). The protein is predicted to have 
channels created by a monomeric 22 strand anti-SDUDOOHOȕ-barrel, ligand-binding 
large extracellular loops and a N-terminal 50-200 residues that form a plug from 
the periplasmic end of barrel (Gundogdu et al., 2007; Parkhill et al., 2000). 
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Figure 6. 1 | Schematic representation of iron-uptake systems in Gram-negative bacteria. 
Bacteria iron-acquisition (IA) starts with the binding of Fe3+-containing proteins (light purple) 
such as iron-loaded siderophores or haem to high-affinity surface receptor proteins (Wooley & 
Blue). These are subsequently translocated into the periplasmic space with the aid of the Ton 
complex (TonB±ExbBD). Iron transported further into the cytoplasm through periplasmic 
binding proteins (light blue) and ATP-driven transporters (Purple et al.). In E. coli, the 
siderophore enterobactin is recruited through the outer membrane receptor, FepA and the 
FepBCDG system. IA in Neisseria species is achieved through receptor-mediated removal of 
iron from Lf/Tf, which is transported the Tf/Lf-binding protein (T/Lbp) AB and Ferric-binding 
protein (Fbp) ABC system. Haem is sequestered from haemoglobin (Hb) and haemoglobin±
haptoglobin (Hb±Hp) by outer-membrane proteins such as HpuAB and HmbR or taken up 
directly by the HemRTUV system in Yersinia enterocolitica, or delivered by haemophores such 
as HasA in Serratia marscensis through HasR. Under anaerobic conditions, soluble Fe2+ can 
diffuse across outer-membrane porins, and is subsequently imported by energy-dependent 
systems such as the FeoABC [Adopted from Faraldo et al., 2003; Nat Rev Mol Cell Biol 4, 105-
116]. 
The well-characterized C. jejuni adhesin, PEB1, is a periplasmic protein that has 
a signal peptidase II cleave site and has been demonstrated in culture 
supernatants (Young et al., 2007). Furthermore, a putative periplasmic solute 
binding protein for ABC transport system, Cj0143c (ZntC), is predicted to be a 
metal-binding protein, that functions as an initial receptor in ABC transport of 
metal ions (Gundogdu et al., 2007; Parkhill et al., 2000). Another putative 
haemagglutination activity domain containing protein, Cj0737 (FhaB), which is 
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also a periplasmic protein is believed to possess exoproteins involved in haem-
utilization or adhesion (Gundogdu et al., 2007; Parkhill et al., 2000). 
Therefore, given the unique characteristics of Cj0609c as a periplasmic protein 
with a possibility of also being non-classically secreted, it is possible that the 
protein encoded by this gene could shuttle between the periplasmic space and 
the cell surface, enabling it to bind to Lf. Alternatively it may have a dual 
location and hence a dual role in binding Lf and delivering iron to the cells 
ZLWKRXWµVKXWWOLQJ¶DVVXFK 
Furthermore, the E. coli thioesterase I (TAP), which belongs to the SGNH-
hydrolase family, has been shown to be a multifunctional enzyme possessing 
activities of thioesterase, esterase, arylesterase, protease, and lysophospholipase 
(Lo et al., 2003). The protein encoded by Cj0609c could therefore also possess a 
protease function, given that it belongs to the SGNH-hydrolase family, thus, 
capable of hydrolyzing Lf to release its Fe3+ in the process.  
In the well-accepted model of TonB-dependent iron-acquisition from Lf/Tf, the 
role of the periplasmic binding protein in the process is overlooked, suggesting 
that transport across the outer membrane and subsequent capture of ligand by 
the periplasmic binding protein are independent processes. However, in a recent 
study by Khan and co-workers, it was observed that high-affinity binding of iron 
by the periplasmic binding protein is required to drive transport across the outer 
membrane (Khan et al., 2007). In fact, the published affinity constants for 
Lf/Tf-iron complexes are near or below the threshold affinity observed by Khan 
in his periplasmic binding protein construct (Khan et al., 2007).  With the high 
pI of 10.3 predicted in Cj0609c, it is likely to have a higher affinity for Fe3+ than 
would Lf, and thus could competitively sequester Fe3+ from holo-Lf. 
Furthermore, should the genes downstream of Cj0609c, which together are in 
reverse orientation to their flanking genes, be tightly regulated, then it could be 
hypothesized that Cj0609c-Cj0612c could form an operon for iron acquisition 
based on the accepted mechanism described above. This is because Cj0610c is 
periplasmic protein but has no signal peptide cleavage site, whilst Cj0611c is a 
probable transmembrane transport protein with acyltransferase functions, and 
Cj0612c encodes a ferritin. Being an enteropathogen, it is likely that 
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Campylobacter utilizes Lf-bound iron as part of its iron acquisition mechanisms 
for survival. 
Lastly, with its role in iron homeostasis, it is believed that the internalization of 
both apo- and holo-Lf in mammalian cells is dependent on a clathrin-mediated 
endocytosis (Lopez et al., 2008; McAbee et al., 1993). Thus, some 
microorganisms have evolved Lf receptors which are not used in iron 
sequestration but employed to enable them to enter into host cells alongside Lf. 
For instance, it has been recently reported that Streptococcus uberis, an 
important causative agent of mastitis in dairy cattle throughout the world, 
utilises Lf as a molecular bridge for internalization into bovine mammary 
epithelial cells (Patel et al., 2009). By extrapolation therefore, should Cj0609c 
not be involved in iron acquisition, it could be considered as a potential adhesin 
that binds to Lf within the human gut to aid internalization of the organism into 
the intestinal epithelial cell. In view of the above, we designate the product of 
Cj0609c as lactoferrin-interacting molecule of Campylobacter jejuni (LimC). 
6.2 Conclusions 
Based on the characterization of CapA and in silico analysis of Cj0609c, it is 
likely that these two genes, Cj0628 (capA) and Cj0609c (limC), which encode 
an autotransporter protein and a periplasmic protein in Campylobacter jejuni 
NCTC11168 respectively, may be involved in Campylobacter adhesion to host 
cells and Campylobacter utilization of lactoferrin-bound iron respectively, thus, 
contributing to the pathogenesis of the organism. Given that no mechanism for 
the utilization of Lf-bound iron has been reported in Campylobacter, and CapA 
is the first autotransporter with adhesion properties to be reported in the 
organism, these studies provide great insights that need further investigations. 
6.3 Future Directions 
While Cj0628 has been characterised genetically and shown to have a role in 
pathogenesis and colonisation, it has not been shown to date to interact directly 
with any host protein. Furthermore, the protein has not been functionally 
characterised since we could not consistently express the full-length protein. 
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Thus, further attempts at expression and purification of a full-length native 
protein should not be abandoned since it will constitute the first step towards 
these goals. In this regard, it is my wish that newer protein expression vectors 
and E. coli hosts be explored in order to consistently express CapA. This could 
then be used in adhesion and inhibition assays. 
Here is the first evidence that the product of Cj0609c (limC) interacts with Lf. 
However, this needs to be confirmed using other methods to ascertain the role of 
Cj0609c in iron acquisition and hence the pathogenic processes of C. jejuni. 
Ideally, the first step would involve cloning the full-length Cj0609c into an 
appropriate vector to express the protein. This would then be used in ELISA 
assays, immuno-precipitation, far-Western analysis, surface plasmon resonance 
(SPR) spectroscopy etc. to confirm its binding to Lf.  
Following confirmation of binding between Lf and Cj0609c, cellular 
fractionation would then be carried out to determine the final or other locations 
of the encoded protein. Mutagenesis of this gene would also help to determine 
whether this protein has a role in iron uptake from Lf. Several site-directed 
mutants could then be constructed to explore the functions of the encoded 
protein in iron-acquisition in C. jejuni or its involvement in internalization of C. 
jejuni into host cells. 
In collaboration with researchers of protein structure and function, following 
successful initial characterization, the structure of the encoded protein could be 
elucidated to lend further understanding to the mechanisms employed by Gram-
negative organisms in sequestration of iron from Lf and/or Tf. 
We have a long way to go towards fully understanding the relationship between 
C. jejuni and its human and animal hosts. Phage display technology is one tool 
which may lead to new insights into this complex interaction. 
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Appendix 3: Supplementary Information on Materials and Methods 
3.1 Enzymes 
a. SnaBI 
 SnaBI is derived from an E. coli strain that carries the SnaBI gene from 
Sphaerotilus natans, has a recognition site of 
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b. SnaBI 
 SnaBI is derived from an E. coli strain that carries the SnaBI gene from 
Sphaerotilus natans, has a recognition site of 
  
 
c. BglII 
BglII is derived from an E. coli strain that carries the BglII gene from Bacillus 
globigii, has a recognition site of  
 
 
d. BfuCI 
BfuCI is derived from an E. coli strain that carries the BfuCI gene from 
Bacillus fusiformis, has a recognition site of  
 
   
e. BamHI 
BamHI is derived from an E. coli strain that carries the BamHI gene from 
Bacillus amyloliquefaciens H, has a recognition site 
of 
 
f. SmaI 
SmaI is derived from an E. coli strain that carries the SmaI gene from Serratia 
marcescens, has a recognition site of  
 
 
g. EcoRV 
 EcoRV is derived from an E. coli strain that carries the EcoRV gene from the 
plasmid J62 pLG74, has a recognition site of  
 
 
h. Alkaline Phosphatase Variants 
a. Calf Intestinal Alkaline Phosphatase (CIAP) 
This enzyme, obtained from calf intestine, catalyzes the removal of 5´ 
phosphate groups from DNA and RNA, thus making DNA and RNA 
deficient of the 5´ phosphoryl termini required by ligases for ligation 
(Sambrook & Rusell, 2001). This therefore prevents self-ligation, 
decreasing the vector background in the cloning experiments. 
b. Shrimp Alkaline Phosphatase (SAP) 
This enzyme, obtained from shrimp, catalyzes the removal of 5´ phosphate 
groups from DNA and RNA, thus making DNA and RNA deficient of the 
5´ phosphoryl termini required by ligases for ligation (Sambrook & Rusell, 
2001). This therefore prevents self-ligation, decreasing the vector 
background in the cloning experiments. 
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c. Antarctic Phosphatase (AP) 
This enzyme, obtained from an E. coli strain that carries the TAB5 AP 
gene, originally cloned in pNI and re-cloned in plasmid pEGTAB7-4.1 
(Rina et al., 2000), catalyzes the removal of 5´ phosphate groups from 
DNA and RNA, thus making DNA and RNA deficient of the 5´ 
phosphoryl termini required by ligases for ligation (Sambrook & Rusell, 
2001). This therefore prevents self-ligation, decreasing the vector 
background in the cloning experiments. 
i. Klenow Fragment 
.OHQRZ )UDJPHQW ĺ  H[R- ), which is derived from  an E. coli strain 
containing a plasmid with a fragment of the E. coli polA gene starting at 
codon 324, is an N-terminal truncation of DNA polymerase I, which retains 
SRO\PHUDVH DFWLYLW\ EXW KDV ORVW WKH ĺ  H[RQXFOHDVH DFWLYLW\ DQG KDV D
PXWDWLRQZKLFKGLPLQLVKHVWKHĺH[RQXFOHDVHDFWLYLW\(Derbyshire et al., 
1988). 
$ ³ILOO-LQ´ UHDFWLRQ LQ WKH SUHVHQFH RI .OHQRZ DQG QXFOHRWLGHV LV XVHG WR
create blunt ends on chromosomal DNA fragments with 5´overhangs 
following sonication such as this: 
 
 
 
 
 
$OWKRXJK PLQLPDO WKH ĺ  H[RQXFOHDVH DFWLYLW\ RI .OHQRZ FDQ GLJHVW
away the protruding overhangs following sonication such as this. 
 
 
 
 
 
In a Klenow reaction, removal of nucleotides from the 3´ ends will continue, 
but, in the presence of nucleotides, the polymerase activity will balance the 
exonuclease activity, yielding blunt ends. This reaction is more efficiently 
conducted with T4 DNA polymerase which has much more potent 
exonuclease activity. 
j. T4 DNA Polymerase 
T4 DNA polymerase, derived from a strain of E. coli that carries a T4 DNA 
polymerase overproducing plasmid, catalyzes the synthesis of DNA in the 
ĺGLUHFWLRQLQWKHSUHVHQFHRIWHPSODWHDQGSULPHUVXFKDVWKHsonicated-
chromosomal DNA of C. jejuni NCTC11168 ,W DOVR KDV D ĺ 
exonuclease activity which is much more active than that found in the Klenow 
IUDJPHQW RU WKH FRPSOHWH '1$ 3RO\PHUDVH , ZKLOVW ODFNLQJ D ĺ 
exonuclease function (Sambrook & Rusell, 2001). 
k. T4 DNA Ligase 
T4 DNA ligase, derived from E. coli C600 pcl857 pPLc28 lig8, catalyzes the 
formation of a phosphodiester bond between juxtaposed 5´ phosphate and 3´  
hydroxyl termini in duplex DNA or RNA and is employed in the ligation of 
blunt end and cohesive end termini as well as repair single stranded nicks in 
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duplex DNA, RNA or DNA/RNA hybrids (Rossi et al., 1997; Sambrook & 
Rusell, 2001). 
l. Taq DNA Polymerase 
Taq DNA polymerase, a 95-kDa single polypeptide chain is used in 
Polymerase Chain Reaction (PCR). Taq DNA polymerase is a thermostable 
DNA polymerase, named after the thermophilic eubacterium Thermus 
aquaticus BM from which it was originally isolated and possesses a ĺ
polymerase activity and a double stranded specific ĺ  exonuclease 
activity but lacks  a ĺexonuclease activity (Chien et al., 1976; Lawyer 
et al., 1993; Tindall & Kunkel, 1988). It was supplied with a 10× standard Taq 
reaction (PCR) buffer with magnesium chloride (MgCl2). 
m. ([SDQG+LJK)LGHOLW\3&5System 
7KH ([SDQG +LJK )LGHOLW\ +L)L 3&5 System, from Roche Diagnostics, is 
used in high fidelity PCR amplification. 7KH ([SDQG +LJK )LGHOLW\ 3&5
System is composed of a mixture of Taq DNA polymerase and Tgo DNA 
polymerase, which has a ĺexonuclease activity. The combined effect of 
the proofreading activities of the Taq and the Tgo DNA polymerases is the 
generation of longer (3-27kb) PCR products of 3-fold yield, with high fidelity 
and high specificity from all types of DNA compared with a conventional Taq 
DNA polymerase alone (Barnes, 1992; Barnes, 1994). 
3.2 Culture Media 
vii. LB Media 
Premade Luria-Bertani (LB), according to the Miller recipe, is prepared by 
dissolving 10 g of tryptone, 5 g of yeast extract and 10 g of NaCl in 1 litre of 
distilled water (Miller, 1972). The broth is then sterilized by autoclaving at 
121°C, 15 lb. inch-2 for 15 min. 
LB agar is made in an identical fashion except for the addition of 1% (w/v) 
agar to LB broth prior to autoclave sterilization. Following cooling to 
approximately 40°C, any necessary antibiotics are added and the agar 
transferred to Petri dishes. 
LB has been in use since time immemorial and continues to be one of the most 
commonly used media in molecular biology applications for the maintenance 
and propagation of recombinant strains of Escherichia coli (Anderson, 1946; 
Bertani, 2004). According to Giuseppe Bertani, the acronym LB was 
originally intended to stDQGIRU³O\VRJHQ\EURWK´(Bertani, 2004). However, it 
has been variously interpreted, perhaps flatteringly, but incorrectly, as Luria 
broth, Lennox broth, or Luria-Bertani media (Bertani, 1951; Lennox, 1955; 
Luria & Burrous, 1957). The low salt formulations, Lennox (5 g/l NaCl) and 
Luria (0.5 g/l NaCl), are ideal for cultures requiring salt-sensitive antibiotics 
media (Bertani, 1951; Lennox, 1955; Luria & Burrous, 1957). 
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3.3 Complementary Experiments [By Ashgar & Oldfield, Ashgar et al. 2007] 
The following characterization experiments were carried out by Sammi Ashgar 
and Neil Oldfield. These experiments are therefore mentioned here to fill in the 
gaps in this chapter. Detailed descriptions of the procedures are given in Ashgar et 
al. 2007. 
 
i. Cloning of Truncated-forms of capA 
Two fragments of the capA gene, corresponding to the upstream and the 
downstream open reading frames (ORFs) Cj0628 and Cj0629, were amplified 
by PCR from nucleotide positions 114-1115 and 751-3413 using C. jejuni 
NCTC11168 genomic DNA and ORF-specific primers capA_F1/capA_R1 and 
capA_F2/capA_R2 respectively (Table 4.1). Using 1 µl of cDNA preparations 
for the PCR amplification reaction, a 50-µl reaction mixture contained 0.2 µM 
each of capA_F1/capA_R1 or capA_F2/capA_R2, 0.2 µM dNTPs, 5 µl of 10 
× PCR buffer (Roche), 0.25 mM MgCl2, and 4 U Biotaq (Roche). The reaction 
conditions were as follows: 95°C for 2 min, followed by 35 cycles of 94°C for 
30 s, 55°C for 30 s, and 68°C for 60 s, and a terminal extension step at 68°C 
for 5 min. PCR products were then analyzed by gel electrophoresis using 
ethidium bromide staining.  
The resulting PCR products were labelled as truncated capA and truncated 
capAB, trcapA/trcapAB respectively. The PCR products were ligated into 
pMAL-&[YHFWRU1(%DFFRUGLQJWRPDQXIDFWXUHU¶VLQVWUXFWLRQVJHQHUDWLQJ
two recombinant genes pMAL-trcapA and pMAL-trcapAB respectively. 
ii. Expression and Purification of Recombinant CapA Proteins 
The resulting recombinant capA gene products, pMAL-trcapA and pMAL-
trcapAB, encoded maltose-binding protein (MBP) fusions, MBP-trCapA and 
MBP-trCapAB, with calculated molecular masses of ca. 35 and 102 kDa 
respectively, compared to the full-length CapA protein of ca. 120 kDa. 
pMAL-trCapA and pMAL-trCapAB represented amino acid (aa) 38-372 and 
243-1144 respectively on the capA gene, Cj0608/Cj0629.  
E. coli JM83 cells harbouring either pMAL-trCapA or pMAL-trCapAB were 
cultured in LB broth to mid-log phase, and then induced using isopropyl-ȕ-D-
thiogalactopyranoside (IPTG). Cells were grown for a further 4 h and then 
harvested by centrifugation at 4000 × g. Recombinant fusion proteins were 
affinity purified using amylase-resin columns (NEB), and further purified by 
electro-elution SDS-PAGE as described above. 
iii. Mutagenesis of capA and capB  
C. jejuni single-knockout mutants for capA and capB (11168capA and 
11168capB, respectively), as well as a double mutant (11168capAcapB) in 
which both genes were disrupted, were constructed to serve as controls for 
expression studies and for phenotypic studies. Each gene was disrupted by 
insertion of either a kanamycin or a chloramphenicol resistance cassette 
toward the beginning of the structural gene. Successful insertion of the 
respective antibiotic genes at the intended locations was confirmed by PCR 
and sequencing (Ashgar et al., 2007). 
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iv. Cloning and Expression of CapB 
Two fragments of the capB gene, corresponding to the upstream and the 
downstream open reading frames (ORFs) Cj1677 and Cj1678 respectively, 
were amplified by PCR, cloned into the pMAL-C2x vector, expressed as 
MBP-trCapB, or MBP-trCapAB and used to raise rabbit anti-serum against the 
recombinant proteins. MBP-trCapAB obtained from capA and capB genes 
were identical due to the 100% homology between the C-terminal two-thirds 
of the two genes. 
v. Generation of Rabbit Anti-serum against Recombinant CapA Proteins 
New Zealand white female rabbits New Zealand white female rabbits were 
immunized four times at 2-week intervals with ca. 30 µg of purified MBP-
trCapA, or MBP-WU&DS$% HPXOVLILHG LQ )UHXQG¶V FRPSOHWH ILUVW
immunization only) or incomplete adjuvant. The animals were test bled 7 days 
after the third dose and sacrificed 10 days after the final inoculation to 
JHQHUDWH UDEELW DQWLVHUXP DJDLQVW &DS$ RU &DS$% >5Į&DS$% RU 5Į&DS$@
Pre-immune sera were obtained prior to immunization for comparison.  
Before use in immunoblotting experiments and other immuno-related 
experiments the sera were pre-adsorbed overnight at 4°C with a 20% (vol/vol) 
suspension of C. jejuni mutant 11168capA (for rabbit antiserum against 
&DS$% >5Į&DS$%@ RU 5Į&DS$ FHOOV JURZQ LQ 0+ EURWK EHIRUH EHLQJ
cleared by centrifugation and filtration as previously described. 
vi. Southern Blotting 
Using GeneImages random prime labeling and CDP-star detection modules 
(Amersham) HindIII-digested genomic DNA of C. jejuni NCTC11168, 
southern blotting was carried out with capA-specific probes. 
vii. Sub-cellular Fractionation 
To determine the cellular localization of CapA, C. jejuni cells [wild type, 
CapA-carrying type and CapA null-mutant] were cultured in MH broth as 
described and then fractionated into the various sub-cellular fractions [secreted 
proteins, outer membrane, cytoplasmic membrane, periplasmic and cytosolic 
fractions]. These fractions were analyzed by SDS-PAGE and immunoblotting. 
viii. Electron Microscopy and Immunogold Labelling 
C. jejuni cells were cultured as described and prepared for immunogold 
staining and electron microscopy using JOEL JEM1010 electron microscope. 
Pre-DGVRUEHG5Į&DS$ZDVXVHGDVSULPDU\DQWLERG\ZLWKSUHLPPXQHVHUXP
from the same rabbit as negative control. 
ix. In vitro Association and Invasion Assays 
Association and invasion assays were carried out using Caco2 cells grown in 
'XOEHFFR¶VPRGLILHd eagle medium (DMEM; Invitrogen) and C. jejuni cells 
cultured as described. 
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x. Chicken Colonization 
Using day-of-hatch specific-pathogen-free Rhode Island Red chicks, 
colonization assays were carried out to determine the influence of CapA on 
chicken colonization (Ashgar et al., 2007; Velayudhan et al., 2004). 
 
